CCAP 10-Q Quarterly Report Sept. 30, 2021 | Alphaminr
Crescent Capital BDC, Inc.

CCAP 10-Q Quarter ended Sept. 30, 2021

CRESCENT CAPITAL BDC, INC.
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
10-Q 1 d205002d10q.htm 10-Q 10-Q
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended September 30, 2021

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission file number 814-01132

Crescent Capital BDC, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Maryland 47-3162282

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

11100 Santa Monica Blvd., Suite 2000, Los Angeles, CA 90025
(Address of Principal Executive Offices) (Zip Code)

Registrant’s Telephone Number, Including Area Code: (310) 235-5900

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol

Name of each exchange on which registered

Common Stock, $0.001 par value per share CCAP The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ☐    No  ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ☐    No  ☒

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit files).    Yes  ☐    No  ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer Accelerated filer
Non-Accelerated filer Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).    Yes  ☐    No  ☒

The number of shares of the Registrant’s common stock, $.001 par value per share, outstanding at November 10, 2021 was 28,167,360


Table of Contents

CRESCENT CAPITAL BDC, INC.

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2021

Table of Contents

INDEX

PAGE
NO.

PART I.

FINANCIAL INFORMATION 2

Item 1.

Financial Statements 2
Consolidated Statements of Assets and Liabilities as of September 30, 2021 (Unaudited) and December 31, 2020 2
Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020 (Unaudited) 3
Consolidated Statements of Changes in Net Assets for the three and nine months ended September 30, 2021 and 2020 (Unaudited) 4
Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020 (Unaudited) 6
Consolidated Schedule of Investments as of September 30, 2021 (Unaudited) 7
Consolidated Schedule of Investments as of December 31, 2020 25
Notes to Consolidated Financial Statements (Unaudited) 44

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations 72

Item 3.

Quantitative and Qualitative Disclosures About Market Risk 86

Item 4.

Controls and Procedures 87

PART II.

OTHER INFORMATION 88

Item 1.

Legal Proceedings 88

Item 1A

Risk Factors 88

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds 88

Item 3.

Defaults Upon Senior Securities 89

Item 4.

Mine Safety Disclosures 89

Item 5.

Other Information 89

Item 6.

Exhibits 90


Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about us, our current or prospective portfolio investments, our industry, our beliefs, and our assumptions. We believe that it is important to communicate our future expectations to our investors. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “would,” “will,” “should,” “targets,” “projects,” and variations of these words and similar expressions identify forward-looking statements, although not all forward-looking statements include these words. These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and are difficult to predict, that could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

The following factors and factors listed under “Risk Factors” in this report and other documents Crescent Capital BDC, Inc. has filed with the Securities and Exchange Commission, or SEC, provide examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements. The occurrence of the events described in these risk factors and elsewhere in this report could have a material adverse effect on our business, results of operation and financial position. The following factors are among those that may cause actual results to differ materially from our forward-looking statements:

uncertainty surrounding the financial stability of the United States, Europe and China;

the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments;

potential fluctuation in quarterly operating results;

potential impact of economic recessions or downturns;

adverse developments in the credit markets;

regulations governing our operation as a business development company;

operation in a highly competitive market for investment opportunities;

changes in interest rates may affect our cost of capital and net investment income;

the impact of changes in London Interbank Offered Rate (“LIBOR”) on our operating results;

financing investments with borrowed money;

potential adverse effects of price declines and illiquidity in the corporate debt markets;

the impact of COVID-19 on our portfolio companies and the markets in which they operate, interest rates and the economy in general;

lack of liquidity in investments;

the outcome and impact of any litigation;

the timing, form and amount of any dividend distributions;

risks regarding distributions;

potential adverse effects of new or modified laws and regulations;

the social, geopolitical, financial, trade and legal implications of Brexit;

potential resignation of the Adviser and or the Administrator;

uncertainty as to the value of certain portfolio investments;

defaults by portfolio companies;

our ability to successfully complete and integrate any acquisitions;

risks associated with original issue discount (“OID”) and payment-in-kind (“PIK”) interest income; and

the market price of our common stock may fluctuate significantly.

Although we believe that the assumptions on which these forward-looking statements are based upon are reasonable, some of those assumptions may be based on the work of third parties and any of those assumptions could prove to be inaccurate; as a result, forward-looking statements based on those assumptions also could prove to be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this report should not be regarded as a representation by us that our plans and objectives will be achieved. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this report. We do not undertake any obligation to update or revise any forward-looking statements or any other information contained herein, except as required by applicable law. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which preclude civil liability for certain forward-looking statements, do not apply to the forward-looking statements in this report because we are an investment company.

1


Table of Contents

Crescent Capital BDC, Inc.

Consolidated Statements of Assets and Liabilities

(in thousands, except share and per share data)

As of
September 30, 2021

(Unaudited)
As of
December 31,
2020

Assets

Investments, at fair value

Non-controlled non-affiliated (cost of $1,030,512 and $920,693, respectively)

$ 1,047,087 $ 923,912

Non-controlled affiliated (cost of $42,997 and $50,431, respectively)

51,336 71,354

Controlled (cost of $40,000 and $40,000, respectively)

40,207 38,735

Cash and cash equivalents

6,467 1,896

Restricted cash and cash equivalents

13,027 12,953

Receivable for investments sold

15,302 6

Interest and dividend receivable

7,581 3,859

Unrealized appreciation on foreign currency forward contracts

1,915 264

Deferred tax assets

54 630

Other assets

210 543

Total assets

$ 1,183,186 $ 1,054,152

Liabilities

Debt (net of deferred financing costs of $4,830 and $4,600)

$ 557,071 $ 471,932

Distributions payable

11,549 11,549

Incentive fees payable

7,882

Interest and other debt financing costs payable

3,503 3,923

Management fees payable

3,055 1,867

Deferred tax liabilities

1,079 1,324

Unrealized depreciation on foreign currency forward contracts

587 896

Directors’ fees payable

127 98

Accrued expenses and other liabilities

2,181 2,563

Total liabilities

$ 587,034 $ 494,152

Commitments and Contingencies (Note 8)

Net assets

Preferred stock, par value $0.001 per share (10,000 shares authorized, zero outstanding, respectively) $ $
Common stock, par value $0.001 per share (200,000,000 shares authorized, 28,167,360 shares issued and outstanding, respectively) 28 28

Paid-in capital in excess of par value

594,658 594,658

Accumulated earnings (loss)

1,466 (34,686 )

Total net assets

$ 596,152 $ 560,000

Total liabilities and net assets

$ 1,183,186 $ 1,054,152

Net asset value per share

$ 21.16 $ 19.88

See accompanying notes

2


Table of Contents

Crescent Capital BDC, Inc.

Consolidated Statements of Operations

(in thousands, except share and per share data)

(Unaudited)

For the three
months ended
September 30,
For the nine
months ended
September 30,
2021 2020 2021 2020

Investment Income:

From non-controlled non-affiliated investments:

Interest income

$ 22,232 $ 16,132 $ 60,570 $ 48,424

Paid-in-kind interest

184 501 966 1,747

Dividend income

1,373 7 1,427 182

Other income

254 577 1,060

From non-controlled affiliated investments:

Interest income

305 338 904 1,009

Paid-in-kind interest

139 485 1,168 970

Dividend income

291 511 2,134 1,940

From controlled investments:

Dividend income

700 700 2,100 1,500

Total investment income

25,478 18,674 69,846 56,832

Expenses:

Interest and other debt financing costs

5,695 3,504 14,482 11,484

Management fees

3,531 2,909 10,082 8,327

Income based incentive fees

2,663 2,136 7,528 6,335

Capital gains based incentive fees

757 6,150

Professional fees

522 354 1,516 1,060

Directors’ fees

127 100 361 339

Other general and administrative expenses

692 631 2,076 1,852

Total expenses

13,987 9,634 42,195 29,397

Management fee waiver

(476 ) (1,163 ) (3,096 ) (3,427 )

Income based incentive fees waiver

(931 ) (2,136 ) (5,796 ) (6,335 )

Net expenses

12,580 6,335 33,303 19,635

Net investment income before taxes

12,898 12,339 36,543 37,197

Income and excise taxes

170 131 1,403 480

Net investment income

12,728 12,208 35,140 36,717

Net realized and unrealized gains (losses) on investments:

Net realized gain (loss) on:

Non-controlled non-affiliated investments

280 2 4,497 (1,021 )

Non-controlled affiliated investments

27,513 (526 ) 27,513 (526 )

Foreign currency transactions

80 6 359 (155 )

Foreign currency forward contracts

(56 ) (193 )

Net change in unrealized appreciation (depreciation) on:

Non-controlled non-affiliated investments and foreign currency translation

2,897 19,051 13,336 (20,274 )

Non-controlled affiliated investments

(28,198 ) 5,694 (12,583 ) 14,086

Controlled investments

302 3,416 1,472 (5,513 )

Foreign currency forward contracts

1,523 (1,349 ) 1,959 623

Net realized and unrealized gains (losses) on investments

4,341 26,294 36,360 (12,780 )

Realized loss on asset acquisition

(3,825 )

Net realized and unrealized gains (losses) on investments and asset acquisition

4,341 26,294 36,360 (16,605 )

Benefit (provision) for taxes on realized gain on investments

2 (370 )

Benefit (provision) for taxes on unrealized appreciation (depreciation) on investments

(392 ) (161 ) (332 ) 101

Net increase (decrease) in net assets resulting from operations

$ 16,679 $ 38,341 $ 70,798 $ 20,213

Per common share data:

Net increase (decrease) in net assets resulting from operations per share (basic and diluted):

$ 0.59 $ 1.36 $ 2.51 $ 0.73

Net investment income per share (basic and diluted):

$ 0.45 $ 0.43 $ 1.25 $ 1.33

Weighted average shares outstanding (basic and diluted):

28,167,360 28,167,360 28,167,360 27,518,708

See accompanying notes

3


Table of Contents

Crescent Capital BDC, Inc.

Consolidated Statements of Changes in Net Assets

(in thousands, except share and per share data)

(Unaudited)

Common Stock
Shares Par Amount Paid in Capital
in

Excess of Par
Value
Accumulated
Loss
Total
Net Assets

Balance at June 30, 2021

28,167,360 $ 28 $ 594,658 $ (3,664 ) $ 591,022

Net increase (decrease) in net assets resulting from operations:

Net investment income

12,728 12,728
Net realized gain (loss) on investments, foreign currency transactions and foreign currency forwards 27,817 27,817
Net change in unrealized appreciation (depreciation) on investments, foreign currency forward contracts and foreign currency translation (23,476 ) (23,476 )
Benefit (provision) for taxes on realized gain on investments 2 2
Benefit (provision) for taxes on unrealized appreciation/(depreciation) on investments (392 ) (392 )
Stockholder distributions:
Distributions to stockholders (11,549 ) (11,549 )

Total increase (decrease) for the three months ended September 30, 2021 $ $ $ 5,130 $ 5,130

Balance at September 30, 2021 28,167,360 $ 28 $ 594,658 $ 1,466 $ 596,152

Distributions declared per share $ 0.41
Balance at December 31, 2020 28,167,360 $ 28 $ 594,658 $ (34,686 ) $ 560,000
Net increase (decrease) in net assets resulting from operations:

Net investment income 35,140 35,140
Net realized gain (loss) on investments, foreign currency transactions and foreign currency forwards 32,176 32,176
Net change in unrealized appreciation (depreciation) on investments, foreign currency forward contracts and foreign currency translation 4,184 4,184
Benefit (provision) for taxes on realized gain on investments (370 ) (370 )
Benefit (provision) for taxes on unrealized appreciation/(depreciation) on investments (332 ) (332 )
Stockholder distributions:
Distributions to stockholders (34,646 ) (34,646 )

Total increase (decrease) for the nine months ended September 30, 2021 $ $ $ 36,152 $ 36,152

Balance at September 30, 2021

28,167,360 $ 28 $ 594,658 $ 1,466 $ 596,152

Distributions declared per share

$ 1.23

See accompanying notes

4


Table of Contents

Crescent Capital BDC, Inc.

Consolidated Statements of Changes in Net Assets

(in thousands, except share and per share data)

(Unaudited)

Common Stock
Shares Par Amount Paid in Capital
in
Excess of Par
Value
Accumulated
Loss
Total
Net Assets

Balance at June 30, 2020

28,167,360 $ 28 $ 558,913 $ (48,643 ) $ 510,298

Net increase (decrease) in net assets resulting from operations:

Net investment income

12,208 12.208
Net realized gain (loss) on investments and foreign currency transactions (518 ) (518 )
Net change in unrealized appreciation (depreciation) on investments, foreign currency forward contracts and foreign currency translation 26,812 26,812
Benefit/(Provision)) for taxes on unrealized appreciation/(depreciation)) on investment ( 161 ) (161 )
Stockholder distributions:

Distributions to stockholders

(11,549 ) (11,549 )

Total increase (decrease) for the three months ended September 30, 2020

26,792 26,792

Balance at September 30, 2020

28,167,360 $ 28 $ 558,913 $ (21,851 ) $ 537,090

Distributions declared

$ 0.41

Balance at December 31, 2019

20,862.314 $ 21 $ 414,293 $ (7,397 ) $ 406,917

Net increase (decrease) net assets resulting from operations:

Net investment income

36.717 36.717
Net realized gain (loss) on investments and foreign currency transactions (1,702 ) (1,702 )
Net change in unrealized appreciation (depreciation) on investments. foreign currency Forward contracts and foreign currency translation (11,078 ) (11,078 )
Realized loss on asset acquisition (3,825 ) (3,825 )
Benefit/(Provision) for taxes on unrealized appreciation/(depreciation) on investments 101 101
Stockholder distributions:
Issuance of common stock 2,265,021 2 44,293 44,297
Issuance in connection with asset acquisition (Note 13) 5,202.312 5 101,944 101.949
Issuance of common shares pursuant to dividend reinvestment plan 30,128 589 589

Repurchase of common stock

(192,415 ) (2.208 ) (2.208 )

Distributions to stockholders

(34,667 ) (34,667 )

Total increase (decrease) for the nine months ended September 30, 2020 7,305,046 7 144,620 (14,454 ) 130,173

Balance at September 30, 2020

28,167,360 $ 28 $ 558,913 $ (21,851 ) $ 537,090

Distributions declared

$ 1.23

See accompanying notes

5


Table of Contents

Crescent Capital BDC, Inc.

Consolidated Statements of Cash Flows

(in thousands, except share and per share data)

(Unaudited)

For the nine months ended September 30,
2021 2020

Cash flows from operating activities:

Net increase (decrease) in net assets resulting from operations

70,798 20,213
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used for) operating activities:

Purchases of investments

(367,663 ) (228,280 )

Paid-in-kind interest income

(2,372 ) (2,717 )

Proceeds from sales of investments and principal repayments

309,592 182,275

Net realized (gain) loss on investments, foreign currency transactions and foreign currency forwards

(32,652 ) 1,903

Realized loss on asset acquisition (2)

3,825

Acquisition of Alcentra Capital Corporation, net of cash acquired (2)

(12,884 )

Net change in unrealized (appreciation) depreciation on investments and foreign  currency translation

(2,225 ) 11,701

Net change in unrealized (appreciation) depreciation on foreign currency forward contracts

(1,959 ) (623 )

Amortization of premium and accretion of discount, net

(9,289 ) (3,714 )

Amortization of deferred financing costs

1,956 985

Change in operating assets and liabilities:

(Increase) decrease in receivable for investments sold

(15,296 ) (515 )

(Increase) decrease in interest receivable

(3,722 ) 232

(Increase) decrease in deferred tax asset

576 (355 )

(Increase) decrease in other assets

333 2,421

Increase (decrease) in management fees payable

1,188 403

Increase (decrease) in incentive fees payable

7,882

Increase (decrease) in directors’ fees payable

29 26

Increase (decrease) in interest and other debt financing costs payable

(420 ) (1,286 )

Increase (decrease) in deferred tax liability

(245 ) 254

Increase (decrease) in accrued expenses and other liabilities

(382 ) (1,116 )

Net cash provided by (used for) operating activities

$ (43,871 ) $ (27,252 )

Cash flows from financing activities:

Issuance of common stock

44,297

Repurchase of common stock

(2,208 )

Deferred financing and debt issuance costs paid

(2,186 ) (2,199 )

Distributions paid

(34,646 ) (31,083 )

Borrowings on credit facilities

332,737 279,592

Repayments on credit facilities

(365,950 ) (229,127 )

Issuance of unsecured debt

135,000

Repayments on InterNotes ®

(16,418 ) (33,853 )

Net cash provided by (used for) financing activities

48,537 25,419

Effect of exchange rate changes on cash denominated in foreign currency

(21 ) (25 )

Net increase (decrease) in cash, cash equivalents, restricted cash and foreign currency

4,645 (1,858 )

Cash, cash equivalents, restricted cash and foreign currency, beginning of period

14,849 13,427

Cash, cash equivalents, restricted cash and foreign currency, end of period (1)

$ 19,494 $ 11,569

Supplemental and non-cash financing activities:

Cash paid during the period for interest

$ 12,325 $ 11,407

Issuance of common stock pursuant to dividend reinvestment plan

$ 589

Accrued but unpaid distributions

$ 11,549 $ 11,549

Issuance of shares in connection with asset acquisition (Note 13)

101,949

(1)

As of September 30, 2021, the balance included cash and cash equivalents of $6,467 (including cash denominated in foreign currency of $1,899) and restricted cash and cash equivalents of $13,027 (including cash denominated in foreign currency of $131). As of September 30, 2020, the balance included cash and cash equivalents of $3,047 (including cash denominated in foreign currency of $861) and restricted cash and cash equivalents of $8,522, respectively.

(2)

After the close of business on January 31, 2020, in connection with the Alcentra Acquisition (as defined in Note 1 and further discussed in Note 13), the Company acquired net assets of $114,431 which included $195,682 of investments, $3,409 cash and cash equivalents and $1,398 of other assets, net of $86,058 of assumed liabilities, for the total cash and stock consideration of $118,256, inclusive of $7,250 of asset acquisition costs.

See accompanying notes

6


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Investments (1)(2)

United States

Debt Investments

Automobiles & Components

Auto-Vehicle Parts, LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

01/2023 $ $ (2 ) % $

Auto-Vehicle Parts, LLC (6)

Senior Secured First Lien Term Loan


L + 550
(100 Floor)

(7)
6.50 % 01/2023 4,529 4,510 0.8 4,529

Auto-Vehicle Parts, LLC (6)

Senior Secured First Lien Term Loan


L + 550
(100 Floor)

(7)
6.50 % 01/2023 2,294 2,270 0.4 2,294

Continental Battery Company (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor)

(7)
7.00 % 01/2027 7,285 7,152 1.2 7,299

Continental Battery Company (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

01/2027 (24 ) 0.0 5

Empire Auto Parts, LLC (6)

Unitranche First Lien Term Loan


L + 550
(100 Floor)

(8)
6.50 % 09/2024 2,352 2,324 0.4 2,352

Empire Auto Parts, LLC (6)

Unitranche First Lien Term Loan


L + 550
(100 Floor)

(8)
6.50 % 09/2024 2,425 2,400 0.4 2,425

Empire Auto Parts, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

09/2024 (4 )

Sun Acquirer Corp. (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 575
(75 Floor)

(8)
6.50 % 09/2028 1,359 1,250 0.2 1,359

Sun Acquirer Corp. (3)(4)(5)(6)

Unitranche First Lien Revolver

09/2028 (36 )

Sun Acquirer Corp. (6)

Unitranche First Lien Term Loan


L + 575
(75 Floor)

(8)
6.50 % 09/2028 13,043 12,785 2.2 13,043

33,287 32,625 5.6 33,306

Capital Goods

Envocore Holding, LLC (6)

Senior Secured First Lien Term Loan




L + 750
(200 Floor)
(including
150 PIK)



(8)
11.00 % 06/2022 18,619 15,971 2.1 12,361

Painters Supply & Equipment Company (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

08/2027 (9 ) (9 )

Painters Supply & Equipment Company (3)(4)(5)(6)

Unitranche First Lien Revolver

08/2027 (10 ) (5 )

Painters Supply & Equipment Company (6)

Unitranche First Lien Term Loan


L + 575
(100 Floor) (7)

6.75 % 08/2027 2,050 2,009 0.3 2,030

Potter Electric Signal Company (5)(6)(9)

Senior Secured First Lien Delayed Draw Term Loan


L + 425
(100 Floor)

(8)
5.25 % 12/2025 848 834 0.1 846

Potter Electric Signal Company (3)(4)(5)

Senior Secured First Lien Revolver

12/2024 (3 ) (2 )

Potter Electric Signal Company (6)

Senior Secured First Lien Term Loan


L + 425
(100 Floor)

(8)
5.25 % 12/2025 2,461 2,445 0.4 2,455

Potter Electric Signal Company (6)

Senior Secured First Lien Term Loan


L + 425
(100 Floor)

(8)
5.25 % 12/2025 468 465 0.1 466

24,446 21,702 3.0 18,142

Commercial & Professional Services

ASP MCS Acquisition Corp. (6)(10)

Senior Secured Second Lien Term Loan


L + 600
(100 Floor)

(8)
7.00 % 10/2025 293 272 0.0 289

Battery Solutions, Inc. (6)(10)

Unsecured Debt

1400 PIK (11) 14.00 % 06/2023 1,387 1,378 0.2 1,306

See accompanying notes

7


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Battery Solutions, Inc. (6)(10)

Unsecured Debt

1400 PIK (11) 14.00 % 06/2023 370 370 0.1 348

CHA Holdings, Inc. (6)

Senior Secured First Lien Delayed Draw Term Loan


L + 450
(100 Floor) (8)

5.50 % 04/2025 1,005 1,002 0.2 954

CHA Holdings, Inc. (6)

Senior Secured First Lien Term Loan


L + 450
(100 Floor) (8)

5.50 % 04/2025 4,765 4,753 0.8 4,527

Consolidated Label Co., LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

07/2026 (10 ) (1 )

Consolidated Label Co., LLC (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (8)

6.00 % 07/2026 4,317 4,246 0.7 4,313

Consolidated Label Co., LLC (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (8)

6.00 % 07/2026 3,840 3,768 0.6 3,836

GH Parent Holdings Inc. (6)

Unitranche First Lien Term Loan


L + 550
(100 Floor) (7)

6.50 % 05/2027 13,175 12,985 2.2 13,057

GH Parent Holdings Inc. (4)(5)(6)

Unitranche First Lien Revolver


L + 550
(100 Floor) (7)

6.50 % 05/2027 208 179 0.0 190

GH Parent Holdings Inc. (5)(6)

Unitranche First Lien Delayed Draw Term Loan

05/2027 (50 )

Hepaco, LLC (6)

Senior Secured First Lien Delayed Draw Term Loan




L + 500
(100 Floor)
(including
50 PIK) (7)



6.50 % 08/2024 4,131 4,110 0.6 3,866

Hepaco, LLC (6)

Senior Secured First Lien Term Loan




L + 500
(100 Floor)
(including
50 PIK) (7)



6.50 % 08/2024 5,065 5,040 0.8 4,741

Hepaco, LLC (4)(5)(6)

Senior Secured First Lien Revolver




L + 500
(100 Floor)
(including
50 PIK) (7)



6.50 % 08/2024 765 765 0.1 706

Hercules Borrower LLC (6)

Unitranche First Lien Term Loan


L + 650
(100 Floor) (8)

7.50 % 12/2026 19,030 18,615 3.4 19,409

Hercules Borrower LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

12/2026 (48 ) 44

Hercules Borrower LLC (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

12/2026

Hercules Borrower LLC (6)

Unitranche First Lien Term Loan


L + 550
(100 Floor) (8)

6.50 % 12/2026 247 242 0.0 247

Hsid Acquisition, LLC (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (7)

6.00 % 01/2026 3,834 3,776 0.6 3,834

Hsid Acquisition, LLC (6)

Senior Secured First Lien Delayed Draw Term Loan


L + 500
(100 Floor) (7)

6.00 % 01/2026 2,871 2,829 0.5 2,871

Hsid Acquisition, LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

01/2026 (11 )

Hsid Acquisition, LLC (6)

Senior Secured First Lien Term Loan


L + 475
(100 Floor) (7)

5.75 % 01/2026 250 245 0.0 250

ISS Compressors Industries, Inc. (3)(4)(5)(6)

Senior Secured First Lien Revolver

02/2026 (6 ) (19 )

ISS Compressors Industries, Inc. (6)

Senior Secured First Lien Term Loan


L + 550
(100 Floor) (8)

6.50 % 02/2026 8,988 8,922 1.5 8,779

MHS Acquisition Holdings, LLC (6)

Unsecured Debt

1350 PIK (11) 13.50 % 03/2026 214 206 0.0 214

MHS Acquisition Holdings, LLC (6)

Unsecured Debt

1350 PIK (11) 13.50 % 03/2026 644 640 0.1 644

MHS Acquisition Holdings, LLC (5)(6)(9)

Senior Secured First Lien Delayed Draw Term Loan


L + 575
(100 Floor) (8)

6.75 % 07/2027 11 9 0.0 11

MHS Acquisition Holdings, LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

07/2027 (3 )

MHS Acquisition Holdings, LLC (6)

Senior Secured First Lien Term Loan


L + 575
(100 Floor) (8)

6.75 % 07/2027 1,728 1,694 0.3 1,728

See accompanying notes

8


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Nexant Volt MergerSub, Inc. (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (8)

6.00 % 05/2027 5,686 5,575 1.0 5,686

Nexant Volt MergerSub, Inc. (4)(5)(6)

Senior Secured First Lien Revolver


L + 500
(100 Floor) (8)

6.00 % 05/2027 335 325 0.1 335

Pinstripe Holdings, LLC (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (8)

7.00 % 01/2025 9,750 9,584 1.6 9,652

Pye-Barker Fire & Safety, LLC (6)

Unitranche First Lien Delayed Draw Term Loan


L + 600
(100 Floor) (8)

7.00 % 11/2025 4,981 4,892 0.8 5,030

Pye-Barker Fire & Safety, LLC (6)

Unitranche First Lien Delayed Draw Term Loan


L + 600
(100 Floor) (8)

7.00 % 11/2025 3,705 3,620 0.6 3,742

Pye-Barker Fire & Safety, LLC (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (8)

7.00 % 11/2025 9,948 9,740 1.7 10,047

Pye-Barker Fire & Safety, LLC (4)(5)(6)

Unitranche First Lien Delayed Draw Term Loan


L + 575
(75 Floor)

6.50 % 11/2025 1,188 1,157 0.2 1,188

Receivable Solutions, Inc. (3)(4)(5)(6)

Senior Secured First Lien Revolver

10/2024 (3 )

Receivable Solutions, Inc. (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (7)

6.00 % 10/2024 1,837 1,816 0.3 1,837

Receivable Solutions, Inc. (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (7)

6.00 % 10/2024 718 706 0.1 718

SavATree, LLC (6)

Senior Secured First Lien Delayed Draw Term Loan


L + 525
(100 Floor) (8)

6.25 % 06/2022 888 885 0.1 888

SavATree, LLC (6)

Senior Secured First Lien Term Loan


L + 525
(100 Floor) (8)

6.25 % 06/2022 3,880 3,868 0.7 3,880

SavATree, LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

06/2022 (1 )

Seko Global Logistics Network, LLC (4)(5)(6)(17)

Senior Secured First Lien Revolver

12/2026 (13 )

Seko Global Logistics Network, LLC (6)(17)

Senior Secured First Lien Term Loan


L + 500
(100 Floor)

6.00 % 12/2026 5,050 4,974 0.8 5,000

Service Logic Acquisition, Inc. (6)

Senior Secured Second Lien Term Loan


L + 850
(100 Floor) (8)

9.50 % 10/2028 8,755 8,515 1.5 9,018

Service Logic Acquisition, Inc. (3)(5)(6)(9)

Senior Secured Second Lien Delayed Draw Term Loan

10/2028 (69 ) 73

Spear Education (3)(5)(6)(9)

Senior Secured First Lien Delayed Draw Term Loan

02/2025 (22 )

Spear Education (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (8)

6.00 % 02/2025 6,772 6,723 1.1 6,772

TecoStar Holdings, Inc. (6)

Senior Secured Second Lien Term Loan


L + 850
(100 Floor) (8)

9.50 % 11/2024 5,000 4,938 0.8 4,840

UP Acquisition Corp. (6)

Unitranche First Lien Delayed Draw Term Loan


L + 625
(100 Floor) (7)

7.25 % 05/2024 1,179 1,165 0.2 1,160

UP Acquisition Corp. (4)(5)(6)

Unitranche First Lien Revolver


L + 625
(100 Floor) (7)

7.25 % 05/2024 339 325 0.1 318

UP Acquisition Corp. (6)

Unitranche First Lien Term Loan


L + 625
(100 Floor) (7)

7.25 % 05/2024 4,301 4,251 0.7 4,232

Xcentric Mold and Engineering
Acquisition Company, LLC (6)

Senior Secured First Lien Revolver




L + 600
(100 Floor)
(including
100 PIK) (7)



8.00 % 01/2022 716 715 0.1 608

Xcentric Mold and Engineering
Acquisition Company, LLC (6)

Senior Secured First Lien Term Loan




L + 600
(100 Floor)
(including
100 PIK) (7)



8.00 % 01/2022 4,411 4,404 0.6 3,750

156,577 154,051 25.8 154,855

See accompanying notes

9


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Consumer Durables & Apparel

EiKo Global, LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

06/2023 (5 )

EiKo Global, LLC (6)

Senior Secured First Lien Term Loan


L + 600
(100 Floor) (8)

7.00 % 06/2023 3,142 3,116 0.5 3,142

3,142 3,111 0.5 3,142

Consumer Services

Everlast Parent Inc. (6)

Unitranche First Lien Term Loan


L + 650
(100 Floor) (8)

7.50 % 10/2026 13,923 13,618 2.3 13,819

Everlast Parent Inc. (3)(4)(5)(6)

Unitranche First Lien Revolver

10/2026 (34 ) (12 )

Everlast Parent Inc. (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

10/2026 (36 ) (26 )

HGH Purchaser, Inc. (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 625
(100 Floor) (8)

7.25 % 11/2025 989 969 0.2 1,023

HGH Purchaser, Inc. (6)

Unitranche First Lien Delayed Draw Term Loan


L + 625
(100 Floor) (8)

7.25 % 11/2025 3,348 3,269 0.6 3,381

HGH Purchaser, Inc. (3)(4)(5)(6)

Unitranche First Lien Revolver

11/2025 (17 ) 10

HGH Purchaser, Inc. (6)

Unitranche First Lien Term Loan


L + 625
(100 Floor) (8)

7.25 % 11/2025 7,966 7,820 1.3 8,046

Learn-It Systems, LLC (4)(5)(6)

Senior Secured First Lien Revolver


L + 450
(100 Floor) (13)

5.50 % 03/2025 150 132 0.0 143

Learn-It Systems, LLC (5)(6)(14)

Senior Secured First Lien Delayed Draw Term Loan


L + 450
(100 Floor) (8)

5.50 % 03/2025 2,544 2,491 0.4 2,524

Learn-It Systems, LLC (6)

Senior Secured First Lien Term Loan


L + 450
(100 Floor) (8)

5.50 % 03/2025 4,304 4,215 0.7 4,270

Learn-It Systems, LLC (3)(5)(6)(14)

Senior Secured First Lien Delayed Draw Term Loan

05/2023 (41 )

Southern HVAC Corporation (6)

Unitranche First Lien Term Loan


L + 625
(100 Floor) (8)

7.25 % 10/2025 7,215 7,091 1.2 7,287

Southern HVAC Corporation (4)(5)(6)

Unitranche First Lien Revolver


L + 625
(100 Floor) (8)

7.25 % 10/2025 329 312 0.1 339

Southern HVAC Corporation (6)

Unitranche First Lien Delayed Draw Term Loan


L + 625 (100
Floor) (8)

7.25 % 10/2025 2,444 2,410 0.4 2,468

Stepping Stones Healthcare Services, LLC (6)

Unitranche First Lien Term Loan


L + 625
(100 Floor) (8)

7.25 % 03/2027 5,871 5,790 1.0 5,871

Stepping Stones Healthcare Services, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

03/2026 (10 )

Stepping Stones Healthcare Services, LLC (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 625
(100 Floor) (8)

7.25 % 03/2027 253 242 0.0 253

United Language Group, Inc. (4)(6)

Senior Secured First Lien Revolver


L + 675
(100 Floor) (7)

7.75 % 12/2021 400 400 0.1 388

United Language Group, Inc. (6)

Senior Secured First Lien Term Loan


L + 675
(100 Floor) (7)

7.75 % 12/2021 4,605 4,601 0.7 4,468

WeddingWire, Inc.

Senior Secured Second Lien Term Loan

L + 825 (8) 8.38 % 12/2026 5,000 4,960 0.8 4,950

Wrench Group LLC (6)

Senior Secured Second Lien Term Loan

L + 788 (8) 8.01 % 04/2027 2,500 2,442 0.4 2,525

61,841 60,624 10.2 61,727

Energy

BJ Services, LLC (6)

Unitranche First Lien Term Loan


L + 700 (150
Floor) (8)

8.50 % 01/2023 1,195 1,191 0.2 1,195

See accompanying notes

10


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

BJ Services, LLC (6)(15)(16)

Unitranche First Lien—Last Out Term Loan

01/2023 8,075 8,014 0.9 5,507

Black Diamond Oilfiefld Rentals, LLC (6)

Senior Secured First Lien Term Loan


L + 950
(100 Floor) (8)

10.50 % 03/2022 9,533 9,533 1.6 9,294

18,803 18,738 2.7 15,996

Food & Staples Retailing

Isagenix International, LLC

Senior Secured First Lien Term Loan


L + 575
(100 Floor) (8)

6.75 % 06/2025 5,729 5,712 0.8 4,798

Food, Beverage & Tobacco

JTM Foods LLC (6)

Senior Secured First Lien Term Loan


L + 475
(100 Floor) (8)

5.75 % 05/2027 5,037 4,953 0.8 4,995

JTM Foods LLC (4)(5)(6)

Senior Secured First Lien Revolver


L + 475
(100 Floor) (8)

5.75 % 05/2027 160 147 0.0 153

JTM Foods LLC (3)(4)(5)(6)

Senior Secured First Lien Delayed Draw Term Loan

05/2027 (7 ) (6 )

Mann Lake Ltd. (4)(5)(6)

Senior Secured First Lien Revolver


L + 675
(100 Floor) (8)

7.75 % 10/2024 720 711 0.1 712

Mann Lake Ltd. (6)

Senior Secured First Lien Term Loan


L + 675
(100 Floor) (8)

7.75 % 10/2024 3,797 3,754 0.6 3,764

9,714 9,558 1.5 9,618

Health Care Equipment & Services

ACI Group Holdings, Inc. (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

08/2028 (25 )

ACI Group Holdings, Inc. (3)(4)(5)(6)

Unitranche First Lien Revolver

08/2027 (14 )

ACI Group Holdings, Inc. (6)

Unitranche First Lien Term Loan


L + 550
(75 Floor) (7)

6.25 % 08/2028 7,010 6,870 1.2 7,010

Advanced Diabetes Supply (6)

Senior Secured First Lien Term Loan


L + 525
(100 Floor) (8)

6.25 % 07/2025 3,750 3,714 0.6 3,713

Aegis Sciences Corporation (6)

Senior Secured First Lien Term Loan


L + 550
(100 Floor) (8)

6.50 % 05/2025 5,942 5,624 1.0 5,772

Ameda, Inc. (6)

Senior Secured First Lien Term Loan


L + 700
(100 Floor) (7)

8.00 % 09/2022 2,181 2,172 0.3 2,068

Ameda, Inc. (4)(5)(6)

Senior Secured First Lien Revolver


L + 700
(100 Floor) (7)

8.00 % 09/2022 188 186 0.0 172

Anne Arundel Dermatology Management, LLC (6)

Senior Secured First Lien Term Loan


L + 600
(100 Floor) (8)

7.00 % 10/2025 2,432 2,391 0.4 2,432

Anne Arundel Dermatology Management, LLC (4)(5)(6)

Senior Secured First Lien Revolver


L + 600
(100 Floor) (8)

7.00 % 10/2025 110 101 0.0 110

Anne Arundel Dermatology Management, LLC (5)(6)(9)

Senior Secured First Lien Delayed Draw Term Loan


L + 600
(100 Floor) (8)

7.00 % 10/2025 1,291 1,265 0.2 1,291

Avalign Technologies, Inc. (6)

Senior Secured First Lien Term Loan

L + 450 (8) 4.63 % 12/2025 16,708 16,602 2.8 16,457

Centria Subsidiary Holdings, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

12/2025 (41 ) 9

See accompanying notes

11


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Centria Subsidiary Holdings, LLC (6)

Unitranche First Lien Term Loan


L + 575
(100 Floor) (8)

6.75 % 12/2025 11,664 11,409 2.0 11,718

CRA MSO, LLC (6)

Senior Secured First Lien Term Loan


L + 700
(100 Floor) (7)

8.00 % 12/2023 1,216 1,204 0.2 1,188

CRA MSO, LLC (4)(5)(6)

Senior Secured First Lien Revolver


L + 700
(100 Floor) (7)

8.00 % 12/2023 60 58 0.0 56

ExamWorks Group, Inc. (6)

Senior Secured Second Lien Term Loan


L + 725
(100 Floor) (8)

8.25 % 07/2024 5,735 5,657 1.0 5,793

FH MD Buyer, Inc

Senior Secured First Lien Term Loan


L + 500
(75 Floor) (8)

5.75 % 722/2028 20,000 19,805 3.5 19,974

GrapeTree Medical Staffing, LLC (6)

Senior Secured First Lien Term Loan


L + 525
(100 Floor) (7)

6.25 % 10/2022 1,299 1,290 0.2 1,299

GrapeTree Medical Staffing, LLC (6)

Senior Secured First Lien Term Loan


L + 525
(100 Floor) (7)

6.25 % 10/2022 1,545 1,539 0.3 1,545

GrapeTree Medical Staffing, LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

10/2022 (2 )

Great Lakes Dental Partners, LLC (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (7)

7.00 % 06/2026 4,988 4,892 0.8 4,944

Great Lakes Dental Partners, LLC (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

06/2026 (16 ) (7 )

Great Lakes Dental Partners, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

06/2026 (8 ) (3 )

HCAT Acquisition, Inc. (6)

Unitranche First Lien Term Loan


L + 825
(100 Floor) (8)

9.25 % 11/2022 14,302 13,603 2.3 13,873

HCAT Acquisition, Inc. (6)

Unitranche First Lien Revolver


L + 825
(100 Floor) (8)

9.25 % 11/2022 3,836 3,649 0.6 3,721

HCAT Acquisition, Inc. (6)

Unitranche First Lien Delayed Draw Term Loan


L + 825
(100 Floor) (8)

9.25 % 11/2022 2,250 2,140 0.4 2,183

HCOS Group Intermediate III LLC (6)

Senior Secured First Lien Term Loan


L + 600
(100 Floor) (8)

7.00 % 09/2026 11,484 11,287 1.9 11,254

HCOS Group Intermediate III LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

09/2026 (15 ) (18 )

Homecare Partners Management, LLC (6)

Senior Secured First Lien Term Loan


L + 475
(100 Floor) (8)

5.75 % 05/2027 4,550 4,461 0.8 4,489

Homecare Partners Management, LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

05/2027 (21 ) (15 )

Homecare Partners Management, LLC (5)(6)(9)

Senior Secured First Lien Delayed Draw Term Loan


L + 475
(100 Floor) (8)

5.75 % 05/2027 1,836 1,804 0.3 1,791

Hospice Care Buyer, Inc. (6)

Unitranche First Lien Term Loan


L + 650
(100 Floor) (8)

7.50 % 12/2026 14,343 13,991 2.4 14,343

Hospice Care Buyer, Inc. (6)

Unitranche First Lien Term Loan


L + 650
(100 Floor) (8)

7.50 % 12/2026 2,620 2,549 0.4 2,620

Hospice Care Buyer, Inc. (4)(5)(6)

Unitranche First Lien Revolver


L + 650
(100 Floor) (7)

7.50 % 12/2026 577 535 0.1 577

Hospice Care Buyer, Inc. (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 650
(100 Floor) (13)

7.50 % 12/2026 1,287 1,235 0.2 1,287

IvyRehab Intermediate II, LLC (6)

Unitranche First Lien Term Loan


L + 675
(100 Floor) (8)

7.75 % 12/2024 7,970 7,839 1.3 7,970

IvyRehab Intermediate II, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

12/2024 (8 )

IvyRehab Intermediate II, LLC (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 675
(100 Floor) (8)

7.75 % 12/2024 1,379 1,356 0.2 1,379

IvyRehab Intermediate II, LLC (3)(5)(6)

Unitranche First Lien Delayed Draw Term Loan

12/2024 (18 )

IvyRehab Intermediate II, LLC (6)

Unitranche First Lien Term Loan


L + 675 (100
Floor) (8)

7.75 % 12/2024 6,800 6,688 1.1 6,800

Lightspeed Buyer, Inc. (6)

Unitranche First Lien Term Loan


L + 550 (100
Floor) (7)

6.50 % 02/2026 9,850 9,700 1.7 9,850

See accompanying notes

12


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Lightspeed Buyer, Inc. (3)(4)(5)(6)

Unitranche First Lien Revolver

02/2026 (15 )

Lightspeed Buyer, Inc. (6)

Unitranche First Lien Delayed Draw Term Loan


L + 550
(100 Floor) (7)

6.50 % 02/2026 1,784 1,762 0.3 1,784

Lightspeed Buyer, Inc. (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

02/2026

Lightspeed Buyer, Inc. (6)

Unitranche First Lien Term Loan


L + 575
(100 Floor) (7)

6.75 % 02/2026 2,750 2,696 0.5 2,750

MDVIP, Inc.

Senior Secured First Lien Term Loan


L + 425
(100 Floor) (7)

5.25 % 11/2024 9,487 9,487 1.6 9,487

NMN Holdings III Corp. (6)

Senior Secured Second Lien Delayed Draw Term Loan

L + 775 (7) 7.83 % 11/2026 1,667 1,630 0.3 1,646

NMN Holdings III Corp. (6)

Senior Secured Second Lien Term Loan

L + 775 (7) 7.83 % 11/2026 7,222 7,067 1.2 7,131

NMSC Holdings, Inc. (6)

Senior Secured Second Lien Term Loan


L + 1000
(100 Floor) (8)

11.00 % 10/2023 4,307 4,249 0.7 4,307

Omni Ophthalmic Management Consultants, LLC (6)

Senior Secured First Lien Revolver


L + 750
(100 Floor) (7)

8.50 % 05/2023 850 845 0.1 850

Omni Ophthalmic Management Consultants, LLC (6)

Senior Secured First Lien Term Loan


L + 750
(100 Floor) (7)

8.50 % 05/2023 6,825 6,784 1.1 6,825

Omni Ophthalmic Management Consultants, LLC (6)

Senior Secured First Lien Term Loan


L + 750
(100 Floor) (7)

8.50 % 05/2023 896 881 0.2 896

Patriot Acquisition Topco S.A.R.L (6)(17)

Unitranche First Lien Term Loan


L + 675
(100 Floor) (8)

7.75 % 01/2028 5,031 4,915 0.9 5,116

Patriot Acquisition Topco S.A.R.L (3)(4)(5)(6)(17)

Unitranche First Lien Revolver

01/2026 (38 ) 30

Patriot Acquisition Topco S.A.R.L (6)(17)

Unitranche First Lien Delayed Draw Term Loan


L + 675
(100 Floor) (8)

7.75 % 01/2028 12,200 11,921 2.1 12,406

Pharmalogics Recruiting, LLC (6)

Unitranche First Lien Term Loan


L + 625
(100 Floor) (8)

7.25 % 02/2027 7,384 7,249 1.2 7,310

Pharmalogics Recruiting, LLC (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

02/2027 (26 ) (14 )

Pinnacle Treatment Centers, Inc. (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 575
(100 Floor) (8)

6.75 % 12/2022 679 674 0.1 679

Pinnacle Treatment Centers, Inc. (6)

Unitranche First Lien Term Loan


L + 575
(100 Floor) (8)

6.75 % 12/2022 8,052 8,015 1.4 8,052

Pinnacle Treatment Centers, Inc. (3)(4)(5)(6)

Unitranche First Lien Revolver

12/2022 (3 )

Premier Dental Care Management, LLC (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

08/2028 (25 ) (103 )

Premier Dental Care Management, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

08/2027 (30 ) (31 )

Premier Dental Care Management, LLC (6)

Unitranche First Lien Term Loan


L + 575
(75 Floor) (7)

6.50 % 08/2028 9,524 9,335 1.6 9,333

Professional Physical Therapy (6)

Senior Secured First Lien Term Loan




L + 600
(100 Floor)
(including
250 PIK) (8)



9.50 % 12/2022 9,079 8,783 1.1 6,261

PromptCare Intermediate, LP (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

09/2027 (44 ) (89 )

PromptCare Intermediate, LP (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (8)

7.00 % 09/2027 10,500 10,292 1.7 10,290

PT Network, LLC (4)(5)(6)

Senior Secured First Lien Revolver

11/2023

See accompanying notes

13


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

PT Network, LLC (6)

Senior Secured First Lien Term Loan




L + 550
(100 Floor)
(including
200 PIK) (8)



8.50 % 11/2023 4,827 4,821 0.8 4,827

Safco Dental Supply, LLC (4)(5)(6)

Unitranche First Lien Revolver


L + 400
(100 Floor) (8)

5.00 % 06/2025 240 233 0.0 240

Safco Dental Supply, LLC (6)

Unitranche First Lien Term Loan


L + 400
(100 Floor) (8)

5.00 % 06/2025 4,043 3,995 0.7 4,043

Seniorlink Incorporated (3)(4)(5)(6)

Unitranche First Lien Revolver

07/2026 (25 )

Seniorlink Incorporated (6)

Unitranche First Lien Term Loan


L + 700
(100 Floor) (8)

8.00 % 07/2026 11,220 10,940 1.9 11,220

Smile Doctors LLC (4)(5)(6)

Senior Secured First Lien Revolver

10/2022

Smile Doctors LLC (6)

Senior Secured First Lien Term Loan


L + 600
(100 Floor) (8)

7.00 % 10/2022 16,158 16,146 2.7 16,158

Unifeye Vision Partners (6)

Senior Secured First Lien Delayed Draw Term Loan


L + 500
(100 Floor) (8)

6.00 % 09/2025 3,042 2,991 0.5 3,042

Unifeye Vision Partners (3)(4)(5)(6)

Senior Secured First Lien Revolver

09/2025 (23 )

Unifeye Vision Partners (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (8)

6.00 % 09/2025 5,306 5,231 0.9 5,306

Unifeye Vision Partners (5)(6)(14)

Senior Secured First Lien Delayed Draw Term Loan


L + 475
(100 Floor) (8)

5.75 % 09/2025 45 45 0.0 45

Vital Care Buyer, LLC (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (8)

7.00 % 10/2025 6,981 6,878 1.2 6,981

Vital Care Buyer, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

10/2025 (32 )

Zest Acquisition Corp.

Senior Secured First Lien Term Loan

L + 350 (7) 3.59 % 03/2025 6,586 6,583 1.1 6,444

325,888 319,635 54.1 320,867

Household & Personal Products

Tranzonic (4)(5)(6)

Senior Secured First Lien Revolver


L + 450
(100 Floor) (7)

5.50 % 03/2023 713 708 0.1 713

Tranzonic (6)

Senior Secured First Lien Term Loan


L + 450
(100 Floor) (7)

5.50 % 03/2023 3,782 3,769 0.6 3,782

4,495 4,477 0.7 4,495

Insurance

Comet Acquisition, Inc.

Senior Secured Second Lien Term Loan

L + 750 (8) 7.63 % 10/2026 1,782 1,779 0.3 1,741

Evolution BuyerCo, Inc. (6)

Unitranche First Lien Term Loan


L + 625
(100 Floor) (8)

7.25 % 04/2028 8,313 8,224 1.4 8,479

Evolution BuyerCo, Inc. (3)(5)(6)

Unitranche First Lien Revolver

04/2028 (8 ) 15

Evolution BuyerCo, Inc. (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

04/2028 (8 ) 29

Integrity Marketing Acquisition, LLC (6)

Unitranche First Lien Delayed Draw Term Loan


L + 575
(100 Floor) (8)

6.75 % 08/2025 5,029 4,936 0.8 5,017

Integrity Marketing Acquisition, LLC (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 575
(100 Floor) (8)

6.75 % 08/2025 3,041 2,985 0.5 3,033

Integrity Marketing Acquisition, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

08/2025 (33 ) (4 )

Integrity Marketing Acquisition, LLC (6)

Unitranche First Lien Term Loan


L + 575
(100 Floor) (8)

6.75 % 08/2025 12,781 12,562 2.1 12,749

Integro Parent, Inc. (17)

Senior Secured First Lien Term Loan


L + 575
(100 Floor) (8)

6.75 % 10/2022 469 468 0.1 461

See accompanying notes

14


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Integro Parent, Inc. (6)(17)

Senior Secured Second Lien Term Loan


L + 925
(100 Floor) (7)

10.25 % 10/2023 2,915 2,897 0.5 2,755

Integro Parent, Inc. (6)(17)

Senior Secured Second Lien Delayed Draw Term Loan


L + 925
(100 Floor) (7)

10.25 % 10/2023 380 378 0.1 359

The Hilb Group, LLC (6)

Unitranche First Lien Term Loan


L + 575
(100 Floor) (8)

6.75 % 12/2026 3,576 3,506 0.6 3,562

The Hilb Group, LLC (6)

Unitranche First Lien Delayed Draw Term Loan


L + 575
(100 Floor) (8)

6.75 % 12/2026 1,011 991 0.2 1,007

The Hilb Group, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

12/2025 (6 ) (1 )

The Hilb Group, LLC (6)

Unitranche First Lien Term Loan


L + 625
(100 Floor) (8)

7.25 % 12/2026 1,061 1,037 0.2 1,072

The Hilb Group, LLC (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 625
(100 Floor) (8)

7.25 % 12/2026 512 490 0.1 530

The Hilb Group, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

12/2025 (3 ) 1

40,870 40,195 6.9 40,805

Materials

Kestrel Parent, LLC (3)(5)(6)(19)

Unitranche First Lien Revolver

11/2023 (9 )

Kestrel Parent, LLC (6)

Unitranche First Lien Term Loan


L + 575
(100 Floor) (8)

6.75 % 11/2025 6,621 6,516 1.1 6,621

6,621 6,507 1.1 6,621

Pharmaceuticals, Biotechnology & Life Sciences

Teal Acquisition Co., Inc (6)

Unitranche First Lien Term Loan


L + 625
(100 Floor) (8)

7.25 % 09/2026 9,056 8,821 1.5 9,056

Teal Acquisition Co., Inc (3)(4)(5)(6)

Unitranche First Lien Revolver

09/2026 (32 )

Teal Acquisition Co., Inc (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

09/2026 (20 )

Trinity Partners, LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

02/2025 (3 )

Trinity Partners, LLC (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (7)

6.00 % 02/2025 3,681 3,659 0.6 3,681

12,737 12,425 2.1 12,737

Retailing

Savers

Senior Secured First Lien Term Loan


L + 575
(75 Floor) (8)

6.50 % 04/2028 20,000 19,813 3.5 20,249

Slickdeals Holdings, LLC (3)(5)(6)(10)(19)

Unitranche First Lien Revolver

06/2023 (7 ) 2

Slickdeals Holdings, LLC (6)(10)

Unitranche First Lien Term Loan


L + 625
(100 Floor) (8)

7.25 % 06/2024 14,417 14,170 2.4 14,456

34,417 33,976 5.9 34,707

Software & Services

Affinitiv, Inc. (3)(4)(5)(6)

Unitranche First Lien Revolver

08/2024 (6 )

Affinitiv, Inc. (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (8)

7.00 % 08/2024 6,386 6,315 1.1 6,386

Ansira Partners, Inc. (6)(15)

Unitranche First Lien Term Loan

12/2024 7,518 6,687 0.9 5,454

Ansira Partners, Inc. (6)(15)

Unitranche First Lien Delayed Draw Term Loan

12/2024 1,029 931 0.1 747

Apps Associates LLC (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

07/2027 (9 ) (18 )

See accompanying notes

15


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Apps Associates LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

07/2027 (15 ) (8 )

Apps Associates LLC (6)

Unitranche First Lien Term Loan


L + 550
(100 Floor) (7)

6.50 % 07/2027 5,650 5,540 0.9 5,594

Banker’s Toolbox, Inc. (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

07/2027 (65 )

Banker’s Toolbox, Inc. (3)(4)(5)(6)

Unitranche First Lien Revolver

07/2027 (47 )

Banker’s Toolbox, Inc. (6)

Unitranche First Lien Term Loan


L + 550
(75 Floor) (8)

6.25 % 07/2027 15,883 15,572 2.7 15,883

Belay Inc. (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (7)

6.00 % 06/2026 4,938 4,855 0.8 4,938

Belay Inc. (3)(4)(5)(6)

Senior Secured First Lien Revolver

06/2026 (11 )

Benesys Inc. (6)

Senior Secured First Lien Term Loan


L + 475
(100 Floor) (7)

5.75 % 10/2024 1,403 1,392 0.2 1,403

Benesys Inc. (6)

Senior Secured First Lien Term Loan


L + 475
(100 Floor) (7)

5.75 % 10/2024 298 293 0.0 298

Benesys Inc. (3)(4)(5)(6)

Senior Secured First Lien Revolver

10/2024 (1 )

C-4 Analytics, LLC (3)(4)(5)(6)

Senior Secured First Lien Revolver

08/2023 (3 )

C-4 Analytics, LLC (6)

Senior Secured First Lien Term Loan


L + 525
(100 Floor) (7)

6.25 % 08/2023 9,837 9,775 1.7 9,837

CAT Buyer, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

04/2024 (6 )

CAT Buyer, LLC (6)

Unitranche First Lien Term Loan


L + 550
(100 Floor) (7)

6.50 % 04/2024 6,114 6,048 1.0 6,114

Claritas, LLC (4)(5)(6)

Senior Secured First Lien Revolver


L + 575
(100 Floor) (7)

6.75 % 12/2023 23 21 0.0 23

Claritas, LLC (6)

Senior Secured First Lien Term Loan


L + 575
(100 Floor) (8)

6.75 % 12/2023 1,071 1,065 0.2 1,071

Granicus, Inc. (6)

Unitranche First Lien Term Loan


L + 650
(100 Floor) (8)

7.50 % 01/2027 9,172 8,976 1.5 8,988

Granicus, Inc. (3)(4)(5)(6)

Unitranche First Lien Revolver

01/2027 (17 ) (16 )

Granicus, Inc. (6)

Unitranche First Lien Delayed Draw Term Loan

01/2027

Granicus, Inc. (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 600
(100 Floor) (8)

7.00 % 01/2027 4,781 4,658 0.8 4,623

List Partners, Inc. (3)(4)(5)(6)

Senior Secured First Lien Revolver

01/2023 (2 ) (6 )

List Partners, Inc. (6)

Senior Secured First Lien Term Loan


L + 500
(100 Floor) (7)

6.00 % 01/2023 4,109 4,087 0.7 4,053

MRI Software LLC (3)(5)(9)

Unitranche First Lien Delayed Draw Term Loan

02/2026 (2 )

MRI Software LLC

Unitranche First Lien Term Loan


L + 550
(100 Floor) (8)

6.50 % 02/2026 17,943 17,736 3.1 17,931

MRI Software LLC (3)(4)(5)

Unitranche First Lien Revolver

02/2026 (14 ) (1 )

MRI Software LLC (3)(5)(9)

Unitranche First Lien Delayed Draw Term Loan

02/2026 (2 )

MRI Software LLC

Unitranche First Lien Term Loan


L + 550
(100 Floor) (8)

6.50 % 02/2026 935 921 0.2 935

New Era Technology, Inc. (6)

Unitranche First Lien Term Loan


L + 625
(100 Floor) (8)

7.25 % 10/2026 3,166 3,105 0.5 3,180

New Era Technology, Inc. (3)(4)(5)(6)

Unitranche First Lien Revolver

10/2026 (4 ) 1

New Era Technology, Inc. (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 625
(100 Floor) (13)

7.25 % 10/2026 1,126 1,098 0.2 1,135

See accompanying notes

16


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Ontario Systems, LLC (5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan


L + 550
(100 Floor) (8)

6.50 % 08/2025 1,100 1,081 0.2 1,079

Ontario Systems, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

08/2025 (3 ) (6 )

Ontario Systems, LLC (6)

Unitranche First Lien Term Loan


L + 550
(100 Floor) (8)

6.50 % 08/2025 3,634 3,602 0.6 3,587

Park Place Technologies, LLC (6)

Unsecured Debt

1250 PIK (11) 12.50 % 05/2029 758 758 0.1 758

Perforce Software, Inc. (6)

Senior Secured Second Lien Term Loan

L + 800 (7) 8.08 % 07/2027 5,000 4,981 0.8 5,000

Prism Bidco, Inc. (3)(4)(5)(6)

Unitranche First Lien Revolver

06/2026 (20 ) 17

Prism Bidco, Inc. (6)

Unitranche First Lien Term Loan


L + 700
(100 Floor) (8)

8.00 % 06/2026 7,406 7,222 1.3 7,554

Prism Bidco, Inc. (6)

Unitranche First Lien Term Loan


L + 575
(100 Floor) (8)

6.75 % 06/2026 1,466 1,438 0.2 1,466

Right Networks, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

05/2026 (3 )

Right Networks, LLC (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (7)

7.00 % 05/2026 9,301 9,162 1.6 9,301

Right Networks, LLC (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (7)

7.00 % 05/2026 8,328 8,167 1.4 8,328

Right Networks, LLC (3)(5)(6)(9)

Unitranche First Lien Delayed Draw Term Loan

05/2026 (40 )

Ruffalo Noel Levitz, LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

05/2022 (1 ) (1 )

Ruffalo Noel Levitz, LLC (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (8)

7.00 % 05/2022 2,486 2,477 0.4 2,480

Saturn Borrower Inc (6)

Unitranche First Lien Term Loan


L + 650
(100 Floor) (8)

7.50 % 09/2026 20,370 19,845 3.4 19,906

Saturn Borrower Inc (6)

Unitranche First Lien Term Loan


L + 650
(100 Floor) (8)

7.50 % 09/2026 2,481 2,414 0.4 2,425

Saturn Borrower Inc (4)(5)(6)

Unitranche First Lien Revolver


L + 650
(100 Floor) (8)

7.50 % 09/2026 605 567 0.1 571

Transportation Insight, LLC (6)

Senior Secured First Lien Term Loan

L + 450 (7) 4.58 % 12/2024 5,102 5,074 0.9 5,089

Transportation Insight, LLC (6)

Senior Secured First Lien Delayed Draw Term Loan

L + 450 (7) 4.58 % 12/2024 1,268 1,260 0.2 1,264

Transportation Insight, LLC (4)(6)(5)

Senior Secured First Lien Revolver

L + 450 (7) 4.58 % 12/2024 179 175 0.0 177

Trident Technologies, LLC (6)

Senior Secured First Lien Term Loan


L + 600
(150 Floor) (8)

7.50 % 12/2025 14,738 14,572 2.5 14,738

Trident Technologies, LLC (6)

Senior Secured First Lien Term Loan


L + 600
(150 Floor) (8)

7.50 % 12/2025 4,988 4,953 0.8 4,988

Winxnet Holdings LLC (6)

Unitranche First Lien Delayed Draw Term Loan


L + 600
(100 Floor) (7)

7.00 % 06/2023 636 630 0.1 636

Winxnet Holdings LLC (6)

Unitranche First Lien Delayed Draw Term Loan


L + 600
(100 Floor) (7)

7.00 % 06/2023 1,042 1,027 0.2 1,042

Winxnet Holdings LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

06/2023 (3 )

Winxnet Holdings LLC (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (7)

7.00 % 06/2023 1,935 1,920 0.3 1,935

Winxnet Holdings LLC (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (7)

7.00 % 06/2023 1,542 1,518 0.3 1,542

Winxnet Holdings LLC (3)(4)(5)(6)

Unitranche First Lien Revolver

06/2023 (4 )

Winxnet Holdings LLC (6)

Unitranche First Lien Term Loan


L + 600
(100 Floor) (7)

7.00 % 06/2023 1,150 1,130 0.2 1,150

196,897 192,770 32.6 193,571

See accompanying notes

17


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Technology, Hardware & Equipment

Onvoy, LLC (6)

Senior Secured Second Lien Term Loan


L + 1050
(100 Floor) (7)

11.50 % 02/2025 1,459 1,422 0.2 1,459

Transportation

Pilot Air Freight, LLC (6)

Senior Secured First Lien Delayed Draw Term Loan


L + 475
(100 Floor) (8)

5.75 % 07/2024 765 764 0.1 765

Pilot Air Freight, LLC (5)(6)(9)

Senior Secured First Lien Revolver

07/2024

Pilot Air Freight, LLC (6)

Senior Secured First Lien Delayed Draw Term Loan


L + 475
(100 Floor) (8)

5.75 % 07/2024 1,184 1,184 0.2 1,184

Pilot Air Freight, LLC (6)

Senior Secured First Lien Term Loan


L + 475
(100 Floor) (8)

5.75 % 07/2024 5,321 5,305 0.9 5,321

Pilot Air Freight, LLC (6)

Senior Secured First Lien Term Loan


L + 475
(100 Floor) (8)

5.75 % 07/2024 800 788 0.1 800

8,070 8,041 1.3 8,070

Total Debt Investments

United States

$ 944,993 $ 925,569 155.0 % $ 924,916

Equity Investments

Automobiles & Components

Sun Acquirer Corp. (6)

Common Stock Common Equity

5,435 543 0.1 543

543 0.1 543

Capital Goods

Envocore Holding, LLC (6)

Preferred Stock

1,139,725

Commercial & Professional Services

Allied Universal Holdings, LLC (6)

Common Stock Class A

2,805,726 1,011 0.8 4,919

Allied Universal Holdings, LLC (6)

Common Stock Class A

684,903 685 0.2 1,201

ASP MCS Acquisition Corp. (10)

Common Stock

11,792 1,150 0.2 1,362

Battery Solutions, Inc. (6)(10)

Preferred Stock Class E

5,417,655 3,669 0.2 1,201

Battery Solutions, Inc. (6)(10)

Preferred Stock Class A

50,000

Battery Solutions, Inc. (6)(10)

Preferred Stock Class F

3,333,333

Hercules Borrower LLC (6)

Common Stock

1,153,075 1,153 0.2 1,126

IGT Holdings LLC (6)

Preferred Stock

645,730

IGT Holdings LLC (6)

Common Stock

1,000,000

MHS Acquisition Holdings, LLC (6)

Preferred Stock

1,018 923 0.2 1,030

MHS Acquisition Holdings, LLC (6)

Common Stock

10 9

Receivable Solutions, Inc. (6)

Preferred Stock Class A

137,000 137 0.1 309

Service Logic Acquisition, Inc. (6)

Common Stock

13,132 1,313 0.2 1,416

TecoStar Holdings, Inc. (6)

Common Stock

500,000 500 0.1 460

10,550 2.2 13,024

See accompanying notes

18


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Consumer Services

Everlast Parent Inc. (6)

Common Stock

948 948 0.2 1,305

HGH Purchaser, Inc. (6)

Common Stock Class A

4,171 417 0.1 770

Legalshield (6)

Common Stock

372 372 0.1 663

Southern Technical Institute, Inc. (6)(10)

Common Stock Common Equity

3,164,063 0.1 309

Southern Technical Institute, Inc. (6)(10)

Common Stock Common Equity

6,000,000 1.4 8,135

Wrench Group LLC (6)

Common Stock Common Equity

4,082 410 0.1 770

Wrench Group LLC (6)

Common Stock Common Equity

1,143 115 0.0 216

2,262 2.0 12,168

Diversified Financials

CBDC Senior Loan Fund LLC (17)(21)(22)

Partnership Interest

40,000,000 40,000 6.8 40,207

GACP II LP (10)(17)(22)(23)

Partnership Interest

13,763,514 13,665 2.3 13,437

WhiteHawk III Onshore Fund L.P. (5)(10)(17)(22)(23)

Partnership Interest

4,835,531 4,939 0.8 4,919

58,604 9.9 58,563

Health Care Equipment & Services

ACI Group Holdings, Inc. (6)

Common Stock

907,499 909 0.1 800

ACI Group Holdings, Inc. (6)

Preferred Stock

3,719 3,645 0.6 3,719

Centria Subsidiary Holdings, LLC (6)

Common Stock

11,911 1,191 0.3 1,719

ExamWorks Group, Inc. (6)

Common Stock

7,500 750 0.3 1,646

Hospice Care Buyer, Inc. (6)

Common Stock

13,985 1,398 0.4 2,147

MDVIP, Inc. (6)

Common Stock

46,807 648 0.4 2,117

NMN Holdings III Corp. (6)

Common Stock

11,111 1,111 0.2 1,321

Patriot Acquisition Topco S.A.R.L (6)(17)

Common Stock Class A

913 913 0.2 962

Patriot Acquisition Topco S.A.R.L (6)(17)

Common Stock Class B

12,576 0.0 95.0

PT Network, LLC (6)

Common Stock Class C

0.93

Seniorlink Incorporated (6)

Common Stock

68,182 518 0.2 1,098

11,083 2.7 15,624

Insurance

Evolution BuyerCo, Inc. (6)

Common Stock

2,917 292 0.0 292

Integrity Marketing Acquisition, LLC (6)

Common Stock

539,693 648 0.3 2,075

Integrity Marketing Acquisition, LLC (6)

Preferred Stock

1,247 1,215 0.3 1,631

Integro Parent, Inc. (6)(17)

Common Stock

4,468 454 0.1 542

2,609 0.7 4,540

Materials

Kestrel Parent, LLC (6)

Common Stock Class A

41,791 209 0.0 286

See accompanying notes

19


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Pharmaceuticals, Biotechnology & Life Sciences

Teal Acquisition Co., Inc (6)

Common Stock

4,562 456 0.1 492

Retailing

Palmetto Moon LLC (6)

Common Stock

61 0.2 928

Slickdeals Holdings, LLC (6)(10)

Common Stock

89 891 0.3 1,529

Vivid Seats Ltd. (6)(10)

Common Stock

608,109 608 0.1 849

Vivid Seats Ltd. (6)(10)

Preferred Stock

1,891,892 1,892 0.5 3,194

3,391 1.1 6,500

Software & Services

Curvature (6)(24)

Residual Interest

1,975,461 1,975 0.3 1,603

Park Place Technologies, LLC (6)

Common Stock Class A2

479 479 0.1 479

Park Place Technologies, LLC (6)

Common Stock Class W

685,018

Park Place Technologies, LLC (6)

Common Stock Class B2

442,203 27 0.0 27

Saturn Borrower Inc (6)

Common Stock

434,163 434 0.1 444

2,915 0.5 2,553

Technology, Hardware & Equipment

Onvoy, LLC (6)

Common Stock Class A

3,649 365 0.1 464

Onvoy, LLC (6)

Common Stock Class B

2,536 0.0 88

365 0.1 552

Transportation

Xpress Global Systems, LLC (6)

Common Stock

12,544

Total Equity Investments

United States

$ 92,987 $ 19.4 % $ 114,845

Total United States

$ 1,018,556 174.4 % $ 1,039,761

Canada

Debt Investments

Health Care Equipment & Services

VetStrategy (6)(17)

Unsecured Debt

1050 PIK (25) 11.50 % 03/2031 C$ 2,671 $ 2,040 0.4 $ 2,109

VetStrategy (6)(9)(17)

Unitranche First Lien Delayed Draw Term Loan


C + 700
(100 Floor) (26)

8.00 % 07/2027 1,716 1,253 0.2 1,382

VetStrategy (6)(9)(17)

Unitranche First Lien Delayed Draw Term Loan


C + 700
(100 Floor) (26)

8.00 % 07/2027 1,716 1,308 0.2 1,382

VetStrategy (6)(9)(17)

Unitranche First Lien Delayed Draw Term Loan


C + 700
(100 Floor) (26)

8.00 % 07/2027 4,981 3,883 0.7 4,012

VetStrategy (6)(17)

Unitranche First Lien Term Loan


C + 700
(100 Floor) (26)

8.00 % 07/2027 9,199 6,688 1.2 7,410

VetStrategy (5)(6)(9)(17)

Unitranche First Lien Delayed Draw Term Loan


C + 575
(100 Floor) (26)

6.75 % 07/2027 5,071 3,799 0.7 4,144

25,354 18,971 3.4 20,439

Telecommunication Services

Sandvine Corporation (17)

Senior Secured Second Lien Term Loan

L + 800 (7) 8.08 % 11/2026 $ 4,500 4,374 0.8 4,489

Total Debt Investments

Canada

$ 23,345 4.2 % $ 24,928

See accompanying notes

20


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value

Equity Investments

Health Care Equipment & Services

VetStrategy (6)(17)

Common Stock

1,016,357 $ 776 0.3 $ 1,521

Total Equity Investments

Canada

1,016,357 776 0.3 % 1,521

Total Canada

$ 24,121 4.5 % $ 26,449

United Kingdom

Debt Investments

Commercial & Professional Services

Crusoe Bidco Limited (6)(17)

Unitranche First Lien Term Loan

L + 625 (28) 6.30 % 12/2025 £ 6,067 $ 7,454 1.4 % $ 8,176

Crusoe Bidco Limited (5)(6)(17)(28)

Unitranche First Lien Delayed Draw Term Loan

12/2025

Crusoe Bidco Limited (5)(6)(17)(28)

Unitranche First Lien Delayed Draw Term Loan

L + 625 (28) 6.30 % 12/2025 303 398 0.1 409

Nurture Landscapes (6)(17)

Unitranche First Lien Term Loan

S + 650 (34) 6.50 % 06/2028 1,416 1,940 0.3 1,851

Nurture Landscapes (6)(17)

Unitranche First Lien Delayed Draw Term Loan

S + 650 (34) 6.50 % 06/2028 392 519 0.1 512

8,178 10,311 1.9 10,948

Consumer Durables & Apparel

Lion Cashmere Bidco Limited (6)(17)

Unitranche First Lien Term Loan


L + 600
(50 Floor) (28)

6.50 % 03/2028 $ 4,352 $ 4,241 0.7 $ 4,352

Lion Cashmere Bidco Limited (6)(17)

Unitranche First Lien Term Loan


L + 600
(50 Floor) (28)

6.50 % 03/2028 9,939 9,687 1.7 9,939

Lion Cashmere Bidco Limited (6)(17)

Unitranche First Lien Term Loan


L + 600
(50 Floor) (28)

6.50 % 03/2028 4,953 4,828 0.8 4,953

Lion Cashmere Bidco Limited (4)(5)(6)(17)(30)

Unitranche First Lien Revolver


L + 600
(50 Floor) (28)

6.50 % 03/2026 319 374 0.1 365

Lion Cashmere Bidco Limited (3)(5)(6)(17)(30)

Unitranche First Lien Delayed Draw Term Loan

03/2028 (85 )

19,045 3.3 19,609

Software & Services

Jordan Bidco, Ltd. (5)(6)(17)

Unitranche First Lien Delayed Draw Term Loan

08/2028 £ $ $ (113 )

Jordan Bidco, Ltd. (5)(6)(17)

Senior Secured First Lien Revolver

02/2028 (57 )

Jordan Bidco, Ltd. (6)(17)

Unitranche First Lien Term Loan

S + 650 (34) 6.50 % 08/2028 13,234 17,700 2.9 17,342

17,700 2.9 17,172

Total Debt Investments

United Kingdom

$ 47,056 8.1 % $ 47,729

Total United Kingdom

$ 47,056 8.1 % $ 47,729

See accompanying notes

21


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity/
Dissolution
Date
Principal
Amount,
Par

Value or
Shares **
Cost Percentage
of Net
Assets ***
Fair
Value
Netherlands

Debt Investments

Pharmaceuticals, Biotechnology & Life Sciences

PharComp Parent B.V. (5)(6)(17)(27)

Unitranche First Lien Delayed Draw Term Loan

E + 650 (31)(32) 6.50 % 02/2026 1,245 $ 1,417 0.2 % $ 1,442

PharComp Parent B.V. (6)(16)(17)

Unitranche First Lien—Last Out Term Loan


E + 650 (31)
(32)

6.50 % 02/2026 6,910 7,676 1.3 8,004

8,155 9,093 1.5 9,446

Total Debt Investments

Netherlands

$ 9,093 1.5 % $ 9,446

Total Netherlands

$ 9,093 1.5 % $ 9,446

Belgium

Debt Investments

Commercial & Professional Services

Miraclon Corporation (6)(17)

Unitranche First Lien Term Loan


E + 625 (31)
(32)

6.25 % 04/2026 9,507 10,519 1.8 11,013

Miraclon Corporation (6)(17)

Unitranche First Lien Term Loan

L + 625 (12) 6.46 % 04/2026 $ 4,162 4,072 0.7 4,162

14,591 2.5 15,175

Total Debt Investments

Belgium

$ 14,591 2.5 % $ 15,175

Equity Investments

Commercial & Professional Services

Miraclon Corporation (6)(17)

Common Stock

921 1

Miraclon Corporation (6)(17)

Preferred Stock

81,384 91 0.0 70

92 0.0 70

Total Equity Investments

Belgium

$ 92 0.0 % $ 70

Total Belgium

$ 14,683 2.5 % $ 15,245

Total Investments

$ 1,113,509 191.0 % $ 1,138,630

See accompanying notes

22


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

*

The majority of the investments bear interest at a rate that may be determined by reference to London Interbank Offered Rate (“LIBOR” or “L”), Prime (“P”), CDOR (“C”), EURIBOR (“E”), or SONIA (“S”) and which reset monthly, bi-monthly, quarterly, semiannually or annually. For each, the Company has provided the spread over LIBOR or Prime and the current interest rate in effect at Septemebr 30, 2021. Certain investments are subject to a LIBOR or Prime interest rate floor. For fixed rate loans, a spread above a reference rate is not applicable.

**

The total par amount is presented for debt investments, while the number of shares or units owned is presented for equity investments. Par amount is denominated in U.S. Dollars (“$”) unless otherwise noted, Canadian Dollar (“C$”), Euro (“€”), or Pound Sterling (“£”).

***

Percentage is based on net assets of $596,152 as of September 30, 2021

(1)

All positions held are non-controlled/non-affiliated investments, unless otherwise noted, as defined by the Investment Company Act of 1940, as amended (“1940 Act”). Non-controlled/non-affiliated investments are investments that are neither controlled nor affiliated.

(2)

All debt investments are income-producing, unless otherwise noted. Equity and member interests are non-income-producing unless otherwise noted. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended, or the Securities Act. Its investments are therefore generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act.

(3)

The negative cost, if applicable, is the result of the capitalized discount or unfunded commitment being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount or unfunded commitment on the loan.

(4)

Investment pays 0.50% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(5)

Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 8 “Commitments and Contingencies”.

(6)

The fair value of the investment was determined using significant unobservable inputs. See Note 2 “Summary of Significant Accounting Policies”.

(7)

The interest rate on these loans is subject to the greater of a LIBOR floor or 1 month LIBOR plus a base rate. The 1 month LIBOR as of September 30, 2021 was 0.08%. For some of these loans, the interest rate is based on the last reset date.

(8)

The interest rate on these loans is subject to the greater of a LIBOR floor or 3 month LIBOR plus a base rate. The 3 month LIBOR as of September 30, 2021 was 0.13%. For some of these loans, the interest rate is based on the last reset date.

(9)

Investment pays 1.00% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(10)

As defined in the 1940 Act, the portfolio company is deemed to be a “non-controlled affiliated person” of the Company because the Company owns, either directly or indirectly, 5% or more of the portfolio company’s outstanding voting securities. See Note 3 “Agreements and Related Party Transactions”.

(11)

Fixed rate investment.

(12)

The interest rate on these loans is subject to the greater of a LIBOR floor or 6 month LIBOR plus a base rate. The 6 month LIBOR as of September 30, 2021 was 0.16%. For some of these loans, the interest rate is based on the last reset date.

(13)

The interest rate on these loans is subject to the greater of a LIBOR floor or 2 month LIBOR plus a base rate. The 2 month LIBOR as of September 30, 2021 was 0.11%. For some of these loans, the interest rate is based on the last reset date.

(14)

Investment pays 0.75% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(15)

The investment is on non-accrual status as of September 30, 2021.

(16)

These loans are unitranche first lien/last-out term loans. In addition to the interest earned based on the effective interest rate of this loan, which is the amount reflected in this schedule, the Company is entitled to receive additional interest as a result of an agreement among lenders whereby the loan has been allocated to “first-out” and “last-out” tranches, whereby the “first-out” tranche will have priority as to the “last-out” tranche with respect to payments of principal, interest and any amounts due thereunder. The Company holds the “last-out” tranche.

(17)

Investment is not a qualifying investment as defined under section 55 (a) of the Investment Company Act of 1940. Qualifying assets must represent at least 70% of total assets at the time of acquisition. The Company’s percentage of non-qualifying assets based on fair value was 16.38% as of September 30, 2021.

(18)

The interest rate on these loans is subject to the greater of a LIBOR floor or 12 month LIBOR plus a base rate. The 12 month LIBOR as of September 30, 2021 was 0.24%. For some of these loans, the interest rate is based on the last reset date.

(19)

Investment pays 0.38% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(20)

The interest rate on these loans is subject to the U.S. Prime rate, which as of September 30, 2021 was 3.25%.

(21)

As defined in the 1940 Act, the portfolio company is deemed to be a “controlled affiliated person” of the Company because the Company owns, either directly or indirectly, 25% or more of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company. See Note 3 “Agreements and Related Party Transactions”.

(22)

This investment was valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels.

(23)

Investment is not redeemable.

(24)

Residual interest in Curvature (Beijing) Technology Limited.

(25)

The interest rate on these loans is subject to the greater of a CDOR floor or 3 month CDOR plus a base rate. The 3 month CDOR as of September 30, 2021 was 0.45%. For some of these loans, the interest rate is based on the last reset date.

(26)

The interest rate on these loans is subject to the greater of a CDOR floor or 1 month CDOR plus a base rate. The 1 month CDOR as of September 30, 2021 was 0.43%. For some of these loans, the interest rate is based on the last reset date.

(27)

Investment pays 2.19% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(28)

The interest rate on these loans is subject to the greater of a GBP LIBOR floor or 3 month GBP LIBOR plus a base rate. The 3 month GBP LIBOR as of September 30, 2021 was 0.08%. For some of these loans, the interest rate is based on the last reset date.

(29)

The interest rate on these loans is subject to the greater of a GBP LIBOR floor or 6 month GBP LIBOR plus a base rate. The 6 month GBP LIBOR as of September 30, 2021 was 0.17%. For some of these loans, the interest rate is based on the last reset date.

(30)

Investment pays 1.80% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(31)

The interest rate on these loans is subject to the greater of a EURIBOR floor or 3 month EURIBOR plus a base rate. The 3 month EURIBOR as of September 30, 2021 was (0.55)%. For some of these loans, the interest rate is based on the last reset date.

(32)

For EURIBOR rate investments where negative rates can be prevalent, a 0% floor is presumed.

(33)

The interest rate on these loans is subject to the greater of a EURIBOR floor or 6 month EURIBOR plus a base rate. The 6 month EURIBOR as of September 30, 2021 was (0.53)%. For some of these loans, the interest rate is based on the last reset date.

(34)

The interest rate on these loans is subject to the Daily SONIA plus a base rate. The Daily SONIA as of June 30, 2021 was 0.05%. For some of these loans, the interest rate is based on the last reset date.

See accompanying notes

23


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

September 30, 2021

(in thousands, except share and per share data)

Foreign Currency Exchange

Contracts

Counterparty

Currency Purchased Currency Sold Settlement Unrealized Appreciation
(Depreciation)

Wells Fargo Bank, N.A.

USD 1,049 CAD 1,348 7/15/2025 $ (1 )

Wells Fargo Bank, N.A.

USD 7,089 CAD 9,712 7/31/2025 (464 )

Wells Fargo Bank, N.A.

USD 635 CAD 864 7/31/2025 (37 )

Wells Fargo Bank, N.A.

USD 622 CAD 839 7/31/2025 (31 )

Wells Fargo Bank, N.A.

USD 612 CAD 801 7/31/2025 (11 )

Wells Fargo Bank, N.A.

USD 325 CAD 422 7/31/2025 (4 )

Wells Fargo Bank, N.A.

USD 576 CAD 738 7/31/2025

Wells Fargo Bank, N.A.

USD 775 CAD 994 7/31/2025 1

Wells Fargo Bank, N.A.

USD 789 CAD 1,005 7/31/2025 5

Wells Fargo Bank, N.A.

USD 1,033 CAD 1,274 7/31/2025 39

Wells Fargo Bank, N.A.

USD 193 CAD 244 7/31/2025 3

Wells Fargo Bank, N.A.

USD 17 CAD 22 7/31/2025

Wells Fargo Bank, N.A.

USD 493 CAD 632 7/31/2025 1

Wells Fargo Bank, N.A.

USD 933 CAD 1,192 7/31/2025 4

Wells Fargo Bank, N.A.

USD 1,035 CAD 1,336 7/31/2025 (6 )

Wells Fargo Bank, N.A.

USD 1,306 CAD 1,703 7/31/2025 (20 )

Wells Fargo Bank, N.A.

USD 1,795 CAD 2,370 2/28/2031 11

Wells Fargo Bank, N.A.

USD 8,603 EUR 6,703 2/20/2024 644

Wells Fargo Bank, N.A.

USD 209 EUR 187 2/20/2024 (13 )

Wells Fargo Bank, N.A.

USD 992 EUR 809 2/20/2024 31

Wells Fargo Bank, N.A.

USD 308 EUR 249 2/20/2024 12

Wells Fargo Bank, N.A.

USD 11,682 EUR 9,222 4/10/2024 710

Wells Fargo Bank, N.A.

USD 7,975 GBP 5,885 12/1/2023 73

Wells Fargo Bank, N.A.

USD 395 GBP 294 12/1/2023

Wells Fargo Bank, N.A.

USD 193 GBP 138 2/13/2025 8

Wells Fargo Bank, N.A.

USD 191 GBP 138 2/13/2025 5

Wells Fargo Bank, N.A.

USD 1,944 GBP 1,362 6/3/2026 91

Wells Fargo Bank, N.A.

USD 170 GBP 121 6/3/2026 6

Wells Fargo Bank, N.A.

USD 371 GBP 272 6/3/2026 1

Wells Fargo Bank, N.A.

USD 17,790 GBP 12,870 8/24/2026 270
Total Foreign Currency Exchange Contracts $ 1,328

CAD

Canadian Dollar

EUR

Euro

GBP

Great British Pound

PIK

Payment In-Kind

USD

United States Dollar

See accompanying notes

24


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Investments (1) (2)

United States

Debt Investments

Automobiles & Components

Auto-Vehicle Parts, LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

01/2023 $ $ (4 ) % $ (10 )

Auto-Vehicle Parts, LLC (3)

Senior Secured First Lien Term Loan


L + 450

(100 Floor


) (7)

5.50 % 01/2023 4,566 4,535 0.8 4,488

Continental Battery Company (3)

Senior Secured First Lien Delayed Draw Term Loan


L + 675

(100 Floor


) (7)

7.75 % 12/2022 6,578 6,522 1.2 6,578

Continental Battery Company (3) (5)

Senior Secured First Lien Delayed Draw Term Loan


L + 675

(100 Floor


) (7)

7.75 % 12/2022 3,465 3,444 0.6 3,465

Continental Battery Company (3) (5) (6)

Senior Secured First Lien Revolver


L + 675

(100 Floor


) (7)

7.75 % 12/2022 283 278 0.1 283

Continental Battery Company (3)

Senior Secured First Lien Term Loan


L + 675

(100 Floor


) (7)

7.75 % 12/2022 3,933 3,902 0.7 3,933

Empire Auto Parts, LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

09/2024 (5 ) (8 )

Empire Auto Parts, LLC (3)

Unitranche First Lien Term Loan


L + 550

(100 Floor


) (8)

6.50 % 09/2024 2,370 2,334 0.4 2,324

Empire Auto Parts, LLC (3)

Unitranche First Lien Term Loan


L + 550

(100 Floor


) (8)

6.50 % 09/2024 2,444 2,411 0.4 2,396

23,639 23,417 4.2 23,449

Capital Goods

Envocore Holding, LLC (3)

Senior Secured First Lien Term Loan


L + 900

(200 Floor

(including

425 PIK


)

) (8)

11.00 % 06/2022 18,541 15,834 2.6 14,335

Potter Electric Signal Company (3) (4) (6) (9)

Senior Secured First Lien Delayed Draw Term Loan

12/2024 (16 ) (8 )

Potter Electric Signal Company (3) (4) (5) (6)

Senior Secured First Lien Revolver

12/2022 (4 ) (4 )

Potter Electric Signal Company (3)

Senior Secured First Lien Term Loan


L + 425

(100 Floor


) (8)

5.25 % 12/2025 2,480 2,461 0.4 2,461

Potter Electric Signal Company (3)

Senior Secured First Lien Term Loan


L + 425

(100 Floor


) (8)

5.25 % 12/2024 471 468 0.1 467

21,492 18,743 3.1 17,251

Commercial & Professional Services

ASP MCS Acquisition Corp. (3) (10)

Senior Secured Second Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 10/2025 295 273 0.1 293

See accompanying notes

25


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Battery Solutions, Inc. (3) (10)

Unsecured Debt

1200 + 200 PIK (11) 14.00 % 11/2021 $ 1,263 $ 1,248 0.2 % $ 1,192

BFC Solmetex LLC & Bonded Filter Co. LLC (3) (5)

Unitranche First Lien Revolver


L + 850

(100 Floor


) (8)

9.50 % 09/2023 750 742 0.1 750

BFC Solmetex LLC & Bonded Filter Co. LLC (3)(5)

Unitranche First Lien Revolver


L + 850

(100 Floor


) (8)

9.50 % 09/2023 300 296 0.1 300

BFC Solmetex LLC & Bonded Filter Co. LLC (3)

Unitranche First Lien Term Loan


L + 850

(100 Floor


) (8)

9.50 % 09/2023 5,920 5,848 1.0 5,920

BFC Solmetex LLC & Bonded Filter Co. LLC (3)

Unitranche First Lien Term Loan


L + 850

(100 Floor


) (8)

9.50 % 09/2023 618 610 0.1 618

CHA Holdings, Inc. (3)

Senior Secured First Lien Delayed Draw Term Loan


L + 450

(100 Floor


) (8)

5.50 % 04/2025 1,013 1,010 0.2 987

CHA Holdings, Inc. (3)

Senior Secured First Lien Term Loan


L + 450

(100 Floor


) (8)

5.50 % 04/2025 4,805 4,789 0.8 4,683

Consolidated Label Co., LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

07/2026 (12 )

Consolidated Label Co., LLC (3)

Senior Secured First Lien Term Loan


L + 575

(100 Floor


) (8)

6.75 % 07/2026 4,339 4,258 0.8 4,339

Digital Room Holdings, Inc. (3)

Senior Secured First Lien Term Loan

L + 500 (12) 5.27 % 05/2026 6,895 6,602 1.2 6,533

GH Holding Company (3)

Senior Secured First Lien Term Loan

L + 450 (7) 4.65 % 02/2023 1,459 1,455 0.2 1,412

GI Revelation Acquisition, LLC (3)

Senior Secured First Lien Term Loan

L + 500 (7) 5.15 % 04/2025 7,321 7,296 1.3 7,049

Hepaco, LLC (3) (6) (9)

Senior Secured First Lien Delayed Draw Term Loan


L + 500

(100 Floor


) (7)

6.00 % 08/2024 4,156 4,130 0.7 3,999

Hepaco, LLC (3) (5) (6)

Senior Secured First Lien Revolver


L + 500

(100 Floor


) (7)

6.00 % 08/2024 825 824 0.1 791

Hepaco, LLC (3)

Senior Secured First Lien Term Loan


L + 500

(100 Floor


) (7)

6.00 % 08/2024 5,098 5,067 0.9 4,911

Hercules Borrower LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

12/2026 (55 ) (55 )

Hercules Borrower LLC (3)

Unitranche First Lien Term Loan


L + 650

(100 Floor


) (8)

7.50 % 12/2026 19,125 18,650 3.3 18,647

Hsid Acquisition, LLC (3) (9)

Senior Secured First Lien Delayed Draw Term Loan


L + 500

(100 Floor


) (8)

6.00 % 01/2026 2,893 2,844 0.5 2,893

Hsid Acquisition, LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

01/2026 (13 )

See accompanying notes

26


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Hsid Acquisition, LLC (3)

Senior Secured First Lien Term Loan


L + 500

(100 Floor


) (7)

6.00 % 01/2026 $ 3,866 $ 3,799 0.7 % $ 3,866

Impact Group, LLC (3)

Senior Secured First Lien Term Loan


L + 737

(100 Floor


) (7)

8.37 % 06/2023 7,040 5,455 1.2 6,585

Impact Sales, LLC (3)

Senior Secured First Lien Delayed Draw Term Loan


L + 737

(100 Floor


) (7)

8.37 % 06/2023 6,645 5,149 1.1 6,216

Institutional Shareholder Services, Inc. (3)

Senior Secured First Lien Term Loan

L + 450 (8) 4.75 % 03/2026 2,948 2,909 0.5 2,936

Institutional Shareholder Services, Inc. (3)

Senior Secured Second Lien Term Loan

L + 850 (8) 8.75 % 03/2027 2,000 1,928 0.3 2,000

ISS Compressors Industries, Inc. (3) (4) (5) (6)

Senior Secured First Lien Revolver

02/2026 (7 ) (27 )

ISS Compressors Industries, Inc. (3)

Senior Secured First Lien Term Loan


L + 550

(100 Floor


) (8)

6.50 % 02/2026 9,098 9,019 1.6 8,807

Jordan Healthcare, Inc. (3)

Senior Secured First Lien Delayed Draw Term Loan


L + 600

(100 Floor


) (8)

7.00 % 07/2022 691 688 0.1 691

Jordan Healthcare, Inc. (3)

Senior Secured First Lien Revolver


L + 600

(100 Floor


) (8)

7.00 % 07/2022 450 449 0.1 450

Jordan Healthcare, Inc. (3)

Senior Secured First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 07/2022 3,980 3,966 0.7 3,980

MHS Acquisition Holdings, LLC (3)

Senior Secured Second Lien Delayed Draw Term Loan


L + 875

(100 Floor


) (8)

9.75 % 03/2025 467 461 0.1 455

MHS Acquisition Holdings, LLC (3)

Senior Secured Second Lien Term Loan


L + 875

(100 Floor


) (8)

9.75 % 03/2025 8,102 7,956 1.4 7,900

MHS Acquisition Holdings, LLC (3)

Unsecured Debt

1350 PIK (11) 13.50 % 03/2026 272 270 264

MHS Acquisition Holdings, LLC (3)

Unsecured Debt

1350 PIK (11) 13.50 % 03/2026 817 810 0.1 792

Pinstripe Holdings, LLC (3)

Unitranche First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 01/2025 9,825 9,618 1.7 9,807

Pye-Barker Fire & Safety, LLC (3)

Unitranche First Lien Delayed Draw Term Loan


L + 600

(100 Floor


) (8)

7.00 % 11/2025 3,715 3,623 0.7 3,715

Pye-Barker Fire & Safety, LLC (3)

Unitranche First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 11/2025 10,024 9,790 1.8 10,024

Receivable Solutions, Inc. (3) (4) (5) (6)

Senior Secured First Lien Revolver

10/2024 (4 ) (3 )

Receivable Solutions, Inc. (3)

Senior Secured First Lien Term Loan


L + 500

(100 Floor


) (7)

6.00 % 10/2024 2,070 2,042 0.4 2,047

SavATree, LLC (3) (6) (9)

Senior Secured First Lien Delayed Draw Term Loan


L + 500

(100 Floor


) (8)

6.00 % 06/2022 772 766 0.1 772

SavATree, LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

06/2022 (3 )

See accompanying notes

27


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

SavATree, LLC (3)

Senior Secured First Lien Term Loan


L + 500

(100 Floor


) (8)

6.00 % 06/2022 $ 3,910 $ 3,887 0.7 % $ 3,910

Service Logic Acquisition, Inc (3) (4) (6) (9)

Senior Secured Second Lien Delayed Draw Term Loan

10/2028 (71 )

Service Logic Acquisition, Inc (3)

Senior Secured Second Lien Term Loan


L + 850

(100 Floor


) (8)

9.50 % 10/2028 8,755 8,496 1.6 8,755

Spear Education (3) (4) (6) (9)

Senior Secured First Lien Delayed Draw Term Loan

02/2025 (26 ) (81 )

Spear Education (3)

Senior Secured First Lien Term Loan


L + 550

(100 Floor


) (8)

6.50 % 02/2025 6,823 6,765 1.2 6,646

TecoStar Holdings, Inc. (3)

Senior Secured Second Lien Term Loan


L + 850

(100 Floor


) (8)

9.50 % 11/2024 5,000 4,925 0.9 5,000

UP Acquisition Corp. (3)

Unitranche First Lien Delayed Draw Term Loan


L + 625

(100 Floor


) (7)

7.25 % 05/2024 1,189 1,170 0.2 1,163

UP Acquisition Corp. (3) (5) (6)

Unitranche First Lien Revolver


L + 625

(100 Floor


) (7)

7.25 % 05/2024 391 374 0.1 364

UP Acquisition Corp. (3)

Unitranche First Lien Term Loan


L + 625

(100 Floor


) (7)

7.25 % 05/2024 4,334 4,272 0.8 4,242

Xcentric Mold and Engineering Acquisition Company, LLC (3)

Senior Secured First Lien Revolver



L + 700

(100 Floor

(including
100 PIK


)


) (8)

8.00 % 01/2022 710 707 0.1 614

Xcentric Mold and Engineering Acquisition Company, LLC (3)

Senior Secured First Lien Term Loan


L + 700

(100 Floor

(including

100 PIK


)

) (8)

8.00 % 01/2022 4,416 4,395 0.7 3,819

175,385 169,440 30.5 170,971

Consumer Durables & Apparel

EiKo Global, LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

06/2023 (8 )

EiKo Global, LLC (3)

Senior Secured First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 06/2023 3,223 3,188 0.6 3,223

3,223 3,180 0.6 3,223

Consumer Services

BJH Holdings III Corp. (3)

Unitranche First Lien Term Loan


L + 525

(100 Floor


) (8)

6.25 % 08/2025 13,355 13,194 2.3 12,921

Cambium Learning Group, Inc. (3)

Senior Secured Second Lien Term Loan



L + 850

(100 Floor


) (8)

9.50 % 12/2026 5,000 4,865 0.9 4,800

Colibri Group LLC (3)

Unitranche First Lien Delayed Draw Term Loan



L + 575

(100 Floor


) (8)

6.75 % 05/2025 1,337 1,312 0.2 1,350

Colibri Group LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

05/2025 (18 ) 10

See accompanying notes

28


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Colibri Group LLC (3)

Unitranche First Lien Term Loan


L + 575

(100 Floor


) (8)

6.75 % 05/2025 $ 8,126 $ 7,970 1.5 % $ 8,208

Everlast Parent Inc. (3) (4) (6) (9)

Unitranche First Lien Delayed Draw Term Loan

10/2026 (41 )

Everlast Parent Inc. (3) (4) (5) (6)

Unitranche First Lien Revolver

10/2026 (39 )

Everlast Parent Inc. (3)

Unitranche First Lien Term Loan


L + 650

(100 Floor


) (8)

7.50 % 10/2026 14,028 13,686 2.5 14,028

HGH Purchaser, Inc. (3) (6) (9)

Unitranche First Lien Delayed Draw Term Loan


L + 675

(100 Floor


) (8)

7.75 % 11/2025 2,815 2,725 0.5 2,815

HGH Purchaser, Inc. (3) (5) (6)

Unitranche First Lien Revolver


L + 675

(100 Floor


) (8)

7.75 % 11/2025 101 81 101

HGH Purchaser, Inc. (3)

Unitranche First Lien Term Loan


L + 675

(100 Floor


) (8)

7.75 % 11/2025 8,027 7,859 1.4 8,027

JLL XDD, Inc. (3)

Senior Secured First Lien Term Loan


L + 600

(100 Floor


) (13)

7.00 % 12/2023 5,970 5,824 1.1 6,030

JLL XDD, Inc. (3)

Senior Secured First Lien Term Loan


L + 550

(100 Floor


) (12)

6.50 % 12/2023 2,113 2,076 0.4 2,105

Learn-It Systems, LLC (3) (6) (14)

Senior Secured First Lien Delayed Draw Term Loan


L + 450

(100 Floor


) (8)

5.50 % 03/2025 1,140 1,079 0.2 1,111

Learn-It Systems, LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

03/2025 (14 ) (7 )

Learn-It Systems, LLC (3)

Senior Secured First Lien Term Loan


L + 450

(100 Floor


) (8)

5.50 % 03/2025 4,337 4,236 0.8 4,288

Southern HVAC Corporation (3) (4) (6) (14)

Unitranche First Lien Delayed Draw Term Loan

10/2025 (24 )

Southern HVAC Corporation (3) (4) (5) (6)

Unitranche First Lien Revolver

10/2025 (19 )

Southern HVAC Corporation (3)

Unitranche First Lien Term Loan


L + 625

(100 Floor


) (8)

7.25 % 10/2025 5,550 5,442 1.0 5,550

Teaching Strategies LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

05/2024 (9 )

Teaching Strategies LLC (3)

Unitranche First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 05/2024 9,141 8,999 1.6 9,141

United Language Group, Inc. (3) (5)

Senior Secured First Lien Revolver


L + 675

(100 Floor


) (7)

7.75 % 12/2021 400 398 0.1 381

United Language Group, Inc. (3)

Senior Secured First Lien Term Loan


L + 675

(100 Floor


) (7)

7.75 % 12/2021 4,641 4,616 0.8 4,419

Vistage Worldwide, Inc.

Senior Secured First Lien Term Loan


L + 400

(100 Floor


) (8)

5.00 % 02/2025 6,134 6,143 1.1 6,092

WeddingWire, Inc. (3)

Senior Secured Second Lien Term Loan

L + 825 (8) 8.46 % 12/2026 5,000 4,955 0.8 4,604

Wrench Group LLC (3)

Senior Secured Second Lien Term Loan

L + 788 (8) 8.13 % 04/2027 2,500 2,436 0.4 2,492

99,715 97,732 17.6 98,466

See accompanying notes

29


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Diversified Financials

GGC Aperio Holdings, L.P. (3)

Unitranche First Lien Term Loan

L + 500 (8) 5.15 % 10/2024 $ 8,405 $ 8,393 1.5 % $ 8,410

Goldentree Loan Management US CLO 2, Ltd. (3) (15)

CLO, Series 2017-2A, Class E

L + 470 4.92 % 11/2030 2,000 1,902 0.3 1,829

10,405 10,295 1.8 10,239

Energy

BJ Services, LLC (3) (16) (17)

Unitranche First Lien—Last Out Term Loan

01/2023 8,075 8,014 1.1 6,463

BJ Services, LLC (3)

Unitranche First Lien Term Loan



L + 700

(150 Floor


) (8)

8.50 % 01/2023 2,668 2,653 0.5 2,668

Black Diamond Oilfield Rentals, LLC (3)

Senior Secured First Lien Term Loan



L + 650

(100 Floor


) (8)

7.50 % 09/2021 10,386 10,332 1.7 9,645

21,129 20,999 3.3 18,776

Food & Staples Retailing

Isagenix International, LLC

Senior Secured First Lien Term Loan


L + 575

(100 Floor


)(8)

6.75 % 06/2025 6,068 6,046 0.6 3,408

PetIQ, LLC (3) (15)

Senior Secured First Lien Term Loan


L + 500

(100 Floor


) (7)

6.00 % 07/2025 14,812 14,703 2.6 14,812

20,880 20,749 3.2 18,220

Food, Beverage & Tobacco

Mann Lake Ltd. (3) (5) (6)

Senior Secured First Lien Revolver



L + 750

(100 Floor


) (8)

8.50 % 10/2024 840 829 0.1 840

Mann Lake Ltd. (3)

Senior Secured First Lien Term Loan



L + 750

(100 Floor


) (8)

8.50 % 10/2024 3,826 3,773 0.7 3,826

4,666 4,602 0.8 4,666

Health Care Equipment & Services

Abode Healthcare, Inc. (3) (4) (5) (6)

Senior Secured First Lien Revolver

08/2025 (18 ) (11 )

Abode Healthcare, Inc. (3)

Senior Secured First Lien Term Loan



L + 525

(100 Floor


) (8)

6.25 % 08/2025 4,740 4,663 0.8 4,693

Aegis Sciences Corporation

Senior Secured First Lien Term Loan



L + 550

(100 Floor


) (8)

6.50 % 05/2025 7,328 6,936 1.2 6,442

Ameda, Inc. (3) (5) (6)

Senior Secured First Lien Revolver



L + 700

(100 Floor


) (7)

8.00 % 09/2022 188 186 163

Ameda, Inc. (3)

Senior Secured First Lien Term Loan



L + 700

(100 Floor


) (7)

8.00 % 09/2022 2,201 2,185 0.4 2,022

Anne Arundel Dermatology Management,
LLC (3) (6) (9)

Senior Secured First Lien Delayed Draw Term Loan



L + 600

(100 Floor


) (8)

7.00 % 10/2025 491 460 0.1 491

Anne Arundel Dermatology Management,
LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

10/2025 (11 )

See accompanying notes

30


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Anne Arundel Dermatology Management,
LLC (3)

Senior Secured First Lien Term Loan



L + 600

(100 Floor


) (8)

7.00 % 10/2025 $ 2,450 $ 2,403 0.4 % $ 2,450

Avalign Technologies, Inc. (3)

Senior Secured First Lien Term Loan

L + 450 (8) 4.73 % 12/2025 16,837 16,709 3.0 16,753

BAART Programs, Inc. (3)

Senior Secured Second Lien Delayed Draw Term Loan


L + 800

(100 Floor


) (8)

9.00 % 03/2025 1,000 957 0.2 997

BAART Programs, Inc. (3)

Senior Secured Second Lien Term Loan


L + 825

(100 Floor


) (18)

9.25 % 03/2025 7,000 6,700 1.3 6,977

Centria Subsidiary Holdings, LLC (3) (5) (6)

Unitranche First Lien Revolver

P + 500 (19) 8.25 % 12/2025 158 109 158

Centria Subsidiary Holdings, LLC (3)

Unitranche First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 12/2025 11,753 11,452 2.1 11,753

CRA MSO, LLC (3) (5) (6)

Senior Secured First Lien Revolver


L + 700

(100 Floor


) (7)

8.00 % 12/2023 80 78 72

CRA MSO, LLC (3)

Senior Secured First Lien Term Loan


L + 700

(100 Floor


) (7)

8.00 % 12/2023 1,225 1,210 0.2 1,173

ExamWorks Group, Inc. (3)

Senior Secured Second Lien Term Loan


L + 725

(100 Floor


) (8)

8.25 % 07/2024 5,735 5,642 1.0 5,735

FH MD Buyer, Inc (3)

Senior Secured First Lien Term Loan


L + 575

(100 Floor


) (7)

6.75 % 10/2026 17,264 16,845 3.0 16,832

GrapeTree Medical Staffing, LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

10/2022 (3 ) (3 )

GrapeTree Medical Staffing, LLC (3)

Senior Secured First Lien Term Loan


L + 525

(100 Floor


) (7)

6.25 % 10/2022 1,645 1,633 0.3 1,634

GrapeTree Medical Staffing, LLC (3)

Senior Secured First Lien Term Loan


L + 525

(100 Floor


) (7)

6.25 % 10/2022 1,383 1,367 0.2 1,374

HCAT Acquisition, Inc. (3)

Unitranche First Lien Delayed Draw Term Loan


L + 925

(100 Floor


) (8)

10.25 % 11/2022 2,307 2,195 0.4 2,104

HCAT Acquisition, Inc. (3) (20)

Unitranche First Lien Revolver


L + 925

(100 Floor


) (8)

10.25 % 11/2022 3,837 3,649 0.6 3,499

HCAT Acquisition, Inc. (3)

Unitranche First Lien Term Loan


L + 925

(100 Floor


) (8)

10.25 % 11/2022 14,666 13,948 2.4 13,375

HCOS Group Intermediate III LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

09/2026 (17 ) (13 )

HCOS Group Intermediate III LLC (3)

Senior Secured First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 09/2026 11,571 11,348 2.0 11,397

Hospice Care Buyer, Inc. (3) (4) (6) (9)

Unitranche First Lien Delayed Draw Term Loan

12/2026 (40 )

See accompanying notes

31


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Hospice Care Buyer, Inc. (3) (5) (6)

Unitranche First Lien Revolver


L + 650

(100 Floor


) (8)

7.50 % 12/2026 $ 231 $ 183 % $ 231

Hospice Care Buyer, Inc. (3) (6)

Unitranche First Lien Term Loan


L + 650

(100 Floor


) (7)

7.50 % 12/2026 12,743 12,339 2.3 12,743

IvyRehab Intermediate II, LLC (3) (4) (6) (9)

Unitranche First Lien Delayed Draw Term Loan

12/2024 (28 ) (14 )

IvyRehab Intermediate II, LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

12/2024 (10 ) (5 )

IvyRehab Intermediate II, LLC (3)

Unitranche First Lien Term Loan


L + 675

(100 Floor


) (8)

7.75 % 12/2024 8,030 7,872 1.4 7,951

Lightspeed Buyer, Inc. (3) (6) (9)

Unitranche First Lien Delayed Draw Term Loan


L + 550

(100 Floor


) (7)

6.50 % 02/2026 1,146 1,120 0.2 1,114

Lightspeed Buyer, Inc. (3) (5) (6)

Unitranche First Lien Revolver


L + 550

(100 Floor


) (8)

6.50 % 02/2026 350 332 0.1 331

Lightspeed Buyer, Inc. (3)

Unitranche First Lien Term Loan


L + 550

(100 Floor


) (7)

6.50 % 02/2026 9,925 9,752 1.7 9,745

MDVIP, Inc.

Senior Secured First Lien Term Loan


L + 425

(100 Floor


) (7)

5.25 % 11/2024 9,561 9,561 1.7 9,534

Medsurant Holdings, LLC (3)

Senior Secured Second Lien Term Loan

1300 (11) 13.00 % 03/2022 7,945 7,907 1.4 7,859

NMN Holdings III Corp. (3)

Senior Secured Second Lien Delayed Draw Term Loan

L + 775 (7) 7.93 % 11/2026 1,667 1,626 0.3 1,641

NMN Holdings III Corp. (3)

Senior Secured Second Lien Term Loan

L + 775 (7) 7.93 % 11/2026 7,222 7,049 1.3 7,110

NMSC Holdings, Inc. (3)

Senior Secured Second Lien Term Loan


L + 1000

(100 Floor


) (8)

11.00 % 10/2023 4,307 4,230 0.8 4,194

Omni Ophthalmic Management Consultants, LLC (3) (4) (6) (9)

Senior Secured First Lien Delayed Draw Term Loan

03/2021 (2 ) (39 )

Omni Ophthalmic Management Consultants, LLC (3) (5)

Senior Secured First Lien Revolver


L + 750

(100 Floor


) (7)

8.50 % 05/2023 850 843 0.1 797

Omni Ophthalmic Management Consultants, LLC (3)

Senior Secured First Lien Term Loan


L + 750

(100 Floor


) (7)

8.50 % 05/2023 6,878 6,820 1.2 6,452

Pinnacle Treatment Centers, Inc. (3) (6) (9)

Unitranche First Lien Delayed Draw Term Loan


L + 625

(100 Floor


) (8)

7.25 % 12/2022 684 677 0.1 684

Pinnacle Treatment Centers, Inc. (3) (4) (5) (6)

Unitranche First Lien Revolver

12/2022 (5 )

Pinnacle Treatment Centers, Inc. (3)

Unitranche First Lien Term Loan


L + 625

(100 Floor


) (8)

7.25 % 12/2022 8,052 7,996 1.4 8,052

Professional Physical Therapy (3)

Senior Secured First Lien Term Loan




L + 850

(100 Floor

(including
250 PIK


)


) (8)

9.50 % 12/2022 8,975 8,755 1.2 6,855

See accompanying notes

32


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

PT Network, LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

11/2023 $ $ (1 ) % $ (10 )

PT Network, LLC (3)

Senior Secured First Lien Term Loan



L + 750

(100 Floor

(including
200 PIK


)


) (8)

8.50 % 11/2023 4,789 4,782 0.8 4,672

Safco Dental Supply, LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

06/2025 (8 ) (1 )

Safco Dental Supply, LLC (3)

Unitranche First Lien Term Loan


L + 450

(100 Floor


) (8)

5.50 % 06/2025 4,043 3,988 0.7 4,034

Seniorlink Incorporated (3) (4) (5) (6)

Unitranche First Lien Revolver

07/2026 (29 )

Seniorlink Incorporated (3)

Unitranche First Lien Term Loan


L + 700

(100 Floor


) (8)

8.00 % 07/2026 6,818 6,626 1.2 6,818

Smile Brands, Inc. (3)

Senior Secured First Lien Delayed Draw Term Loan



L + 517

(21 Floor


) (8)

5.49 % 10/2024 619 615 0.1 604

Smile Brands, Inc. (3) (4) (5) (6)

Senior Secured First Lien Revolver

09/2024 (2 ) (7 )

Smile Brands, Inc. (3)

Senior Secured First Lien Term Loan


L + 517

(21 Floor


) (8)

5.49 % 10/2024 2,058 2,044 0.4 2,007

Smile Doctors LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

10/2022 (6 )

Smile Doctors LLC (3)

Senior Secured First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 10/2022 16,280 16,261 2.9 16,196

Unifeye Vision Partners (3) (6) (14)

Senior Secured First Lien Delayed Draw Term Loan

P + 400 (19) 7.25 % 09/2025 813 782 0.1 707

Unifeye Vision Partners (3) (5) (6)

Senior Secured First Lien Revolver

P + 400 (19) 7.25 % 09/2025 453 427 0.1 394

Unifeye Vision Partners (3)

Senior Secured First Lien Term Loan


L + 500

(100 Floor


) (8)

6.00 % 09/2025 5,346 5,259 0.9 5,159

Vital Care Buyer, LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

10/2025 (37 ) (39 )

Vital Care Buyer, LLC (3)

Unitranche First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 10/2025 7,778 7,646 1.4 7,642

Zest Acquisition Corp.

Senior Secured First Lien Term Loan

L + 350 (7) 3.66 % 03/2025 8,603 8,604 1.5 8,259

260,025 254,560 44.9 251,731

Household & Personal Products

Tranzonic (3) (5) (6)

Senior Secured First Lien Revolver


P + 375

(100 Floor


) (19)

7.00 % 03/2023 440 438 0.1 440

Tranzonic (3)

Senior Secured First Lien Term Loan


L + 450

(100 Floor


) (7)

5.50 % 03/2023 3,813 3,793 0.7 3,813

4,253 4,231 0.8 4,253

Insurance

Comet Acquisition, Inc. (3)

Senior Secured Second Lien Term Loan

L + 750 (8) 7.75 % 10/2026 3,563 3,556 0.6 3,231

See accompanying notes

33


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Integrity Marketing Acquisition, LLC (3)

Unitranche First Lien Delayed Draw Term Loan


L + 550

(100 Floor


) (8)

6.50 % 08/2025 $ 5,068 $ 4,959 0.9 % $ 5,068

Integrity Marketing Acquisition, LLC (3)

Unitranche First Lien Delayed Draw Term Loan


L + 550

(100 Floor


) (8)

6.50 % 08/2025 3,064 2,997 0.5 3,064

Integrity Marketing Acquisition, LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

08/2025 (39 )

Integrity Marketing Acquisition, LLC (3)

Unitranche First Lien Term Loan


L + 550

(100 Floor


) (8)

6.50 % 08/2025 12,879 12,618 2.3 12,879

Integro Parent, Inc. (3) (15)

Senior Secured First Lien Term Loan


L + 575

(100 Floor


) (7)

6.75 % 10/2022 473 470 0.1 473

Integro Parent, Inc. (3) (15)

Senior Secured Second Lien Delayed Draw Term Loan


L + 925

(100 Floor


) (7)

10.25 % 10/2023 380 378 0.1 369

Integro Parent, Inc. (3) (15)

Senior Secured Second Lien Term Loan


L + 925

(100 Floor


) (7)

10.25 % 10/2023 2,916 2,889 0.5 2,825

The Hilb Group, LLC (3)

Unitranche First Lien Delayed Draw Term Loan


L + 575

(100 Floor


) (7)

6.75 % 12/2026 1,019 996 0.2 1,016

The Hilb Group, LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

12/2025 (7 ) (1 )

The Hilb Group, LLC (3)

Unitranche First Lien Term Loan


L + 575

(100 Floor


) (8)

6.75 % 12/2026 3,603 3,524 0.6 3,594

THG Acquisition, LLC (3) (6) (9)

Unitranche First Lien Delayed Draw Term Loan


L + 600

(100 Floor


) (8)

7.00 % 12/2026 53 31 49

THG Acquisition, LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

12/2025 (4 )

THG Acquisition, LLC (3)

Unitranche First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 12/2026 1,069 1,042 0.2 1,066

34,087 33,410 6.0 33,633

Materials

Kestrel Parent, LLC (3) (4) (6) (20)

Unitranche First Lien Revolver

11/2023 (12 )

Kestrel Parent, LLC (3)

Unitranche First Lien Term Loan


L + 575

(100 Floor


) (8)

6.75 % 11/2025 6,672 6,547 1.2 6,672

6,672 6,535 1.2 6,672

Pharmaceuticals, Biotechnology & Life Sciences

Pharmalogic Holdings Corp. (3)

Senior Secured Second Lien Delayed Draw Term Loan

L + 800 (7) 8.15 % 12/2023 4,760 4,733 0.8 4,663

Pharmalogic Holdings Corp. (3)

Senior Secured Second Lien Term Loan

L + 800 (7) 8.15 % 12/2023 5,460 5,428 1.0 5,349

Pharmalogic Holdings Corp. (3)

Senior Secured Second Lien Term Loan

L + 800 (7) 8.15 % 12/2023 5,880 5,845 1.0 5,760

Teal Acquisition Co., Inc (3) (4) (6) (9)

Unitranche First Lien Delayed Draw Term Loan

09/2026 (24 )

See accompanying notes

34


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Teal Acquisition Co., Inc (3) (5) (6)

Unitranche First Lien Revolver


L + 625

(100 Floor


) (8)

7.25 % 09/2026 $ 274 $ 237 0.1 % $ 274

Teal Acquisition Co., Inc (3)

Unitranche First Lien Term Loan


L + 625

(100 Floor


) (8)

7.25 % 09/2026 9,124 8,861 1.6 9,124

Trinity Partners, LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

02/2025 (4 )

Trinity Partners, LLC (3)

Senior Secured First Lien Term Loan


L + 525

(100 Floor


) (7)

6.25 % 02/2025 3,709 3,682 0.7 3,709

29,207 28,758 5.2 28,879

Retailing

Palmetto Moon LLC, (3)

Senior Secured First Lien Term Loan


1150 +

250 PIK


(11)

14.00 % 10/2021 4,155 3,397 0.7 3,813

Slickdeals Holdings, LLC (3) (4) (6) (10) (20)

Unitranche First Lien Revolver

06/2023 (10 )

Slickdeals Holdings, LLC (3) (10)

Unitranche First Lien Term Loan


L + 625

(100 Floor


) (12)

7.25 % 06/2024 14,528 14,223 2.6 14,528

18,683 17,610 3.3 18,341

Software & Services

Affinitiv, Inc. (3) (4) (5) (6)

Unitranche First Lien Revolver

08/2024 (7 )

Affinitiv, Inc. (3)

Unitranche First Lien Term Loan


L + 700

(100 Floor


) (8)

8.00 % 08/2024 6,435 6,349 1.2 6,435

Ansira Partners, Inc. (3) (16)

Unitranche First Lien Delayed Draw Term Loan

12/2024 964 931 0.1 676

Ansira Partners, Inc. (3) (16)

Unitranche First Lien Term Loan

12/2024 7,122 6,687 0.9 4,997

Avaap USA LLC (3)

Senior Secured First Lien Delayed Draw Term Loan


L + 725

(1007 Floor


) (7)

8.25 % 03/2023 344 340 0.1 336

Avaap USA LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

03/2023 (7 ) (15 )

Avaap USA LLC (3)

Senior Secured First Lien Term Loan


L + 725

(100 Floor


) (7)

8.25 % 03/2023 3,769 3,727 0.7 3,684

Benesys Inc. (3)

Senior Secured First Lien Term Loan


L + 475

(100 Floor


) (7)

5.75 % 10/2024 300 294 0.1 295

Benesys, Inc. (3) (4) (5) (6)

Senior Secured First Lien Revolver

10/2024 (1 ) (3 )

Benesys, Inc. (3)

Senior Secured First Lien Term Loan


L + 475

(100 Floor


) (7)

5.75 % 10/2024 1,414 1,400 0.3 1,388

C-4 Analytics, LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

08/2023 (5 )

C-4 Analytics, LLC (3)

Senior Secured First Lien Term Loan


L + 525

(100 Floor


) (7)

6.25 % 08/2023 9,916 9,832 1.8 9,916

CAT Buyer, LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

04/2024 (8 ) (17 )

CAT Buyer, LLC (3)

Unitranche First Lien Term Loan


L + 550

(100 Floor


) (7)

6.50 % 04/2024 6,239 6,154 1.1 6,041

See accompanying notes

35


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Claritas, LLC (3) (5) (6)

Senior Secured First Lien Revolver


L + 600

(100 Floor


) (8)

7.00 % 12/2023 $ 113 $ 111 $ 113

Claritas, LLC (3)

Senior Secured First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 12/2023 1,093 1,085 0.2 1,093

List Partners, Inc. (3) (4) (5) (6)

Senior Secured First Lien Revolver

01/2023 (4 ) % (6 )

List Partners, Inc. (3)

Senior Secured First Lien Term Loan


L + 500

(100 Floor


) (7)

6.00 % 01/2023 4,495 4,455 0.8 4,440

MRI Software LLC (3) (4) (6) (9)

Unitranche First Lien Delayed Draw Term Loan

02/2026 (22 ) (3 )

MRI Software LLC (3) (4) (5) (6)

Unitranche First Lien Delayed Draw Term Loan

02/2026 (4 ) (1 )

MRI Software LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

02/2026 (16 ) (32 )

MRI Software LLC (3)

Unitranche First Lien Term Loan


L + 550

(100 Floor


) (8)

6.50 % 02/2026 149 145 149

MRI Software LLC (3)

Unitranche First Lien Term Loan


L + 550

(100 Floor


) (8)

6.50 % 02/2026 18,079 17,841 3.2 18,034

Ontario Systems, LLC (3) (4) (6) (9)

Unitranche First Lien Delayed Draw Term Loan

08/2025 (4 ) (38 )

Ontario Systems, LLC (3) (5) (6)

Unitranche First Lien Revolver


L + 550

(100 Floor


) (8)

6.50 % 08/2025 200 196 183

Ontario Systems, LLC (3)

Unitranche First Lien Term Loan


L + 550

(100 Floor


) (7)

6.50 % 08/2025 3,209 3,183 0.6 3,098

Park Place Technologies, LLC (3)

Unsecured Debt

1250 PIK (11) 12.50 % 05/2029 784 784 0.1 784

Perforce Software, Inc. (3)

Senior Secured Second Lien Term Loan

L + 800 (7) 8.15 % 07/2027 5,000 4,977 0.9 5,000

Prism Bidco, Inc. (3) (4) (5) (6)

Unitranche First Lien Revolver

06/2026 (23 ) (13 )

Prism Bidco, Inc. (3)

Unitranche First Lien Term Loan


L + 700

(100 Floor


) (8)

8.00 % 06/2026 7,463 7,254 1.3 7,351

Right Networks, LLC (3) (4) (5) (6)

Unitranche First Lien Revolver

11/2024 (4 )

Right Networks, LLC (3)

Unitranche First Lien Term Loan


L + 600

(100 Floor


) (7)

7.00 % 11/2024 9,645 9,472 1.7 9,645

Ruffalo Noel Levitz, LLC (3) (5) (6)

Unitranche First Lien Revolver


L + 600

(100 Floor


) (8)

7.00 % 05/2022 240 238 237

Ruffalo Noel Levitz, LLC (3)

Unitranche First Lien Term Loan


L + 600

(100 Floor


) (8)

7.00 % 05/2022 2,505 2,489 0.4 2,480

Saturn Borrower Inc (3) (4) (5) (6)

Unitranche First Lien Revolver

09/2026 (43 )

Saturn Borrower Inc (3)

Unitranche First Lien Term Loan


L + 650

(100 Floor


) (8)

7.50 % 09/2026 20,524 19,929 3.7 20,524

Transportation Insight, LLC (3) (9)

Senior Secured First Lien Delayed Draw Term Loan

L + 450 (7) 4.65 % 12/2024 1,277 1,269 0.2 1,226

See accompanying notes

36


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Transportation Insight, LLC (3) (4) (5) (6)

Senior Secured First Lien Revolver

12/2024 $ $ (5 ) $ (30 )

Transportation Insight, LLC (3)

Senior Secured First Lien Term Loan

L + 450 (7) 4.65 % 12/2024 5,142 5,107 0.9 4,936

Trident Technologies, LLC (3)

Senior Secured First Lien Term Loan


L + 600

(150 Floor


) (8)

7.50 % 12/2025 14,850 14,658 2.6 14,726

Winxnet Holdings LLC (3)

Unitranche First Lien Delayed Draw Term Loan


L + 600

(100 Floor


) (7)

7.00 % 06/2023 641 632 0.1 636

Winxnet Holdings LLC (3)

Unitranche First Lien Delayed Draw Term Loan


L + 600

(100 Floor


) (8)

7.00 % 06/2023 1,050 1,029 0.2 1,043

Winxnet Holdings LLC (3) (5) (6)

Unitranche First Lien Revolver


L + 600

(100 Floor


) (7)

7.00 % 06/2023 240 236 237

Winxnet Holdings LLC (3)

Unitranche First Lien Term Loan


L + 600

(100 Floor


) (7)

7.00 % 06/2023 1,950 1,929 0.3 % 1,936

135,152 132,580 23.5 131,481

Technology Hardware & Equipment

Onvoy, LLC (3)

Senior Secured Second Lien Term Loan


L + 1050

(100 Floor


) (7)

11.50 % 02/2025 2,635 2,556 0.5 2,585

Transportation

Pilot Air Freight, LLC (3)

Senior Secured First Lien Delayed Draw Term Loan


L + 475

(100 Floor


) (8)

5.75 % 07/2024 1,196 1,196 0.2 1,184

Pilot Air Freight, LLC (3)

Senior Secured First Lien Delayed Draw Term Loan


L + 475

(100 Floor


) (8)

5.75 % 07/2024 771 769 0.1 764

Pilot Air Freight, LLC (3) (4) (6) (9)

Senior Secured First Lien Revolver

07/2024 (1 )

Pilot Air Freight, LLC (3)

Senior Secured First Lien Term Loan


L + 475

(100 Floor


) (8)

5.75 % 07/2024 5,363 5,343 1.0 5,310

7,330 7,308 1.3 7,257

Total Debt Investments

United States

$ 878,578 $ 856,705 151.8 % $ 850,093

Equity Investments

Capital Goods

Alion Science and Technology Corporation (3)

Common Stock

745,504 766 0.2 1,392

Envocore Holding, LLC (3)

Preferred Stock

1,139,725

1,885,229 766 0.2 1,392

Commercial & Professional Services

Allied Universal holdings, LLC (3)

Common Stock, Class A

2,240,375 1,011 0.5 2,716

ASP MCS Acquisition Corp. (10)

Common Stock

11,792 1,150 0.3 1,500

See accompanying notes

37


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Battery Solutions, Inc. (3) (10)

Preferred Stock, Class E

5,275,561 3,669 0.4 2,373

Battery Solutions, Inc. (3) (10)

Preferred Stock, Class A

50,000

Battery Solutions, Inc. (3) (10)

Preferred Stock, Class F

3,333,333

Hercules Borrower LLC (3)

Common Stock

1,153,075 1,153 0.2 1,153

IGT Holding LLC (3)

Preferred Stock

645,730

IGT Holding LLC (3)

Common Stock

1,000,000

MHS Acquisition Holdings, LLC (3)

Common Stock

10 10

MHS Acquisition Holdings, LLC (3)

Preferred Stock

1,018 923 0.2 799

My Alarm Center, LLC (3)

Common Stock

129,582

My Alarm Center, LLC (3)

Junior Preferred Stock

2,420

My Alarm Center, LLC (3)

Senior Preferred Stock

2,998

PB Parent, LP (3)

Common Stock

1,125,000 1,125 0.2 1,189

RSI Acquisition, LLC (3)

Preferred Stock, Class A

137,000 137 196

Saber Parent Holdings (3)

Common Stock

13,132 1,313 0.2 1,313

TecoStar Holdings, Inc. (3)

Common Stock

500,000 500 0.2 1,024

15,621,026 10,991 2.2 12,263

Consumer Services

Everlast Holding, Inc. (3)

Common Stock

948 948 0.2 948

Green Wrench Acquisition, LLC (3)

Common Stock

4,082 410 0.1 569

HGH Investment, LP (3)

Common Stock, Class A

4,171 417 0.1 562

Legalshield (3)

Common Stock

372 372 0.1 495

Southern Technical Institute, Inc. (3) (10)

Common Stock, Class A1

6,000,000 1.3 6,987

Southern Technical Institute, Inc. (3) (10)

Common Stock, Class A

3,164,063 266

Wrench Group Holdings, LLC (3)

Common Stock, Class A

1,143 115 160

9,174,779 2,262 1.8 9,987

Diversified Financials

CBDC Senior Loan Fund LLC (15) (21) (22)

Partnership Interest

40,000,000 40,000 6.9 38,735

See accompanying notes

38


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

GACP II LP (10) (15) (22) (23)

Partnership Interest

16,227,613 $ 16,228 2.9 % $ 16,154

56,227,613 56,228 9.8 54,889

Health Care Equipment & Services

ExamWorks Group, Inc. (3)

Common Stock

7,500 750 0.3 1,586

Hospice Care Buyer, Inc. (3)

Common Stock

11,265 1,127 0.2 1,127

MDVIP, Inc. (3)

Common Stock

46,807 648 0.2 1,169

NMN Holdings LP (3)

Common Stock

11,111 1,111 0.3 1,454

PT Network, LLC (3)

Common Stock, Class C

0.93

SL Topco Holdings, Inc. (3)

Common Stock

68,182 682 0.2 944

Spartan Healthcare Holdings, LLC (3)

Common Stock

11,911 1,191 0.2 1,353

156,777 5,509 1.4 7,633

Insurance

Integrity Marketing Acquisition, LLC (3)

Common Stock

619,562 648 0.2 1,252

Integrity Marketing Acquisition, LLC (3)

Preferred Stock

1,247 1,216 0.3 1,485

Integro Parent, Inc. (3) (15)

Common Stock

4,468 454 0.1 784

625,277 2,318 0.6 3,521

Materials

Kestrel Upperco, LLC (3)

Common Stock, Class A

41,791 209 240

Media & Entertainment

Conisus, LLC (3) (10)

Common Stock

4,914,556 0.8 4,320

Conisus, LLC (3) (10) (24)

Preferred Stock, Series B

1500 PIK 15.00 % 18,544,370 10,160 3.3 18,545

23,458,926 10,160 4.1 22,865

Pharmaceuticals, Biotechnology & Life Sciences

Teal Parent Holdings, LP (3)

Common Stock

4,562 456 0.1 456

Retailing

Palmetto Moon, LLC (3)

Common Stock

99

Slickdeals Holdings, LLC (3) (10)

Common Stock

61 990 0.3 1,482

Vivid Seats Ltd. (3) (10)

Common Stock

608,108 608 0.1 801

Vivid Seats Ltd. (3) (10)

Preferred Stock

1,891,892 1,892 0.5 2,913

2,500,160 3,490 0.9 5,196

See accompanying notes

39


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Software & Services

Curvature (3) (25)

Residual Interest

2,482 0.4 2,481

Saturn Topco LP (3)

Common Stock

411,511 412 0.1 412

411,511 2,894 0.5 2,893

Technology Hardware & Equipment

Onvoy, LLC (3)

Common Stock, Class A

3,649 365 0.1 410

Onvoy, LLC (3)

Common Stock, Class B

2,536

6,185 365 0.1 410

Transportation

Xpress Global Systems, LLC (3)

Common Stock

12,544

Total Equity Investments

United States

110,126,380 $ 95,648 21.7 % $ 121,745

Total United States

$ 952,353 173.5 % $ 971,838

Canada

Debt Investments

Health Care Equipment & Services

VetStrategy (3) (4) (6) (9) (11)

Unitranche First Lien Delayed Draw Term Loan

07/2027 C$ 657 (35 )

VetStrategy (3) (15)

Unitranche First Lien Term Loan


C + 700

(100 Floor


) (26)

8.00 % 07/2027 9,292 6,738 1.3 7,294

VetStrategy (3) (6) (9) (15)

Unitranche First Lien Delayed Draw Term Loan


C + 700

(100 Floor


) (26)

8.00 % 07/2027 1,399 973 0.2 1,010

VetStrategy (3) (15)

Unitranche First Lien Delayed Draw Term Loan


C + 700

(100 Floor


) (26)

8.00 % 07/2027 1,729 1,259 0.2 1,357

13,077 8,935 1.7 9,661

Telecommunication Services

Sandvine Corporation (3) (15)

Senior Secured Second Lien Term Loan

L + 800 (7) 8.15 % 11/2026 4,500 4,359 0.7 4,062

Total Debt Investments

Canada

C$ 17,577 $ 13,294 2.4 % $ 13,723

Equity Investments

Health Care Equipment & Services

VetStrategy (3) (15)

Common Stock

750,000 $ 560 0.1 % $ 589

750,000 560 0.1 589

Total Equity Investments

Canada

750,000 $ 560 0.1 % $ 589

Total Canada

$ 13,854 2.5 % $ 14,312

United Kingdom

See accompanying notes

40


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Debt Investments

Commercial & Professional Services

Crusoe Bidco Limited (3) (6) (15) (27)

Unitranche First Lien

Delayed Draw Term Loan

L + 625 (28) 6.27 % 12/2025 £ 303 398 0.1 415

Crusoe Bidco Limited (3) (15)

Unitranche First Lien Term Loan

L + 625 (28) 6.28 % 12/2025 6,068 7,431 1.5 8,294

Crusoe Bidco Limited (3) (6) (15) (27)

Unitranche First Lien

Delayed Draw Term Loan

12/2025

6,371 7,829 1.6 8,709

Consumer Services

Auction Technology Group (3) (15)

Unitranche First Lien Term Loan

L + 650 (29) 6.62 % 02/2027 £ 3,339 4,241 0.8 4,564

Auction Technology Group (3) (15)

Unitranche First Lien Term Loan

L + 650 (29) 6.84 % 02/2027 $ 10,687 10,398 1.9 10,687

14,026 14,639 2.7 15,251

Total Debt Investments

United Kingdom

20,397 $ 22,468 4.3 % $ 23,960

Total United Kingdom

$ 22,468 4.3 % $ 23,960

Netherlands

Debt Investments

Pharmaceuticals, Biotechnology & Life Sciences

PharComp Parent B.V. (3) (15) (17)

Unitranche First Lien—Last Out Term Loan

E + 625 (30) (31) 6.25 % 02/2026 6,910 7,654 1.5 8,454

PharComp Parent B.V. (3) (6) (15) (27)

Unitranche First Lien Term Loan

E + 625 (30) (31) 6.25 % 02/2026 187 151 0.1 229

7,097 7,805 1.6 8,683

Total Debt Investments

Netherlands

7,097 $ 7,805 1.6 % $ 8,683

Total Netherlands

$ 7,805 1.6 % $ 8,683

Belgium

Debt Investments

Commercial & Professional Services

MIR Bidco SA (3) (15)

Unitranche First Lien Term Loan

E + 625 (31) (32) 6.25 % 04/2026 9,507 10,491 2.0 11,168

Miraclon Corporation (3) (15)

Unitranche First Lien Term Loan

L + 625 (12) 7.47 % 04/2026 $ 4,162 4,061 0.7 3,983

13,669 14,552 2.7 15,151

Total Debt Investments

Belgium

13,669 $ 14,552 2.7 % $ 15,151

Equity Investments

Commercial & Professional Services

MIR Bidco SA (3) (15)

Common Stock

921 1

MIR Bidco SA (3) (15)

Preferred Stock

81,384 91 57

82,305 92 57

See accompanying notes

41


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Company/Security/Country

Investment Type

Interest
Term *
Interest
Rate
Maturity /
Dissolution
Date
Principal
Amount,
Par
Value or
Shares**
Cost Percentage
of Net
Assets ***
Fair
Value

Total Equity Investments Belgium

82,305 $ 92 % $ 57

Total Belgium

$ 14,644 2.7 % $ 15,208

Total Investments

$ 1,011,124 184.6 % $ 1,034,001

*

The majority of the investments bear interest at a rate that may be determined by reference to London Interbank Offered Rate (“LIBOR” or “L”), Prime (“P”), CDOR (“C”) or EURIBOR (“E”) and which reset monthly, bi-monthly, quarterly, semiannually or annually. For each, the Company has provided the spread over LIBOR or Prime and the current interest rate in effect at December 31, 2020. Certain investments are subject to a LIBOR or Prime interest rate floor. For fixed rate loans, a spread above a reference rate is not applicable.

**

The total par amount is presented for debt investments, while the number of shares or units owned is presented for equity investments. Par amount is denominated in U.S. Dollars (“$”) unless otherwise noted, Canadian Dollar (“C$”), Euro (“€”), or Pound Sterling (“£”).

***

Percentage is based on net assets of $560,000 as of December 31, 2020.

(1)

All positions held are non-controlled/non-affiliated investments, unless otherwise noted, as defined by the Investment Company Act of 1940, as amended (“1940 Act”). Non-controlled/non-affiliated investments are investments that are neither controlled nor affiliated.

(2)

All debt investments are income-producing, unless otherwise noted. Equity and member interests are non-income-producing unless otherwise noted. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended, or the Securities Act. Its investments are therefore generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act.

(3)

The fair value of the investment was determined using significant unobservable inputs. See Note 2 “Summary of Significant Accounting Policies”.

(4)

The negative cost, if applicable, is the result of the capitalized discount or unfunded commitment being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount or unfunded commitment on the loan.

(5)

Investment pays 0.50% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(6)

Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 “Commitments and Contingencies”.

(7)

The interest rate on these loans is subject to the greater of a LIBOR floor or 1 month LIBOR plus a base rate. The 1 month LIBOR as of December 31, 2020 was 0.14%. For some of these loans, the interest rate is based on the last reset date.

(8)

The interest rate on these loans is subject to the greater of a LIBOR floor or 3 month LIBOR plus a base rate. The 3 month LIBOR as of December 31, 2020 was 0.24%. For some of these loans, the interest rate is based on the last reset date.

(9)

Investment pays 1.00% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(10)

As defined in the 1940 Act, the portfolio company is deemed to be a “non-controlled affiliated person” of the Company because the Company owns, either directly or indirectly, 5% or more of the portfolio company’s outstanding voting securities. See Note 3 “Agreements and Related Party Transactions”.

(11)

Fixed rate investment.

(12)

The interest rate on these loans is subject to the greater of a LIBOR floor or 6 month LIBOR plus a base rate. The 6 month LIBOR as of December 31, 2020 was 0.26%. For some of these loans, the interest rate is based on the last reset date.

(13)

The interest rate on these loans is subject to the greater of a LIBOR floor or 2 month LIBOR plus a base rate. The 2 month LIBOR as of December 31, 2020 was 0.19%. For some of these loans, the interest rate is based on the last reset date.

(14)

Investment pays 0.75% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(15)

Investment is not a qualifying investment as defined under section 55 (a) of the Investment Company Act of 1940. Qualifying assets must represent at least 70% of total assets at the time of acquisition. The Company’s percentage of non-qualifying assets based on fair value was 13.30% as of December 31, 2020.

(16)

The investment is on non-accrual status as of December 31, 2020.

(17)

These loans are unitranche first lien/last-out term loans. In addition to the interest earned based on the effective interest rate of this loan, which is the amount reflected in this schedule, the Company is entitled to receive additional interest as a result of an agreement among lenders whereby the loan has been allocated to “first-out” and “last-out” tranches, whereby the “first-out” tranche will have priority as to the “last-out” tranche with respect to payments of principal, interest and any amounts due thereunder. The Company holds the “last-out” tranche.

(18)

The interest rate on these loans is subject to the greater of a LIBOR floor or 12 month LIBOR plus a base rate. The 12 month LIBOR as of December 31, 2020 was 0.34%. For some of these loans, the interest rate is based on the last reset date.

(19)

The interest rate on these loans is subject to the U.S. Prime rate, which as of December 31, 2020 was 3.25%.

(20)

Investment pays 0.38% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(21)

As defined in the 1940 Act, the portfolio company is deemed to be a “controlled affiliated person” of the Company because the Company owns, either directly or indirectly, 25% or more of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company. See Note 3 “Agreements and Related Party Transactions”.

(22)

This investment was valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels.

(23)

Investment is not redeemable.

(24)

Income producing equity security.

(25)

Residual interest in Curvature (Beijing) Technology Limited.

(26)

The interest rate on these loans is subject to the greater of a CDOR floor or 3 month CDOR plus a base rate. The 3 month CDOR as of December 31, 2020 was 0.50%. For some of these loans, the interest rate is based on the last reset date.

(27)

Investment pays 2.19% unfunded commitment fee on delayed draw term loan and/or revolving credit facilities.

(28)

The interest rate on these loans is subject to the greater of a GBP LIBOR floor or 3 month GBP LIBOR plus a base rate. The 3 month GBP LIBOR as of December 31, 2020 was 0.03%. For some of these loans, the interest rate is based on the last reset date.

(29)

The interest rate on these loans is subject to the greater of a GBP LIBOR floor or 6 month GBP LIBOR plus a base rate. The 6 month GBP LIBOR as of December 31, 2020 was 0.03%. For some of these loans, the interest rate is based on the last reset date.

(30)

The interest rate on these loans is subject to the greater of a EURIBOR floor or 3 month EURIBOR plus a base rate. The 3 month EURIBOR as of December 31, 2020 was (0.55)%. For some of these loans, the interest rate is based on the last reset date.

(31)

For EURIBOR rate investments where negative rates can be prevalent, a 0% floor is presumed.

(32)

The interest rate on these loans is subject to the greater of a EURIBOR floor or 6 month EURIBOR plus a base rate. The 6 month EURIBOR as of December 31, 2020 was (0.53)%. For some of these loans, the interest rate is based on the last reset date.

See accompanying notes

42


Table of Contents

CRESCENT CAPITAL BDC, INC.

Consolidated Schedule of Investments (Unaudited)

December 31, 2020

(in thousands, except share and per share data)

Foreign Currency Exchange

Contracts

Counterparty

Currency
Purchased
Currency Sold Settlement Unrealized
Appreciation/
(Depreciation)

Wells Fargo Bank, N.A.

USD 7,089 CAD 9,712 7/31/2025 $ (12 )

Wells Fargo Bank, N.A.

USD 612 CAD 801 7/31/2025 (485 )

Wells Fargo Bank, N.A.

USD 325 CAD 422 7/31/2025 (4 )

Wells Fargo Bank, N.A.

USD 622 CAD 839 7/31/2025 (32 )

Wells Fargo Bank, N.A.

USD 635 CAD 864 7/31/2025 (39 )

Wells Fargo Bank, N.A.

USD 209 EUR 187 2/20/2024 (26 )

Wells Fargo Bank, N.A.

USD 8,063 EUR 6,703 2/20/2024 183

Wells Fargo Bank, N.A.

USD 11,682 EUR 9,222 4/10/2024 81

Wells Fargo Bank, N.A.

USD 7,975 GBP 5,885 12/1/2023 (125 )

Wells Fargo Bank, N.A.

USD 395 GBP 294 12/1/2023 (10 )

Wells Fargo Bank, N.A.

USD 4,317 GBP 3,239 2/13/2025 (163 )
Total Foreign Currency Exchange Contracts

$ (632 )

CAD

Canadian Dollar

EUR

Euro

GBP

Great British Pound

PIK

Payment In-Kind

USD

United States Dollar

See accompanying notes

43


Table of Contents

CRESCENT CAPITAL BDC, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

September 30, 2021 (Unaudited)

Note 1. Organization and Basis of Presentation

Crescent Capital BDC, Inc. (the “Company”) was formed on February 5, 2015 (“Inception”) as a Delaware corporation structured as an externally managed, closed-end management investment company. The Company commenced investment operations on June 26, 2015. On January 30, 2020, the Company changed its state of incorporation from the State of Delaware to the State of Maryland. The Company has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”) and currently operates as a diversified investment company. In addition, the Company has elected to be treated for U.S. federal income tax purposes as a regulated investment company (a “RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). As a RIC, the Company will not be taxed on its income to the extent that it distributes such income each year and satisfies other applicable income tax requirements.

The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. The Company invests primarily in secured debt (including first lien, unitranche first lien and second lien debt) and unsecured debt (including mezzanine and subordinated debt), as well as related equity securities of private U.S. middle-market companies. Although the Company’s focus is to invest in private credit transactions, in certain circumstances it may also invest in broadly syndicated loans and bonds.

The Company is managed by Crescent Cap Advisors, LLC (the “Adviser” and formerly, CBDC Advisors, LLC), an investment adviser that is registered with the Securities and Exchange Commission (the “SEC”) under the Investment Advisers Act of 1940, as amended. CCAP Administration LLC (the “Administrator” and formerly, CBDC Administration, LLC) provides the administrative services necessary for the Company to operate. Company management consists of investment and administrative professionals from the Adviser and Administrator, along with the Company’s Board of Directors (the “Board”). The Adviser directs and executes the investment operations and capital raising activities of the Company subject to oversight from the Board, which sets the broad policies of the Company. The Board has delegated investment management of the Company’s investment assets to the Adviser. The Board consists of five directors, four of whom are independent.

The Company has formed a wholly owned subsidiary that is structured as a tax blocker, to hold equity or equity-like investments in portfolio companies organized as limited liability companies or other forms of pass-through entities. This corporate subsidiary is not consolidated for income tax purposes and may incur income tax expenses as a result of its ownership of portfolio companies.

On January 31, 2020, the Company completed a transaction to acquire Alcentra Capital Corporation in a cash and stock transaction (the “Alcentra Acquisition”). The Company was listed and began trading on the NASDAQ stock exchange on February 3, 2020.

On January 5, 2021, Sun Life Financial Inc. (together with its subsidiaries and joint ventures, “Sun Life”) acquired a majority interest in Crescent Capital Group LP (“Crescent”), the majority member of the Adviser (the “Sun Life Transaction”). Consummation of the Sun Life Transaction resulted in a change of control of Crescent.

Basis of Presentation

The Company’s functional currency is the United States dollar and these consolidated financial statements have been prepared in that currency. The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to Regulation S-X. The Company is an investment company and, therefore, applies the specialized accounting and reporting guidance in Accounting Standards Codification (“ASC”) 946, Financial Services – Investment Companies.

The accompanying interim consolidated financial statements of the Company and related financial information have been prepared pursuant to the requirements for reporting on Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain disclosures accompanying annual consolidated financial statements prepared in accordance with GAAP are omitted. In the opinion of management, the unaudited interim financial results included herein contain all adjustments and reclassifications that are necessary for the fair presentation of consolidated financial statements for the periods included herein. All significant intercompany balances and transactions have been eliminated. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the year ending December 31, 2021.

44


Table of Contents

Note 2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that may affect the amounts reported in the consolidated financial statements and accompanying notes. These consolidated financial statements reflect adjustments that in the opinion of management are necessary for the fair statement of the results for the periods presented. Although management believes that the estimates and assumptions are reasonable, changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially.

Cash and Cash Equivalents

Cash and cash equivalents consist of demand deposits and may include highly liquid investments (e.g., money market funds, U.S. Treasury notes, and similar type instruments) with original maturities of three months or less. Cash and cash equivalents other than money market mutual funds, are carried at cost plus accrued interest, which approximates fair value. Money market mutual funds are carried at their net asset value, which approximates fair value. Restricted cash and cash equivalents consists of deposits and cash collateral held at Wells Fargo Bank N.A. related to the Company’s credit facility and foreign currency forward contracts. The Company holds cash and cash equivalents denominated in foreign currencies. The Company deposits its cash, cash equivalents and restricted cash with highly rated banking corporations and, at times, cash deposits may exceed the insured limits under applicable law.

Investment Transactions

Loan originations are recorded on the date of the binding commitment. Investments purchased on a secondary market are recorded on the trade date. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last business day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.

Investment Valuation

The Company applies Financial Accounting Standards Board ASC 820, Fair Value Measurement (ASC 820), as amended, which establishes a framework for measuring fair value in accordance with GAAP and required disclosures of fair value measurements. ASC 820 determines fair value to be the price that would be received for an investment in a current sale, which assumes an orderly transaction between market participants on the measurement date. Market participants are defined as buyers and sellers in the principal or most advantageous market (which may be a hypothetical market) that are independent, knowledgeable, and willing and able to transact. In accordance with ASC 820, the Company considers its principal market to be the market that has the greatest volume and level of activity. ASC 820 specifies a fair value hierarchy that prioritizes and ranks the level of observability of inputs used in the determination of fair value. In accordance with ASC 820, these levels are summarized below:

Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

Level 2—Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

Investments for which market quotations are readily available are typically valued at those market quotations. To validate market quotations, the Company utilizes a number of factors to determine if the quotations are representative of fair value, including the source and number of the quotations. Debt and equity securities that are not publicly traded or whose market prices are not readily available are valued at fair value as determined in good faith by the Board, based on, among other things, the input of the Adviser, the Company’s Audit Committee and, with certain de minimis exceptions, independent third-party valuation firms engaged at the direction of the Board.

The Board oversees and supervises a multi-step valuation process, which includes, among other procedures, the following:

The valuation process begins with each investment being initially valued by the investment professionals responsible for the portfolio investment in conjunction with the portfolio management team.

45


Table of Contents

The Adviser’s management and Crescent’s alternative investment valuation committee reviews the preliminary valuations with the investment professionals. Agreed upon valuation recommendations are presented to the Audit Committee.

The Audit Committee reviews the valuations presented and recommends values for each investment to the Board.

The Board reviews the recommended valuations and determines the fair value of each investment.

Investments in investment companies are valued at fair value. Fair values are generally determined utilizing the net asset value (“NAV”) supplied by, or on behalf of, management of each investment company, which is net of management and incentive fees or allocations charged by the investment company and is in accordance with the “practical expedient”, as defined by ASC 820 . NAVs received by, or on behalf of, management of each investment company are based on the fair value of the investment company’s underlying investments in accordance with policies established by management of each investment company, as described in each of their financial statements and offering memorandum. Investments which are valued using NAV as a practical expedient are excluded from the above hierarchy.

The Company applies the valuation policy approved by its Board that is consistent with ASC 820. Consistent with the valuation policy, the Company evaluates the source of inputs, including any markets in which its investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. When a security is valued based on prices provided by reputable dealers or pricing services (that is, broker quotes), the Company subjects those prices to various criteria in making the determination as to whether a particular investment would qualify for classification as a Level 2 or Level 3 investment. For example, the Company reviews pricing methodologies provided by dealers or pricing services in order to determine if observable market information is being used, versus unobservable inputs. Some additional factors considered include the number of prices obtained as well as an assessment as to their quality. Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur.

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of such investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that may ultimately be realized. Further, such investments are generally less liquid than publicly traded securities and may be subject to contractual and other restrictions on resale. If the Company were required to liquidate a portfolio investment in a forced or liquidation sale, it could realize amounts that are different from the amounts presented and such differences could be material. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different from the unrealized gains or losses reflected herein.

Foreign Currency

Foreign currency amounts are translated into U.S. dollars on the following basis:

cash and cash equivalents, fair value of investments, outstanding debt on revolving credit facilities, other assets and liabilities: at the spot exchange rate on the last business day of the period; and

purchases and sales of investments, borrowings and repayments of such borrowings, income and expenses: at the rates of exchange prevailing on the respective dates of such transactions.

Although net assets and fair values are presented based on the applicable foreign exchange rates described above, the Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in fair values of investments held. Gains or losses on foreign currency transactions are included with net realized gain (loss) on foreign currency transactions on the Consolidated Statements of Operations. Fluctuations arising from the translation of foreign currency on cash, investments and borrowings are included with net change in unrealized appreciation (depreciation) on investments and foreign currency translation on the Consolidated Statements of Operations.

The Company’s approach to hedging the foreign currency exposure in its non-U.S. dollar denominated investments is to enter into foreign currency forward contracts.

Foreign currency forward contracts

The Company may enter into foreign currency forward contracts to reduce the Company’s exposure to foreign currency exchange rate fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another, at a pre-determined price at a future date. Forward foreign currency contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts are recorded on the Consolidated Statements of Assets and Liabilities on a gross basis, not taking into account collateral posted which is recorded separately, if applicable. All foreign currency forward contracts are currently held with a single counterparty. Notional amounts and the gross fair value of foreign currency forward contract assets and liabilities are presented separately on the Consolidated Schedules of Investments. Purchases and sales of foreign currency forward contracts having the same notional value, settlement date and counterparty are generally settled net (which results in a net foreign currency position of zero with the counterparty) and any realized gains or losses are recognized on the settlement date.

46


Table of Contents

The Company does not utilize hedge accounting and as such, the Company recognizes its derivatives at fair value with changes in the net unrealized appreciation (depreciation) on foreign currency forward contracts recorded on the Consolidated Statements of Operations.

Debt Issuance Costs

The Company records costs related to the issuance of debt obligations as deferred financing costs. These costs are amortized over the life of the related debt instrument using the straight-line method or the effective yield method, depending on the type of debt instrument. As of September 30, 2021 and December 31, 2020, there were $4,830 and $4,600, respectively, of deferred financing costs netted against debt balances on the Company’s Consolidated Statements of Assets and Liabilities.

Equity Offering Expenses

The Company records expenses related to registration statement filings and applicable offering costs as deferred offering costs. To the extent such expenses relate to equity offerings, these expenses are charged as a reduction of paid-in-capital upon each such offering.

Interest and Dividend Income Recognition

Interest income is recorded on an accrual basis and includes the amortization of purchase discounts and premiums. Discounts and premiums to par value are accreted or amortized into interest income over the contractual life of the respective security using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion and amortization of discounts and premiums, if any. Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income.

Dividend income from common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies. Dividend income from preferred equity securities is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Each distribution received from an equity investment is evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from equity investments as dividend income unless there is sufficient current or accumulated earnings prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.

Certain investments have contractual payment-in-kind (“PIK”) interest or dividends. PIK represents accrued interest or accumulated dividends that are added to the loan principal or cost basis of the investment on the respective interest or dividend payment dates rather than being paid in cash and generally becomes due at maturity or upon being called by the issuer. PIK is recorded as interest income, as applicable. If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. Accrued PIK interest or dividends are generally reversed through interest or dividend income, respectively, when an investment is placed on non-accrual status.

Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management’s judgment, are likely to remain current. Management may determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection. As of September 30, 2021, the Company had two portfolio companies with three investment positions on non-accrual status, which represented 1.5% and 1.1% of the total debt investments at cost and fair value, respectively. As of December 31, 2020, the Company had two portfolio companies with three investment positions on non-accrual status, which represented 1.7% and 1.3% of the total debt investments at cost and fair value, respectively.

Other Income

Other income may include income such as consent, waiver, amendment, agency, underwriting and arranger fees associated with the Company’s investment activities. Such fees are recognized as income when earned or the services are rendered.

47


Table of Contents

Income Taxes

The Company has elected to be treated as a BDC under the 1940 Act. The Company also has elected to be treated as a RIC under the Internal Revenue Code. So long as the Company maintains its status as a RIC, it will generally not pay corporate-level U.S. federal income or excise taxes on any ordinary income or capital gains that it distributes at least annually to its stockholders as dividends. As a result, any tax liability related to income earned and distributed by the Company represents obligations of the Company’s stockholders and will not be reflected in the consolidated financial statements of the Company.

The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reversed and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof. The Company accounts for income taxes in conformity with ASC 740 — Income Taxes (“ASC 740”). ASC 740 provides guidelines for how uncertain tax positions should be recognized, measured, presented and disclosed in financial statements.

The Company intends to comply with the applicable provisions of the Code, pertaining to regulated investment companies and to make distributions of taxable income sufficient to relieve it from substantially all federal income taxes. As of September 30, 2021, the Company is subject to examination by U.S. federal tax authorities for returns filed for the three most recent calendar years and by state tax authorities for returns filed for the four most recent calendar years.

In order for the Company not to be subject to federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its ordinary income (taking into account certain deferrals and elections), (ii) 98.2% of its net capital gains from the current year and (iii) any undistributed ordinary income and net capital gains from preceding years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% excise tax on this income. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders. The Company accrues excise tax on estimated undistributed taxable income as required on a quarterly basis. For the three and nine months ended September 30, 2021, the Company expensed an excise tax of $170 and $431, respectively, of which $480 remained payable. For the three and nine months ended September 30, 2020 the Company expensed an excise tax of $116 and $458, respectively, of which $294 remained payable.

CBDC Universal Equity, Inc., a wholly-owned subsidiary of the Company, is a taxable entity (“Taxable Subsidiary”). The Taxable Subsidiary permits the Company to hold equity investments in portfolio companies which are “pass through” entities for tax purposes and continues to comply with the “source income” requirements contained in RIC tax provisions of the Code. The Taxable Subsidiary is not consolidated with the Company for income tax purposes and may generate income tax expense, benefit, and the related tax assets and liabilities, as a result of its ownership of certain portfolio investments. The income tax expense, or benefit, if any, and related tax assets and liabilities are reflected in the Company’s consolidated financial statements.

For the three and nine months ended September 30, 2021, the Company recognized a benefit/(provision) for taxes of $(392) and $(332), respectively, on unrealized appreciation/(depreciation) on investments and net operating losses and federal tax credits related to the Taxable Subsidiary. For the three and nine months ended September 30, 2020, the Company recognized a benefit/(provision) for taxes of $(161) and $101, respectively, on unrealized appreciation/(depreciation) on investments and net operating losses and federal tax credits related to the Taxable Subsidiary. As of September 30, 2021 and December 31, 2020, $54 and $630, respectively, was included in deferred tax assets on the Consolidated Statements of Assets and Liabilities relating to net operating loss carryforwards and unrealized losses on investments and other temporary book to tax differences that are expected to be used in future periods. As of September 30, 2021 and December 31, 2020, $1,079 and $1,324, respectively, was included in deferred tax liabilities on the Consolidated Statements of Assets and Liabilities primarily relating to deferred taxes on unrealized gains on investments held in the Company’s corporate subsidiary and other temporary book to tax differences of the corporate subsidiary.

For the three and nine months ended September 30, 2021, the Company recognized an income tax expense of $0 and $972 related to allocated taxable income. For the three and nine months ended September 30, 2021, the Company recognized a benefit/(provision) of $2 and $(370) related to realized gains on investments. For the three and nine months ended September 30, 2020, the Company recognized no income tax expense or provision on realized gains.

48


Table of Contents

Dividends and Distributions to Stockholders

Dividends and distributions to common stockholders are recorded on the record date. The amount to be paid out as a dividend is determined by the Board each quarter. Net realized capital gains, if any, are distributed at least annually, although the Company may decide to retain such capital gains for investment.

The Company adopted a dividend reinvestment plan that provides for reinvestment of the Company’s dividends and other distributions on behalf of the stockholders unless a stockholder elects to receive cash. As a result, if the Company’s Board authorizes, and the Company declares, a cash dividend, or other distribution then stockholders who are participating in the dividend reinvestment plan will have their cash dividends and distributions automatically reinvested in additional shares of common stock, rather than receiving cash dividends and distributions.

New Accounting Standards

In March 2020, the FASB issued Accounting Standard Update (“ASU”) No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” and in January 2021, the FASB issued Accounting Standards Update 2021-01 (“ASU 2021-01”) “Reference Rate Reform (Topic 848): Scope. This ASU provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected reference rate reform if certain criteria are met. ASU 2020-04 and 2021-01 are elective and can be adopted between March 12, 2020 and December 31, 2022. The Company doesn’t expect that the adoption of this guidance will have a material impact on its consolidated financial statements.

Note 3. Agreements and Related Party Transactions

Administration Agreement

On June 2, 2015, the Company entered into the administration agreement with the Administrator, as amended and restated on February 1, 2020. Under the terms of (the “Administration Agreement”), the Administrator provides administrative services to the Company. These services include providing office space, equipment and office services, maintaining financial records, preparing reports to stockholders and reports filed with the SEC, and managing the payment of expenses and the performance of administrative and professional services rendered by others. Certain of these services are reimbursable to the Administrator under the terms of the Administration Agreement. In addition, the Administrator is permitted to delegate its duties under the Administration Agreement to affiliates or third parties. To the extent the Administrator outsources any of its functions, the Company will pay the fees associated with such functions on a direct basis, without incremental profit to the Administrator. The Administration Agreement may be terminated by either party without penalty on 60 days’ written notice to the other party.

For the three and nine months ended September 30, 2021, the Company incurred administrative services expenses of $257 and $771, respectively, which are included in other general and administrative expenses on the Consolidated Statements of Operations. For the three and nine months ended September 30, 2020, the Company incurred administrative expenses of $204 and $615, respectively, which are included in other general and administrative expenses on the Consolidated Statements of Operations. In addition to administrative services expenses, the payable balances may include other operating expenses paid by the Administrator on behalf of the Company. As of September 30, 2021 and December 31, 2020, $441 and $321, respectively, was payable to the Administrator.

No person who is an officer, director or employee of the Administrator or its affiliates and who serves as a director of the Company receives any compensation from the Company for his or her services as a director. However, the Company reimburses the Administrator (or its affiliates) for an allocable portion of the compensation paid by the Administrator or its affiliates to the Company’s accounting professionals, legal counsel, and compliance professionals who spend time on such related activities (based on the percentage of time those individuals devote, on an estimated basis, to the business and affairs of the Company). The allocable portion of the compensation for these officers and other professionals are included in the administration expenses paid to the Administrator. Directors who are not affiliated with the Administrator or its affiliates receive compensation for their services and reimbursement of expenses incurred to attend meetings, which are included as directors’ fees on the Consolidated Statements of Operations.

Investment Advisory Agreement

On June 2, 2015, the Company entered into an investment advisory agreement with the Adviser, which was subsequently amended and restated (the “Investment Advisory Agreement”) and approved by the Company’s stockholders on January 29, 2020 in connection with the Alcentra Acquisition. Subsequently on December 17, 2020 in connection with the Sun Life Transaction, the Investment Advisory Agreement was re-approved by the Company’s stockholders. Under the terms of the Investment Advisory Agreement, the Adviser provides investment advisory services to the Company and its portfolio investments. The Adviser’s services under the Investment Advisory Agreement are not exclusive, and the Adviser is free to furnish similar or other services to others so long as its services to the Company are not impaired. Under the terms of the Advisory Agreements, the Adviser is entitled to receive a base management fee and may also receive incentive fees, as discussed below.

49


Table of Contents

Base Management Fee

Effective February 1, 2020, pursuant to the Investment Advisory Agreement, the base management fee is calculated and payable quarterly in arrears at an annual rate of 1.25% of the Company’s gross assets, including assets acquired through the incurrence of debt but excluding any cash, cash equivalents and restricted cash. The base management fee is calculated based on the average value of gross assets at the end of the two most recently completed calendar quarters, and appropriately adjusted for any share issuances or repurchases during the current calendar quarter. For purposes of the Investment Advisory Agreement, cash equivalents means U.S. government securities and commercial paper maturing within one year of purchase.

Under the terms of the Investment Advisory Agreement, the Adviser agreed to waive a portion of the management fee from February 1, 2020 through July 31, 2021 after the closing of the Alcentra Acquisition so that only 0.75% shall be charged for such time period. The Adviser has also voluntarily waived its right to receive management fees on the Company’s investments in GACP II LP and WhiteHawk III Onshore Fund LP for any period in which these investments remain in the investment portfolio.

Prior to February 1, 2020, the base management fee was calculated and payable quarterly in arrears at an annual rate of 1.50% of the Company’s gross assets, including assets acquired through the incurrence of debt but excluding any cash and cash equivalents. The Adviser agreed to waive its right to receive management fees in excess of the sum of (i) 0.25% of the aggregate committed but undrawn capital and (ii) 0.75% of the aggregate gross assets excluding cash and cash equivalents during the period prior to February 3, 2020, the date of the Company’s qualified initial public offering.

For the three and nine months ended September 30, 2021, the Company incurred management fees of $3,055 and $6,986 respectively, which are net of waived amounts of $476 and $3,096, respectively. For the three and nine months ended September 30, 2020, the Company incurred management fees of $1,746 and $4,900, respectively, which are net of waived amounts of $1,163 and $3,427, respectively. As of September 30, 2021 and December 31, 2020, $3,055 and $1,867 of management fees, respectively, remained payable.

Incentive Fee per Investment Advisory Agreement

Under the Investment Advisory Agreement, the incentive fee consists of two parts:

The first part, the income incentive fee, is calculated and payable quarterly in arrears and (a) equals 100% of the excess of the pre-incentive fee net investment income for the immediately preceding calendar quarter, over a preferred return of 1.75% (1.50% prior to February 1, 2020) per quarter (7.0% annualized or 6.0% annualized prior to February 1, 2020) (the “Hurdle”), and a catch-up feature until the Adviser has received 17.5% (15.0% prior to February 1, 2020), of the pre-incentive fee net investment income for the current quarter up to 2.1212% (1.7647% prior to February 1, 2020) (the “Catch-up”), and (b) 17.5% (15.0% prior to February 1, 2020) of all remaining pre-incentive fee net investment income above the “Catch-up.”

The second part, the capital gains incentive fee, is determined and payable in arrears as of the end of each fiscal year at a rate of 17.5% (15.0% prior to February 1, 2020) of the Company’s realized capital gains, if any, on a cumulative basis from the Company’s inception through the end of the fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees. In the event that the Investment Advisory Agreement shall terminate as of a date that is not a fiscal year end, the termination date shall be treated as though it were a fiscal year end for purposes of calculating and paying a capital gains incentive fee.

Under the terms of the Investment Advisory Agreement, the Adviser agreed to waive the income based portion of the incentive fee from February 1, 2020 through July 31, 2021. The income and capital gains incentive fees were previously waived from April 1, 2018 through February 1, 2020. Additionally, On February 22, 2021, the Adviser notified the Board of Directors of its intent to voluntarily waive income incentive fees to the extent net investment income falls short of the declared dividend on a full dollar basis. The waiver is effective from July 31, 2021 through December 31, 2022. The Adviser has also voluntarily waived its right to receive the income incentive fees attributable to the investment income accrued by the Company as a result of its investments in GACP II and WhiteHawk III Onshore Fund LP.

50


Table of Contents

Pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies) accrued during each calendar quarter, minus operating expenses for such quarter (including the base management fee , expenses payable under the Administration Agreement and any interest expense and distributions paid on any issued and outstanding debt or preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as market discount, original issue discount, debt instruments with PIK interest, preferred stock with PIK dividends and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Pre-incentive fee net investment income will be compared to a “Hurdle Amount” equal to the product of (i) the Hurdle rate of 1.50% or 1.75% per quarter, 6.0% or 7.0% annualized, prior to and effective February 1, 2020, respectively, and (ii) our net assets (defined as total assets less indebtedness, before taking into account any incentive fees payable during the period), at the end of the immediately preceding calendar quarter, subject to a “catch-up” provision incurred at the end of each calendar quarter.

For the three and nine months ended September 30, 2021, the Company incurred income incentive fees of $1,732 and $1,732, which are net of waived amounts, of $931 and $5,796 respectively, of which $1,732 was payable at September 30, 2021. For the three and nine months ended September 30, 2020, the Company incurred income incentive fees of $0, which are net of waived amounts of $2,136 and $6,335, respectively, of which $0 was payable at September 30, 2020.

GAAP Incentive Fee on Cumulative Unrealized Capital Appreciation

The Company accrues, but does not pay, a portion of the incentive fee based on capital gains with respect to net unrealized appreciation. Under GAAP, the Company is required to accrue an incentive fee based on capital gains that includes net realized capital gains and losses and net unrealized capital appreciation and depreciation on investments held at the end of each period. In calculating the accrual for the incentive fee based on capital gains, the Company considers the cumulative aggregate unrealized capital appreciation in the calculation, since an incentive fee based on capital gains would be payable if such unrealized capital appreciation were realized, even though such unrealized capital appreciation is not permitted to be considered in calculating the fee payable under the Investment Advisory Agreement. This accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital appreciation or depreciation. If such amount is positive at the end of a period, then the Company records a capital gains incentive fee equal to 15% (prior to February 3, 2020) or 17.5% (effective February 3, 2020) of such amount, minus the aggregate amount of actual incentive fees based on capital gains paid in all prior periods. If such amount is negative, then there is no accrual for such period. There can be no assurance that such unrealized capital appreciation will be realized in the future.

For the three and nine months ended September 30, 2021, the Company recorded capital gains incentive fees on unrealized capital appreciation of $757 and $6,150, respectively, of which $6,150 was accrued and unpaid at September 30, 2021. For the three and nine months ended September 30, 2020, the Company recorded no incentive fee on cumulative unrealized capital appreciation.

Other Related Party Transactions

From time to time, the Administrator may pay amounts owed by the Company to third-party providers of goods or services, including the Board, and the Company will subsequently reimburse the Administrator for such amounts paid on its behalf. Amounts payable to the Administrator are settled in the normal course of business without formal payment terms.

In conjunction with the closing of Alcentra Capital merger, the Company and the Adviser executed a Transaction Support Agreement, as described in Note 13.

A portion of the outstanding shares of the Company’s common stock is owned by Crescent. At September 30, 2021 and December 31, 2020, Crescent and other related parties owned 2.28% and 2.11%, respectively, of the outstanding common shares of the Company. Crescent is also the majority member of the Adviser and sole member of the Administrator. The Company has entered into a license agreement with Crescent under which Crescent granted the Company a non-exclusive, royalty-free license to use the name “Crescent Capital”. The Adviser has entered into a resource sharing agreement with Crescent. Crescent will provide the Adviser with the resources necessary for the Adviser to fulfill its obligations under the Investment Advisory Agreement. On January 5, 2021, Sun Life acquired a majority interest in Crescent. Consummation of the Sun Life Transaction resulted in a change of control of Crescent. There were no changes to the Company’s investment objective, strategies and process or to the Crescent team responsible for the investment operations of the Company as a result of the Sun Life Transaction.

Sun Life is the sole lender of the Company’s 2023 Unsecured Notes and a $10,000 participating lender in the Company’s 2026 Unsecured Notes, both described further in Note 6.

51


Table of Contents

Investments in and affiliated and controlled companies

Under the 1940 Act, the Company is required to separately identify non-controlled investments where it owns 5% or more of a portfolio company’s outstanding voting securities and/or has the power to exercise control over the management or policies of such portfolio company as investments in “affiliated” companies. In addition, under the 1940 Act, the Company is required to separately identify investments where it owns more than 25% of a portfolio company’s outstanding voting securities and/or has the power to exercise control over the management or policies of such portfolio company as investments in “controlled” companies. Detailed information with respect to the Company’s non-controlled, non-affiliated; non-controlled, affiliated; and controlled affiliated investments is contained in the accompanying consolidated financial statements, including the Consolidated Schedule of Investments and the summary tables below.

The Company’s investments in non-controlled affiliates for the nine months ended September 30, 2021 were as follows (in thousands):

Fair Value

as of
December 31, 2020

Gross
Additions (2)
Gross
Reductions (3)
Net Realized
Gains/
(Losses)
Change in
Unrealized
Gains/
(Losses)

Fair Value

as of
September 30, 2021

Dividend,
Interest, PIK
and Other
Income

Non-Controlled Affiliates

ASP MCS Acquisition

$ 1,793 $ 2 $ (2) $ $ (142 ) $ 1,651 $ 18

Battery Solutions, Inc.

3,565 499 (1,209 ) 2,855 165

Conisus, LLC

22,865 1,026 (38,628 ) 27,441 (12,704 ) 1,026

GACP II, LP (1)

16,154 (2,563 ) (154 ) 13,437 1,093

Slickdeals Holdings, LLC

16,010 61 (282 ) 72 126 15,987 863

Southern Technical Institute, Inc.

7,253 1,191 8,444 1,041

Vivid Seats Ltd.

3,714 329 4,043

WhiteHawk III Onshore Fund L.P.

4,939 (20 ) 4,919

Total Non-Controlled Affiliates

$ 71,354 $ 6,527 $ (41,475 ) $ 27,513 $ (12,583 ) $ 51,336 $ 4,206
The Company’s investments in non-controlled affiliates for the nine months ended September 30, 2020 were as follows (in thousands):

Fair Value

as of

December 31, 2019

Gross
Additions (2)
Gross
Reductions (3)
Net Realized
Gains/
(Losses)
Change in
Unrealized
Gains/
(Losses)

Fair Value

as of

September 30, 2020

Dividend,
Interest, PIK
and Other
Income

Non-Controlled Affiliates

APC Auto Technology Intermediate, LLC

$ 928 $ $ $ (1,847 ) $ 919 $ $

Battery Solutions, Inc.

4,907 (1,361 ) 3,546 129

Conisus, LLC

9,681 11,095 20,776 953

GACP II, LP (1)

18,564 2,465 (822 ) (496 ) 19,711 1,940

Slickdeals Holdings, LLC

15,933 62 (311 ) 50 213 15,947 897

Southern Technical Institute, Inc.

(1,271 ) 1,271 3,753 3,753

Vivid Seats Ltd.

3,646 (37 ) 3,609

Xpress Global Systems, LLC

Total Non-Controlled Affiliates

$ 39,071 $ 17,115 $ (2,404 ) $ (526 ) $ 14,086 $ 67,342 $ 3,919
(1) Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. The Company’s investment in GACP II, LP and the related income generated by it were reclassified from non-controlled non-affiliated to non-controlled affiliated investment for the prior periods presented in the consolidated financial statements.

(2) Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest or dividends, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.

(3) Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

52


Table of Contents

The Company’s investments in controlled affiliates for the nine months ended September 30, 2021 were as follows (in thousands):

Fair Value

as of
December 31, 2020

Gross
Additions (2)
Gross
Reductions (3)

Net Realized

Gains/

(Losses)

Change in
Unrealized
Gains/
(Losses)

Fair Value

as of
September 30, 2021

Dividend,
Interest, PIK
and Other
Income

Controlled Affiliates

CBDC Senior Loan Fund LLC (1)

$ 38,735 $ $ $ $ 1,472 $ 40,207 $ 2,100
The Company’s investments in controlled affiliates for the nine months ended September 30, 2020 were as follows (in thousands):

Fair Value

as of

December 31, 2019

Gross
Additions (2)
Gross
Reductions (3)

Net Realized

Gains/

(Losses)

Change in
Unrealized
Gains/
(Losses)

Fair Value

as of

September 30, 2020

Dividend,
Interest, PIK
and Other
Income

Controlled Affiliates

CBDC Senior Loan Fund LLC (1)

$ 34,442 $ 6,000 $ (1,000 ) $ $ (5,513 ) $ 33,929 $ 1,500

(1) Together with Masterland Enterprise Holdings, Ltd. (“Masterland”, and collectively with the Company, the “Members”), the Company invests through the Senior Loan Fund. The Senior Loan Fund is not an extension of the Company’s investment operations given shared power/voting rights exist with Masterland, Additionally, the Company’s investment strategy focuses on middle market lending in senior secured first lien, second lien and equity investments, while the Senior Loan Fund focuses on senior secured broadly syndicated loans. Although the Company owns more than 25% of the voting securities of the Senior Loan Fund, the Company does not have control over the Senior Loan Fund (other than for purposes of the Investment Company Act). See Note 4 “Investments” for further detail.

(2) Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest or dividends, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.

(3) Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

Note 4. Investments

The information in the following tables is presented on an aggregate portfolio basis, without regard to whether they are non-controlled, non-affiliated, non-controlled, affiliated or controlled affiliated, investments.

53


Table of Contents

Investments at fair value consisted of the following at September 30, 2021 and December 31, 2020 (in thousands):

September 30, 2021 December 31, 2020

Investment Type

Cost Fair Value Unrealized
Appreciation/
(Depreciation)
Cost Fair Value Unrealized
Appreciation/
(Depreciation)

Senior Secured First Lien

$ 357,295 $ 349,942 $ (7,353 ) $ 380,909 $ 373,633 $ (7,276 )

Unitranche First Lien

585,785 596,987 11,202 408,177 413,543 5,366

Unitranche First Lien - Last Out

15,690 13,511 (2,179 ) 15,668 14,917 (751 )

Senior Secured Second Lien

55,492 56,375 883 105,056 104,656 (400 )

Unsecured Debt

5,392 5,379 (13 ) 3,112 3,032 (80 )

Equity & Other

35,251 57,873 22,622 41,974 69,331 27,357

LLC/LP Equity Interests

58,604 58,563 (41 ) 56,228 54,889 (1,339 )

Total investments

$ 1,113,509 $ 1,138,630 $ 25,121 $ 1,011,124 $ 1,034,001 $ 22,877

The industry composition of investments at fair value at September 30, 2021 and December 31, 2020 is as follows (in thousands):

Industry

Fair Value
September 30, 2021
Percentage of
Fair Value
Fair Value
December 31, 2020
Percentage of
Fair Value

Health Care Equipment & Services

$ 358,451 31.49 % $ 269,614 26.08 %

Software & Services

213,296 18.74 134,374 13.00

Commercial & Professional Services

194,072 17.05 207,151 20.03

Consumer Services

73,895 6.49 123,704 11.96

Diversified Financials

58,563 5.14 65,128 6.30

Insurance

45,345 3.98 38,018 3.68

Retailing

41,207 3.62 23,537 2.28

Automobiles & Components

33,849 2.97 7,257 0.70

Consumer Durables & Apparel

22,751 2.00 22,865 2.21

Pharmaceuticals, Biotechnology & Life Sciences

22,675 1.99 23,449 2.27

Capital Goods

18,142 1.59 18,643 1.80

Energy

15,996 1.40 18,220 1.76

Food, Beverage & Tobacco

9,618 0.84 4,253 0.41

Transportation

8,070 0.71 6,912 0.67

Materials

6,907 0.61 4,666 0.45

Food & Staples Retailing

4,798 0.42 18,776 1.82

Household & Personal Products

4,495 0.39 3,223 0.31

Telecommunication Services

4,489 0.39 4,062 0.39

Technology, Hardware & Equipment

2,011 0.18 2,995 0.29

Media & Entertainment

37,154 3.59

Total investments

$ 1,138,630 100.00 % $ 1,034,001 100.00 %

54


Table of Contents

The geographic composition of investments at fair value at September 30, 2021 and December 31, 2020 is as follows (in thousands):

Geographic Region

Fair Value
September 30, 2021
Percentage of
Fair Value
Fair Value
December 31, 2020
Percentage of
Fair Value

United States

$ 1,039,761 91.32 % $ 971,838 93.99 %

United Kingdom

47,729 4.19 23,960 2.32

Canada

26,449 2.32 15,208 1.47

Belgium

15,245 1.34 14,312 1.38

Netherlands

9,446 0.83 8,683 0.84

Total investments

$ 1,138,630 100.00 % $ 1,034,001 100.00 %

Note 5. Fair Value of Financial Instruments

Investments

The following table presents fair value measurements of investments as of September 30, 2021 (in thousands):

Fair Value Hierarchy
Level 1 Level 2 Level 3 Total

Senior Secured First Lien

$ $ 67,188 $ 282,753 $ 349,941

Unitranche First Lien

18,865 578,125 596,990

Unitranche First Lien – Last Out

13,511 13,511

Senior Secured Second Lien

6,691 49,684 56,375

Unsecured Debt

5,379 5,379

Equity & Other

57,872 57,872

Subtotal

$ $ 92,744 $ 987,324 $ 1,080,068

Investments Measured at NAV (1)

58,562

Total Investments

$ 1,138,630

Foreign Currency Forward Contracts

$ $ 1,328 $ $ 1,328

The following table presents fair value measurements of investments as of December 31, 2020 (in thousands):

Fair Value Hierarchy
Level 1 Level 2 Level 3 Total

Senior Secured First Lien

$ $ 33,735 $ 339,898 $ 373,633

Unitranche First Lien

413,543 413,543

Unitranche First Lien – Last Out

14,917 14,917

Senior Secured Second Lien

104,656 104,656

Unsecured Debt

3,032 3,032

Equity & Other

1,500 67,831 69,331

Subtotal

$ $ 35,235 $ 943,877 $ 979,112

Investments Measured at NAV (1)

54,889

Total Investments

$ 1,034,001

Foreign Currency Forward Contracts

$ $ (632 ) $ $ (632 )

(1) In accordance with ASC 820-10, certain investments that are measured using the net asset value per shares (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

55


Table of Contents

The following table provides a reconciliation of the beginning and ending balances for total investments that use Level 3 inputs for the nine months ended September 30, 2021, based off of the fair value hierarchy at September 30, 2021 (in thousands):

Senior
Secured
First Lien
Unitranche
First Lien
Unitranche
First -
Last Out
Senior
Secured
Second Lien
Unsecured
Debt
Equity
&
Other
Total

Balance as of January 1, 2021

$ 339,898 $ 413,543 $ 14,917 $ 104,656 $ 3,032 $ 67,831 $ 943,877

Amortized discounts/premiums

5,612 2,448 22 1,000 14 3 9,099

Paid in-kind interest

890 - - - 455 1,026 2,371

Net realized gain (loss)

(11 ) 298 - 1 (104 ) 32,330 32,514

Net change in unrealized appreciation (depreciation)

(3,341 ) 5,813 (1,428 ) 653 68 (4,741 ) (2,976 )

Purchases

61,363 250,625 - - 2,257 7,334 321,579

Sales/return of capital/principal repayments/paydowns

(120,744 ) (76,455 ) - (48,791 ) (343 ) (47,412 ) (293,745 )

Transfers in

6,092 - - - - 1,501 7,593

Transfers out

(7,006 ) (18,147 ) - (7,835 ) - - (32,988 )

Balance as of September 30, 2021

$ 282,753 $ 578,125 $ 13,511 $ 49,684 $ 5,379 $ 57,872 $ 987,324

Net change in unrealized appreciation (depreciation) from investments still held as of September 30, 2021 $ (899 ) $ 6,120 $ (1,429 ) $ 636 $ 68 $ 8,581 $ 13,078

During the nine months ended September 30, 2021, the Company recorded $32,988 in transfers from Level 3 to Level 2 due to an increase in observable inputs in market data and $7,593 in transfers from Level 2 to Level 3 due to a decrease in observable inputs in market data.

The following table provides a reconciliation of the beginning and ending balances for total investments that use Level 3 inputs for the nine months ended September 30, 2020, based off of the fair value hierarchy at September 30, 2020 (in thousands):

Senior
Secured
First Lien
Unitranche
First Lien
Unitranche
First -
Last Out
Secured
Second Lien
Unsecured
Debt
Equity
&
Other
Total

Balance as of January 1, 2020

$ 268,193 $ 218,416 $ 16,044 $ 49,569 $ 7,414 $ 21,432 $ 581,068

Amortized discounts/premiums

1,222 1,067 28 215 114 8 2,654

Paid in-kind interest

717 461 - 2 77 474 1,731

Net realized gain (loss)

(334 ) - - - - (718 ) (1,052 )

Net change in unrealized appreciation (depreciation)

(7,190 ) (4,617 ) (845 ) (4,671 ) (99 ) 16,705 (717 )

Purchases

121,290 173,918 - 49,381 1,252 15,832 361,673

Sales/return of capital/principal repayments/paydowns

(56,113 ) (27,271 ) (213 ) (8,815 ) (6,543 ) (150 ) (99,105 )

Transfers in

6,441 - - 9,318 - - 15,759

Transfers out

- - - - - - -

Balance as of September 30, 2020

$ 334,226 $ 361,974 $ 15,014 $ 94,999 $ 2,215 $ 53,583 $ 862,011

Net change in unrealized appreciation (depreciation) from investments still held as of September 30, 2020 $ (6,161 ) $ (4,703 ) $ (845 ) $ (3,889 ) $ 18 $ 1,688 $ (13,892 )

During the nine months ended September 30, 2020, the Company recorded $0 in transfers from Level 3 to Level 2 and $15,759 in transfers from Level 2 to Level 3 due to a decrease in observable inputs in market data.

The following tables present the fair value of Level 3 investments and the ranges of significant unobservable inputs used to value the Company’s Level 3 investments as of September 30, 2021 and December 31, 2020. These ranges represent the significant unobservable inputs that were used in the valuation of each type of investment. These inputs are not representative of the inputs that could have been used in the valuation of any one investment. For example, the highest market yield presented in the table for senior secured first lien investments is appropriate for valuing a specific investment but may not be appropriate for valuing any other investment. Accordingly, the ranges of inputs presented below do not represent uncertainty in, or possible ranges of, fair value measurements of the Company’s Level 3 investments.

56


Table of Contents

Security Type

Fair Value as of
September 30, 2021
(in thousands)
Valuation Technique Unobservable
Input
Range
(Weighted Average)

Senior Secured First Lien

$ 201,403 Discounted Cash Flows Discount Rate 5.3%-25.4% (8.0%)
18,622 Enterprise Value Comparable EBITDA Multiple 4.3x-8.4x (5.6x)
62,728 Broker Quoted Broker Quote N/A

$ 282,753

Unitranche First Lien

$ 545,002 Discounted Cash Flows Discount Rate 5.0%-13.2% (7.2%)
6,201 Enterprise Value Comparable EBITDA Multiple 9.3x-9.3x (9.3x)
1,195 Collateral Analysis Recovery Rate 100.0%
25,727 Broker Quoted Broker Quote N/A

$ 578,125

Unitranche First Lien - Last Out

$ 8,004 Discounted Cash Flows Discount Rate 6.2%-6.2% (6.2%)
5,507 Collateral Analysis Recovery Rate 68.2%

$ 13,511

Senior Secured Second Lien

$ 41,792 Discounted Cash Flows Discount Rate 7.8%-11.5% (9.0%)
7,892 Broker Quoted Broker Quote N/A

$ 49,684

Unsecured Debt

$ 5,379 Discounted Cash Flows Discount Rate 11.5%-17.9% (13.9%)

Equity & Other

$ 56,510 Enterprise Value Comparable EBITDA Multiple 2.5x-28.1x (12.5x)
1,362 Broker Quoted Broker Quote N/A

$ 57,872

Total

$ 987,324

57


Table of Contents

Security Type

Fair value as of
December 31, 2020
(in thousands)
Valuation Techniques Unobservable
Input
Range
(Weighted Average)

Senior Secured First Lien

$ 301,956 Discounted Cash Flows Discount Rate 4.7%-25.2% (7.3%)
21,189 Enterprise Value Comparable EBITDA Multiple 3.7x-16.6x (7.9x)
16,753 Broker Quoted Broker Quote N/A

$ 339,898

Unitranche First Lien

$ 392,281 Discounted Cash Flows Discount Rate 4.8%-15.0% (7.0%)
5,673 Enterprise Value Comparable EBITDA Multiple 5.9x-5.9x (5.9x)
2,668 Collateral Analysis Recovery Rate 100.0%
12,921 Broker Quoted Broker Quote N/A

$ 413,543

Unitranche First Lien - Last Out

$ 8,454 Discounted Cash Flows Discount Rate 6.2%-6.2% (6.2%)
6,463 Collateral Analysis Recovery Rate 80.0%

$ 14,917

Senior Secured Second Lien

$ 104,362 Discounted Cash Flows Discount Rate 7.5%-14.0% (9.5%)
294 Broker Quoted Broker Quote N/A

$ 104,656

Unsecured Debt

$ 3,032 Discounted Cash Flows Discount Rate 12.5%-21.4% (16.6%)

Equity & Other

$ 66,002 Enterprise Value Comparable EBITDA Multiple 1.5x-25.9x (10.2x)
1,829 Broker Quoted Broker Quote N/A

$ 67,831

Total

$ 943,877

As noted above, the discounted cash flows and market multiple approaches were used in the determination of fair value of certain Level 3 assets as of September 30, 2021 and December 31, 2020. The significant unobservable inputs used in the discounted cash flow approach is the discount rate used to discount the estimated future cash flows expected to be received from the underlying investment, which include both future principal and interest payments. Increases and decreases in the discount rate would result in a decrease and increase in the fair value, respectively. Included in the consideration and selection of discount rates is risk of default, rating of the investment, call provisions and comparable company investments. The significant unobservable inputs used in the market multiple approach are the multiples of similar companies’ earnings before income taxes, depreciation and amortization (“EBITDA”) and comparable market transactions. Increases and decreases in market EBITDA multiples would result in an increase or decrease in the fair value, respectively. The recovery rate represents the extent to which proceeds can be recovered. An increase/decrease in the recovery rate would result in an increase/decrease, respectively, in the fair value.

58


Table of Contents

Note 6. Debt

Debt consisted of the following as of September 30, 2021 and December 31, 2020 (in thousands):

September 30, 2021
Aggregate Principal
Amount Committed
Drawn
Amount
Amount
Available (1)
Carrying
Value (2)
Weighted
Average
Debt
Outstanding
Weighted
Average
Interest
Rate

SPV Asset Facility

$ 350,000 $ 276,747 $ 73,253 $ 276,747 $ 263,642 2.42 %

Corporate Revolving Facility

200,000 100,154 99,846 100,154 101,629 3.00 %

2023 Unsecured Notes

50,000 50,000 50,000 50,000 6.50 %

2026 Unsecured Notes

135,000 135,000 135,000 87,784 4.21 %

InterNotes ®

4,017 %

Total Debt

$ 735,000 $ 561,901 $ 173,099 $ 561,901 $ 507,072 3.32 %

December 31, 2020
Aggregate Principal
Amount Committed
Drawn
Amount
Amount
Available (1)
Carrying
Value (2)
Weighted
Average
Debt
Outstanding
Weighted
Average
Interest
Rate

SPV Asset Facility

$ 350,000 $ 260,210 $ 89,790 $ 260,210 $ 235,263 2.63 %

Corporate Revolving Facility

200,000 149,904 50,096 149,904 150,378 2.93 %

2023 Unsecured Notes

50,000 50,000 50,000 15,027 6.49 %

InterNotes ®

16,418 16,418 16,418 20,398 6.40 %

Total Debt

$ 616,418 $ 476,532 $ 139,886 $ 476,532 $ 421,066 3.26 %

(1)

The amount available is subject to any limitations related to the respective debt facilities’ borrowing bases and foreign currency translation adjustments.

(2)

The amount presented excludes netting of deferred financing costs.

As of September 30, 2021 and December 31, 2020, the carrying amount of the Company’s outstanding debt approximated fair value. The fair values of the Company’s debt are determined in accordance with ASC 820, which defines fair value in terms of the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. The fair value of the Company’s debt is estimated based upon market interest rates and entities with similar credit risk. As of September 30, 2021 and December 31, 2020, the debt would be deemed to be Level 3 of the fair value hierarchy.

As of September 30, 2021 and December 31, 2020, the Company was in compliance with the terms and covenants of its debt arrangements.

SPV Asset Facility

On March 28, 2016, Crescent Capital BDC Funding, LLC (“CCAP SPV”), a wholly owned subsidiary of CCAP, entered into a loan and security agreement, as amended from time to time (the “SPV Asset Facility”), with the Company as the collateral manager, seller and equityholder, CCAP SPV as the borrower, the banks and other financial institutions from time to time party thereto as lenders, and Wells Fargo Bank, National Association (“Wells Fargo”), as administrative agent, collateral agent, and lender. CCAP SPV is consolidated into the Company’s financial statements and no gain or loss is recognized from transfer of assets to and from CCAP SPV.

The maximum commitment amount under the SPV Asset Facility is $350,000 and may be increased with the consent of Wells Fargo or reduced upon request of the Company. Proceeds of the advances under the SPV Asset Facility may be used to acquire portfolio investments, to make distributions to the Company in accordance with the SPV Asset Facility, and to pay related expenses. The maturity date is the earlier of (a) the date the Borrower voluntarily reduces the commitments to zero, (b) June 22, 2026 and (c) the date upon which Wells Fargo declares the obligations due and payable after the occurrence of an Event of Default. Borrowings under the SPV Asset Facility bear interest at LIBOR plus a margin with no LIBOR floor. The margin is between 1.65% and 2.10% as determined by the proportion of liquid and illiquid loans pledged to the SPV Asset Facility. The Company pays unused facility fees of 0.50% per annum on committed but undrawn amounts under the SPV Asset Facility. The unused facility fee rate may vary based on the utilization. The SPV Asset Facility includes customary covenants, including certain limitations on the incurrence of additional indebtedness and liens, as well as usual and customary events of default for revolving credit facilities of this nature. The facility size is subject to availability under the borrowing base, which is based on the amount of CCAP SPV’s assets from time to time, and satisfaction of certain conditions, including certain concentration limits.

59


Table of Contents

Costs incurred in connection with obtaining the SPV Asset Facility were recorded as deferred financing costs and are being amortized over the life of the SPV Asset Facility on an effective yield basis. As of September 30, 2021 and December 31, 2020, deferred financing costs related to the SPV Asset Facility were $2,871 and $2,540, respectively, and were netted against debt outstanding on the Consolidated Statements of Assets and Liabilities.

Corporate Revolving Facility

On August 20, 2019, the Company entered into the “Corporate Revolving Facility” with Ally Bank, as Administrative Agent and Arranger. Proceeds of the advances under the Revolving Credit Agreement may be used to acquire portfolio investments, to make distributions to the Company in accordance with the Revolving Credit Agreement and to pay related expenses. The maximum principal amount of the Corporate Revolving Facility is $200,000, subject to availability under the borrowing base.

Borrowings under the Corporate Revolving Facility bear interest at LIBOR plus a 2.35% with no LIBOR floor. The Company pays unused facility fees of 0.50% per annum on committed but undrawn amounts under the Corporate Revolving Facility. The unused facility fee rate may vary based on the utilization. Interest is payable quarterly in arrears. Any amounts borrowed under the Corporate Revolving Facility, and all accrued and unpaid interest, will be due and payable, on August 20, 2024.

Costs incurred in connection with obtaining the Corporate Revolving Facility have been recorded as deferred financing costs and are being amortized over the life of the Corporate Revolving Facility on an effective yield basis. As of September 30, 2021 and December 31, 2020, deferred financing costs related to the Corporate Revolving Facility were $206 and $1,360, respectively, and were netted against debt outstanding on the Consolidated Statements of Assets and Liabilities.

2023 Unsecured Notes

On July 30, 2020, the Company completed a private offering of $50,000 aggregate principal amount of 5.95% senior unsecured notes due July 30, 2023 (the “2023 Unsecured Notes”). The 2023 Unsecured Notes were issued in two $25,000 issuances on July 30, 2020 and October 28, 2020.

The 2023 Unsecured Notes will mature on July 30, 2023 and may be redeemed in whole or in part, at the Company’s option, at any time or from time to time at par plus a “make-whole” premium, if applicable. Interest on the 2023 Unsecured Notes is due and payable semiannually in arrears on January 30 th and July 30 th of each year. As of September 30, 2021, the Company was in compliance with the terms of the note purchase agreement governing the 2023 Unsecured Notes.

Costs incurred in connection with issuing the 2023 Unsecured Notes were recorded as deferred financing costs and are being amortized over the life of the 2023 Unsecured Notes on an effective yield basis. As of September 30, 2021 and December 31, 2020, deferred financing costs related to the 2023 Unsecured Notes were $498 and $700, respectively, and were netted against debt outstanding on the Consolidated Statements of Assets and Liabilities.

2026 Unsecured Notes

On February 17, 2021, the Company completed a private offering of $135,000 aggregate principal amount of 4.00% senior unsecured notes due February 17, 2026 (the “2026 Unsecured Notes”). The initial issuance of $50,000 of 2026 Unsecured Notes closed February 17, 2021. The issuance of the remaining $85,000 of 2026 Unsecured Notes closed on May 5, 2021.

The 2026 Unsecured Notes will mature on February 17, 2026 and may be redeemed in whole or in part, at the Company’s option, at any time or from time to time at par plus a “make-whole” premium, if applicable. Interest on the 2026 Unsecured Notes is due and payable semiannually in arrears on February 17 th and August 17 th of each year. As of September 30, 2021, the Company was in compliance with the terms of the note purchase agreement governing the 2026 Unsecured Notes.

Costs incurred in connection with issuing the 2026 Unsecured Notes were recorded as deferred financing costs and are being amortized over the life of the 2026 Unsecured Notes on an effective yield basis. As of September 30, 2021 and December 31, 2020, deferred financing costs related to the 2026 Unsecured Notes were $1,253 and $0, respectively, and were netted against debt outstanding on the Consolidated Statements of Assets and Liabilities.

60


Table of Contents

InterNotes ®

On January 31, 2020, in connection with the Alcentra Acquisition, the Company assumed direct unsecured fixed interest rate obligations or “InterNotes ® ”. The InterNotes ® bore interest at fixed interest rates ranging between 6.25% and 6.75% and offered a variety of maturities ranging between February 15, 2021 and April 15, 2022. The Company redeemed or paid down the remaining $16,418 of InterNotes ® during the first quarter of 2021.

Summary of Interest and Credit Facility Expenses

The summary information regarding the SPV Asset Facility, Corporate Revolving Facility, 2023 Unsecured Notes, 2026 Unsecured Notes, and InterNotes ® , for the three and nine months ended September 30, 2021 and 2020 were as follows (in thousands):

For the three months ended
September 30,
For the nine months ended
September 30,
2021 2020 2021 2020

Borrowing interest expense

$ 4,172 $ 2,913 $ 11,707 $ 9,942

Unused facility fees

334 221 819 557

Amortization of financing costs

1,189 370 1,956 985

Total interest and other debt financing costs

$ 5,695 $ 3,504 $ 14,482 $ 11,484

Weighted average outstanding balance

$ 507,072 $ 410,892 $ 529,842 $ 405,912

Note 7. Derivatives

The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies.

In order to better define its contractual rights and to secure rights that will help mitigate its counterparty risk, the Company may enter into an International Swaps and Derivatives Association, Inc. Master Agreement (“ISDA Master Agreement”) or a similar agreement with its derivative counterparties. An ISDA Master Agreement is a bilateral agreement between the Company and a counterparty that governs OTC derivatives, including foreign currency forward contracts, and typically contains, among other things, collateral posting terms and netting provisions in the event of a default and/or termination event. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of a default (close-out netting) or similar event, including the bankruptcy or insolvency of the counterparty.

For financial reporting purposes, cash collateral that has been pledged to cover obligations of the Company and cash collateral received from the counterparty, if any, is included under restricted cash and cash equivalents on the Consolidated Statement of Assets and Liabilities. As of September 30, 2021 and December 31, 2020, $210 and $0, respectively, has been pledged to cover obligations of the Company. The Company minimizes counterparty credit risk by only entering into agreements with counterparties that they believe to be of good standing and by monitoring the financial stability of those counterparties. All of the forward contracts qualify as Level 2 financial instruments.

During the nine months ended September 30, 2021 and 2020 the Company’s average USD notional exposure to foreign currency forward contracts was $70,100 and $34,052, respectively.

61


Table of Contents

The following table sets forth the Company’s net exposure to foreign currency forward contracts that are subject to ISDA Master Agreements or similar agreements as of September 30, 2021 and December 31, 2020.

As of September 30, 2021 (in thousands):

Counterparty

Gross Amount
of Assets on
the Consolidated
Statements of
Assets  and
Liabilities
Gross Amount
of (Liabilities) on
the Consolidated
Statements of
Assets  and
Liabilities
Net Amount of Assets
or (Liabilities)
Presented on the
Consolidated
Statements of
Assets and Liabilities
Collateral
(Received)
Pledged (1)
Net
Amounts (2)

Wells Fargo Bank, N.A.

$ 1,915 $ (587 ) $ 1,328 $ 210 $

As of December 31, 2020 (in thousands):

Counterparty

Gross Amount
of Assets on
the Consolidated
Statements of
Assets and
Liabilities
Gross Amount
of (Liabilities) on
the Consolidated
Statements of
Assets and
Liabilities
Net Amount of Assets
or (Liabilities)
Presented on the
Consolidated
Statements of
Assets and Liabilities
Collateral
(Received)
Pledged (1)
Net
Amounts (2)

Wells Fargo Bank, N.A.

$ 264 $ (896 ) $ (632 ) $ $ (632 )

(1)

Amount excludes excess cash collateral paid.

(2)

Net amount represents the net amount due (to) from counterparty in the event of a default based on the contractual setoff rights under the agreement. Net amount excludes any over-collateralized amounts.

The effect of transactions in derivative instruments to the Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020, was as follows (in thousands):

For the three months ended
September 30,
For the nine months ended
September 30,
2021 2020 2021 2020

Net realized gain (loss) on foreign currency forward contracts

$ (56 ) $ $ (193 ) $

Net change in unrealized appreciation (depreciation) on foreign currency forward contracts

1,523 (1,349 ) 1,959 623

Total net realized and unrealized gains (losses) on foreign currency forward contracts

$ 1,467 $ (1,349 ) $ 1,766 $ 623

Note 8. Commitments, Contingencies and Indemnifications

The Company’s investment portfolio may contain investments that are in the form of lines of credit or unfunded commitments, which require the Company to provide funding when requested by portfolio companies in accordance with the terms of the underlying agreements. Unfunded commitments to provide funds to portfolio companies are not reflected on the Company’s Consolidated Statements of Assets and Liabilities. These commitments are subject to the same underwriting and ongoing portfolio maintenance as are the on-balance sheet financial instruments that the Company holds. Since these commitments may expire without being drawn, the total commitment amount does not necessarily represent future cash requirements. As of September 30, 2021 and December 31, 2020, the Company had aggregated unfunded commitments totaling $166,320 and $80,837 including foreign denominated commitments converted to USD at the balance sheet date, respectively, under loan and financing agreements.

62


Table of Contents

As of September 30, 2021 and December 31, 2020, the Company has the following unfunded commitments to portfolio companies (in thousands):

September 30, 2021 December 31, 2020

Company

Investment Type Commitment
Expiration
Date (1)
Unfunded
Commitment (2)
Commitment
Expiration
Date (1)
Unfunded
Commitment (2)

Abode Healthcare, Inc.

Revolver $ 8/25/2025 $ 1,150

ACI Group Holdings, Inc.

Delayed Draw Term Loan 8/2/2023 2,583

ACI Group Holdings, Inc.

Revolver 8/2/2027 738

Affinitiv, Inc.

Revolver 8/26/2024 567 8/26/2024 567

Ameda, Inc.

Revolver 9/29/2022 113 9/29/2022 113

Anne Arundel Dermatology Management, LLC

Revolver 10/16/2025 440 10/16/2022 1,159

Anne Arundel Dermatology Management, LLC

Delayed Draw Term Loan 10/16/2022 353 10/16/2025 550

Apps Associates LLC

Delayed Draw Term Loan 7/2/2023 1,800

Apps Associates LLC

Revolver 7/2/2027 800

Auto-Vehicle Parts, LLC

Revolver 1/3/2023 600 1/3/2023 600

Avaap USA LLC

Revolver 3/22/2023 650

Banker’s Toolbox, Inc.

Delayed Draw Term Loan 7/27/2023 6,711

Banker’s Toolbox, Inc.

Revolver 7/27/2027 2,406

Belay Inc.

Revolver 11/15/2025 650

Benesys, Inc.

Revolver 10/5/2024 150 10/5/2024 150

C-4 Analytics, LLC

Revolver 8/22/2023 600 8/22/2023 600

CAT Buyer, LLC

Revolver 4/11/2024 550 4/11/2024 550

Centria Subsidiary Holdings, LLC

Revolver 12/9/2025 1,974 12/9/2025 1,816

Claritas, LLC

Revolver 12/21/2023 278 12/21/2023 188

Colibri Group LLC

Revolver 5/1/2025 1,000

Consolidated Label Co., LLC

Revolver 7/15/2026 650 7/15/2026 650

Continental Battery Company

Delayed Draw Term Loan 1/20/2023 2,679 12/14/2022 567

CRA MSO, LLC

Revolver 12/17/2023 140 12/17/2023 120

Crusoe Bidco Limited

Delayed Draw Term Loan 12/10/2022 530 12/5/2020 538

Crusoe Bidco Limited

Delayed Draw Term Loan 12/10/2022 167 12/10/2025 169

EiKo Global, LLC

Revolver 6/1/2023 750 6/1/2023 750

Empire Auto Parts, LLC

Revolver 9/5/2023 400 9/5/2023 400

Everlast Parent Inc.

Revolver 10/30/2026 1,611 10/30/2022 3,412

Everlast Parent Inc.

Delayed Draw Term Loan 10/30/2022 3,412 10/30/2026 1,611

Evolution BuyerCo, Inc.

Revolver 4/30/2027 729

Evolution BuyerCo, Inc.

Delayed Draw Term Loan 4/30/2023 1,458

GH Parent Holdings Inc.

Revolver 5/4/2027 1,875

GH Parent Holdings Inc.

Delayed Draw Term Loan 5/4/2023 5,542

Granicus, Inc.

Revolver 1/29/2027 805

Granicus, Inc.

Delayed Draw Term Loan

Granicus, Inc.

Delayed Draw Term Loan 4/23/2023 3,135

GrapeTree Medical Staffing, LLC

Revolver 10/19/2022 450 10/19/2022 450

Great Lakes Dental Partners, LLC

Delayed Draw Term Loan 6/23/2023 850

Great Lakes Dental Partners, LLC

Revolver 6/23/2026 400

HCOS Group Intermediate III LLC

Revolver 9/30/2026 900 9/30/2026 900

Hepaco, LLC

Revolver 8/18/2024 152 8/18/2023 92

63


Table of Contents
September 30, 2021 December 31, 2020

Company

Investment Type Commitment
Expiration
Date (1)
Unfunded
Commitment (2)
Commitment
Expiration
Date (1)
Unfunded
Commitment (2)

Hepaco, LLC

Delayed Draw Term Loan 8/18/2024 112

Hercules Borrower LLC

Revolver 12/15/2026 2,222 12/15/2026 2,222

Hercules Borrower LLC

Delayed Draw Term Loan 9/10/2023 2,252

HGH Purchaser, Inc.

Delayed Draw Term Loan 2/10/2023 2,389

HGH Purchaser, Inc.

Delayed Draw Term Loan 11/1/2021 557

HGH Purchaser, Inc.

Revolver 11/3/2025 1,014 11/3/2025 912

Homecare Partners Management, LLC

Revolver 5/25/2027 1,100

Homecare Partners Management, LLC

Delayed Draw Term Loan 5/25/2023 1,564

Hospice Care Buyer, Inc.

Revolver 12/9/2026 1,039 6/9/2021 2,679

Hospice Care Buyer, Inc.

Delayed Draw Term Loan 8/11/2022 1,386 12/9/2026 1,386

Hospice Care Buyer, Inc.

Term Loan 12/9/2026 1,668

Hsid Acquisition, LLC

Revolver 1/31/2026 750 1/31/2026 750

Integrity Marketing Acquisition, LLC

Revolver 8/27/2025 1,409 8/27/2025 1,409

ISS Compressors Industries, Inc.

Revolver 2/5/2026 833 2/5/2026 833

IvyRehab Intermediate II, LLC

Revolver 12/4/2024 500 12/4/2022 1,450

IvyRehab Intermediate II, LLC

Delayed Draw Term Loan 12/4/2022 71 12/4/2024 500

IvyRehab Intermediate II, LLC

Delayed Draw Term Loan 9/13/2023 2,400

Jordan Bidco, Ltd.

Delayed Draw Term Loan 8/31/2024 4,115

Jordan Bidco, Ltd.

Revolver 2/28/2028 2,058

Jordan Health Products, Inc.

Revolver

JTM Foods LLC

Revolver 5/14/2027 640

JTM Foods LLC

Delayed Draw Term Loan 11/14/2022 750

Kestrel Parent, LLC

Revolver 11/13/2023 871 11/13/2023 871

Learn-It Systems, LLC

Revolver 3/18/2025 750 3/18/2022 1,456

Learn-It Systems, LLC

Delayed Draw Term Loan 3/18/2022 42 3/18/2025 600

Learn-It Systems, LLC

Delayed Draw Term Loan 5/4/2023 2,600

Lightspeed Buyer, Inc.

Revolver 2/3/2026 1,050 8/3/2021 648

Lightspeed Buyer, Inc.

Delayed Draw Term Loan 2/3/2026 700

Lightspeed Buyer, Inc.

Delayed Draw Term Loan 2/28/2023 5,100

Lion Cashmere Bidco Limited

Revolver 2/23/2026 2,025

Lion Cashmere Bidco Limited

Delayed Draw Term Loan 9/23/2024 3,194

List Partners, Inc.

Revolver 1/5/2023 450 1/5/2023 450

Mann Lake Ltd.

Revolver 10/4/2024 180 10/4/2024 60

MHS Acquisition Holdings, LLC

Delayed Draw Term Loan 7/21/2023 214

MHS Acquisition Holdings, LLC

Revolver 7/21/2027 150

MRI Software LLC

Delayed Draw Term Loan 2/10/2026 98 2/10/2022 519

MRI Software LLC

Revolver 2/10/2026 1,266 2/10/2026 1,184

MRI Software LLC

Delayed Draw Term Loan 2/10/2022 316 2/10/2026 1,266

New Era Technology, Inc.

Revolver 10/31/2026 228

64


Table of Contents
September 30, 2021 December 31, 2020

Company

Investment Type Commitment
Expiration
Date (1)
Unfunded
Commitment (2)
Commitment
Expiration
Date (1)
Unfunded
Commitment (2)

New Era Technology, Inc.

Delayed Draw Term Loan 10/31/2022 905

Nexant Volt MergerSub, Inc.

Revolver 5/11/2027 165

Nurture Landscapes

Delayed Draw Term Loan

Omni Ophthalmic Management Consultants, LLC

Delayed Draw Term Loan 2/28/2021 623

Ontario Systems, LLC

Delayed Draw Term Loan 8/19/2023 550 9/5/2021 1,100

Ontario Systems, LLC

Revolver 8/30/2025 500 8/30/2025 300

Painters Supply & Equipment Company

Delayed Draw Term Loan 8/10/2023 900

Painters Supply & Equipment Company

Revolver 8/10/2027 500

Patriot Acquisition Topco S.A.R.L

Revolver 1/29/2026 1,770

PharComp Parent B.V.

Delayed Draw Term Loan 2/20/2022 721 2/20/2026 2,056

Pharmalogics Recruiting, LLC

Delayed Draw Term Loan 2/5/2027 1,436

Pilot Air Freight, LLC

Revolver 7/25/2024 100 7/25/2024 100

Pinnacle Treatment Centers, Inc.

Delayed Draw Term Loan 1/17/2022 457 1/17/2022 457

Pinnacle Treatment Centers, Inc.

Revolver 12/31/2022 571 12/31/2022 571

Potter Electric Signal Company

Delayed Draw Term Loan 12/19/2021 271 12/19/2021 1,123

Potter Electric Signal Company

Revolver 12/19/2024 550 12/19/2024 550

Premier Dental Care Management, LLC

Delayed Draw Term Loan 8/5/2023 5,148

Premier Dental Care Management, LLC

Revolver 8/5/2027 1,544

Prism Bidco, Inc.

Revolver 6/25/2026 833 6/25/2026 833

PromptCare Intermediate, LP

Delayed Draw Term Loan 9/1/2023 4,444

PT Network, LLC

Revolver 11/30/2023 400 11/30/2023 400

Pye-Barker Fire & Safety, LLC

Delayed Draw Term Loan

Pye-Barker Fire & Safety, LLC

Delayed Draw Term Loan 11/19/2022 812

Receivable Solutions, Inc.

Revolver 10/1/2024 300 10/1/2024 300

Right Networks, LLC

Revolver 11/4/2024 233 11/4/2024 232

Right Networks, LLC

Delayed Draw Term Loan 12/31/2021 2,117

Ruffalo Noel Levitz, LLC

Revolver 5/29/2022 300 5/29/2022 60

Safco Dental Supply, LLC

Revolver 6/14/2025 360 6/14/2025 600

Saturn Borrower Inc

Revolver 9/30/2026 908 9/30/2026 1,513

SavATree, LLC

Delayed Draw Term Loan 6/2/2020 122

SavATree, LLC

Revolver 6/2/2022 550 6/2/2022 550

Seko Global Logistics Network, LLC

Revolver 12/20/2026 1,300

Seniorlink Incorporated

Revolver 7/17/2026 1,038 7/17/2026 1,037

Service Logic Acquisition, Inc

Delayed Draw Term Loan 10/30/2022 2,432 10/30/2022 2,432

Slickdeals Holdings, LLC

Revolver 6/12/2023 727 6/12/2023 727

Smile Brands, Inc.

Revolver 10/12/2023 300

Smile Doctors LLC

Revolver 10/6/2022 1,070 10/6/2022 1,070

Southern HVAC Corporation

Revolver 10/30/2022 671 10/30/2022 2,450

Southern HVAC Corporation

Delayed Draw Term Loan 10/30/2022 1,000

65


Table of Contents
September 30, 2021 December 31, 2020

Company

Investment Type Commitment
Expiration
Date (1)
Unfunded
Commitment (2)
Commitment
Expiration
Date (1)
Unfunded
Commitment (2)

Spear Education

Delayed Draw Term Loan 2/26/2022 3,125 2/3/2026 3,125

Stepping Stones Healthcare Services, LLC

Revolver 3/9/2026 750

Stepping Stones Healthcare Services, LLC

Delayed Draw Term Loan 3/9/2023 547

Sun Acquirer Corp.

Delayed Draw Term Loan 9/8/2023 8,243

Sun Acquirer Corp.

Revolver 9/8/2027 1,812

Teaching Strategies LLC

Revolver 5/14/2024 629

Teal Acquisition Co., Inc

Revolver 9/22/2026 1,277 9/22/2026 1,642

Teal Acquisition Co., Inc

Delayed Draw Term Loan 9/22/2026 1,642 9/22/2026 1,004

The Hilb Group, LLC

Revolver 12/2/2025 340 12/2/2025 340

The Hilb Group, LLC

Delayed Draw Term Loan 12/15/2022 1,269 12/15/2022 1,728

The Hilb Group, LLC

Revolver 12/2/2025 143 12/2/2025 142

Transportation Insight, LLC

Revolver 12/3/2024 571 12/3/2024 750

Tranzonic

Revolver 3/27/2023 38 3/27/2023 110

Trinity Partners, LLC

Revolver 2/21/2023 450 2/21/2023 450

Unifeye Vision Partners

Delayed Draw Term Loan 9/13/2021 2,237

Unifeye Vision Partners

Revolver 9/13/2025 1,700 9/13/2025 1,247

Unifeye Vision Partners

Delayed Draw Term Loan 9/7/2023 5,005

UP Acquisition Corp

Revolver 5/23/2024 911 5/23/2024 859

VetStrategy

Delayed Draw Term Loan 7/31/2027 347

VetStrategy

Delayed Draw Term Loan 7/31/2027 2,355

VetStrategy

Delayed Draw Term Loan 7/31/2027 2,904

Vital Care Buyer, LLC

Revolver 10/19/2025 2,222 10/19/2025 2,222

WhiteHawk III Onshore Fund L.P.

Partnership Interest 5,164

Winxnet Holdings, LLC

Revolver 6/29/2023 400 6/29/2023 160

Winxnet Holdings, LLC

Revolver 6/29/2023 250

Total

$ 166,320 $ 80,837

(1)

Commitments are generally subject to borrowers meeting certain criteria such as compliance with covenants and certain operational metrics. These amounts may remain outstanding until the commitment period of an applicable loan expires, which may be shorter than its maturity.

(2)

Unfunded commitments denominated in currencies other than USD have been converted to USD using the applicable foreign currency exchange rate as of September 30, 2021 and December 31, 2020.

As of September 30, 2021, the Company believes that there is sufficient assets and liquidity to adequately cover future obligations under unfunded commitments. The cash and restricted cash balances, availability under the credit facilities and ongoing investment realizations are expected to provide sufficient liquidity. In addition, broadly syndicated loans in the portfolio could be sold over a relatively short period to generate liquidity.

Other Commitments and Contingencies

In the normal course of business, the Company enters into contracts which provide a variety of representations and warranties, and that provide general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

66


Table of Contents

Note 9. Stockholders’ Equity

The Company authorized 200,000,000 shares of its common stock with a par value of $0.001 per share. The Company has authorized 10,000 shares of its preferred stock with a par value of $0.001 per share. To date, no shares of preferred stock have been issued.

Between June 26, 2015, commencement of operations, and January 31, 2020, the date of Alcentra Acquisition, the Company entered into subscription agreements (collectively, the “Subscription Agreements”) with investors, including Crescent, providing for the private placement of its common shares. Pursuant to the Subscription Agreements, between June 26, 2015 and January 31, 2020, the Company issued 23,127,335 common shares for aggregate proceeds of $456,297, of which $10,000 was from Crescent. Proceeds from the issuances were used to fund investing activities and for other general corporate purposes. Additionally, on January 31, 2020, the Company issued 5,203,016 shares in connection with the Alcentra Acquisition. Upon closing of the Alcentra Acquisition, all unfunded commitments of stockholders subscribing in a private offering were terminated.

For the nine months ended September 30, 2021 and 2020, the Company issued 0 and 30,128 new common shares, respectively, in connection with its dividend reinvestment plan.

The following table summarizes the Company’s recent distributions declared:

Date Declared

Record Date

Payment Date

Amount Per Share

August 11, 2021

September 30, 2021 October 15, 2021 $ 0.41

May 10, 2021

June 30, 2021 July 15, 2021 $ 0.41

February 22, 2021

March 31, 2021 April 15, 2021 $ 0.41

November 4, 2020

December 31, 2020 January 15, 2021 $ 0.41

August 7, 2020

September 30, 2020 October 15, 2020 $ 0.41

At September 30, 2021 and December 31, 2020, Crescent and other related parties owned 2.28% and 2.11%, respectively, of the outstanding common shares of the Company.

Note 10. Earnings Per Share

In accordance with the provisions of ASC 260 – Earnings per Share (“ASC 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis. As of September 30, 2021 and December 31, 2020, there are no dilutive shares.

The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations for the following periods (in thousands):

For the three
months
ended September 30,
For the nine
months
ended September 30,
2021 2020 2021 2020

Net increase (decrease) in net assets resulting from operations

$ 16,679 $ 38,341 $ 70,798 $ 20,213

Weighted average common shares outstanding

28,167,360 28,167,360 28,167,360 27,518,708

Net increase (decrease) in net assets resulting from operations per common share-basic and diluted

$ 0.59 $ 1.36 $ 2.51 $ 0.73

67


Table of Contents

Note 11. Income Taxes

As of September 30, 2021 and December 31, 2020, the Company’s aggregate investment unrealized appreciation and depreciation for federal income tax purposes was (in thousands):

As of
September 30,
2021
As of
December 31,
2020

Tax Cost

$ 1,118,797 $ 1,038,153

Gross Unrealized Appreciation

$ 22,727 $ 26,684

Gross Unrealized Depreciation

(17,238 ) (30,836 )

Net Unrealized Investment Appreciation (Depreciation)

$ 5,489 $ (4,152 )

Note 12. Financial Highlights

Below is the schedule of financial highlights of the Company for the nine months ended September 30, 2021 and 2020 (in thousands, except share and per share data):

For the nine months ended
September 30,
2021 2020

Per Share Data: (1)

Net asset value, beginning of period

$ 19.88 $ 19.50

Net investment income after tax

1.25 1.33

Net realized and unrealized gains (losses) on investments, asset acquisition and forward contracts, net of taxes

1.26 (0.60 )

Net increase (decrease) in net assets resulting from operations

2.51 0.73

Effect of equity issuances, net of share repurchases and rounding

0.07

Distributions declared from net investment income (2)

(1.23 ) (1.23 )

Total increase (decrease) in net assets

1.28 (0.43 )

Net asset value, end of period

$ 21.16 $ 19.07

Shares outstanding, end of period

28,167,360 28,167,360

Market value, end of period

$ 19.13 $ 12.75

Weighted average shares outstanding

28,167,360 27,518,708

Total return based on market value (3)

40.31 % -14.10 %

Total return based on net asset value (4)

12.63 % 4.10 %

Ratio/Supplemental Data:

Net assets, end of period

$ 596,152 $ 537,090

Ratio of total net expenses to average net assets (5)(6)

8.01 % 5.43 %

Ratio of net expenses (without incentive fees and interest and other debt expenses) to average net assets (6)

2.85 % 2.25 %

Ratio of net investment income before taxes to average net assets (6)

8.43 % 10.29 %

Ratio of interest and credit facility expenses to average net assets (6)

3.34 % 3.18 %

Ratio of net incentive fees to average net assets (6)

1.82 %

Ratio of portfolio turnover to average investments at fair value (7)

28.50 % 20.31 %

Asset coverage ratio

205 % 225 %

(1)

Based on actual number of shares outstanding at the end of the corresponding period or the weighted average shares outstanding for the period, unless otherwise noted, as appropriate.

(2)

The per share data for distributions per share reflects the actual amount of distributions declared per share for the applicable periods.

(3)

Total return based on market value is calculated as the change in market value per share during the period, taking into account dividends, if any, reinvested in accordance with the Company’s dividend reinvestment plan. The beginning market value per share for the comparative period is based on the market price of $16.40 per share on February 3, 2020, the date of the Company’s listing on NASDAQ, and not annualized.

(4)

Total return based on net asset value is calculated as the change in net asset value per share during the period plus declared dividends per share during the period, divided by the beginning net asset value per share, and not annualized.

68


Table of Contents
(5)

The ratio of total expenses to average net assets in the table above reflects the Adviser’s voluntary waivers of its right to receive a portion of the management fees and income incentive fees with respect to the Company’s ownership in GACP II and WhiteHawk III Onshore Fund LP. Excluding the effects of waivers, the ratio of total expenses to average net assets would have been 8.03% and 5.46% for the nine months ended September 30, 2021 and 2020, respectively.

(6)

Annualized.

(7)

Not annualized.

Note 13. Alcentra Acquisition

On August 12, 2019, the Company entered into an Agreement and Plan of Merger (as amended on September 27, 2019, the “Merger Agreement”) to acquire Alcentra Capital Corporation (“Alcentra Capital”) in a cash and stock transaction (the “Alcentra Acquisition”).

In connection with the Alcentra Acquisition, which was completed on January 31, 2020, each share of Alcentra Capital common stock issued and outstanding immediately prior to the effective time of the Alcentra Acquisition was converted into the right to receive from the Company, in accordance with the Merger Agreement, (a) approximately $1.50 per share in cash consideration less $0.80 per share spillover dividend declared by Alcentra Capital, and (b) stock consideration at the fixed exchange ratio of 0.4041 shares, par value $0.001 per share, of the Company’s common stock (the “Exchange Ratio”) (and, if applicable, cash in lieu of fractional shares of the Company’s common stock). The Exchange Ratio was fixed on the date of the Merger Agreement, and was not subject to adjustment based on changes in the trading price of Alcentra Capital’s common stock before the closing of the Alcentra Acquisition. Based on the number of shares of Alcentra Capital common stock outstanding on the date of the merger, approximately 5,203,016 of the Company’s shares of common stock were exchanged for approximately 12,875,566 outstanding shares of Alcentra Capital common stock, subject to adjustment in certain limited circumstances. Upon closing of the Alcentra Acquisition, all unfunded commitments of stockholders subscribing in the private offering were terminated.

Additionally, on August 12, 2019, the Company entered into an agreement with the Adviser in connection with the Alcentra Acquisition. Under the terms of the Transaction Support Agreement, in connection with the consummation of the Alcentra Acquisition the Adviser (a) provided cash consideration of approximately $1.68 per share of Alcentra Capital common stock, payable to Alcentra Capital stockholders in accordance with the terms and conditions set forth in the Merger Agreement at closing, (b) entered into an amendment to the Investment Advisory Agreement to (i) permanently reduce the management fee from 1.5% to 1.25%, (ii) increase the incentive fee hurdle from 6% to 7% annualized, (iii) waive a portion of the management fee from February 1, 2020 through July 31, 2021 after the transaction so that only 0.75% shall be charged for such time period, and (iv) waive the income based portion of the incentive fee from February 1, 2020 through July 31, 2021 after the transaction and (c) fund up to $1,419 of expenses that the Company incurs in connection with completing the Alcentra Acquisition.

The merger of Alcentra Capital with and into Crescent Capital BDC was accounted for as an asset acquisition in accordance with ASC 805-50, Business Combinations-Related Issues. Accordingly, transaction expenses of $7,250, net of Adviser transaction support of $1,419, were included in total consideration paid, and no goodwill was recognized.

In evaluating whether the merger was an asset acquisition or business combination, the Company considered (i) whether substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset or group of similar identifiable assets; and (ii) whether the set of acquired assets included at least one substantive process. Since the acquired assets consisted of similar classes of financial assets, and since the Company did not acquire an organized workforce or other substantive processes in the transaction, it was deemed to be an asset acquisition.

Total consideration paid by the Company, including transaction costs related to the merger, of $118,256 was allocated to the acquired assets and assumed liabilities based upon their relative fair values as of the closing date, subject to the limitation that certain “non-qualifying” assets, including financial instruments, could not be assigned an amount greater than their fair values. As a result of this limitation, total consideration paid by the Company exceeded the fair value of the net assets acquired by $3,825, which has been presented as a realized loss in the Company’s Consolidated Statement of Operations for the three months ended March 31, 2020. The Company estimated the fair value of the assets acquired and liabilities assumed in accordance with ASC 820; the methodologies utilized to make these estimates were consistent with those used by the Company in estimating the fair value of its own assets and liabilities.

69


Table of Contents

The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Alcentra Acquisition (in thousands):

Consideration Paid by the Company

Common stock issued by the Company (1)

$ 101,963

Cash Consideration paid by the Company

9,043

Transaction costs

7,250

Total Purchase Price

$ 118,256

Assets (Liabilities) Acquired

Investment portfolio (2)

$ 195,682

Cash

3,409

Portfolio receivables

1,003

Other receivable

395

InterNotes ®

(50,271 )

Secured credit facility

(34,558 )

Borrowing expense payable

(834 )

Other payables

(395 )

Net Assets Acquired

$ 114,431

Realized loss on asset acquisition

$ 3,825

(1)

Common stock consideration was issued at the Company’s Net Asset Value of $19.60 at the date of the Alcentra Acquisition.

(2)

Investments acquired were recorded at fair value at the date of the acquisition, which is also the Company’s initial cost basis.

Note 14. Stock Repurchase Program

On January 31, 2020, the Company entered into a $20,000 repurchase plan which allowed it to purchase shares in the open market any time the Company’s common stock trades below ninety percent (90%) of its most recently disclosed net asset value per share. The plan was subject to compliance with the Company’s liquidity, covenant, leverage and regulatory requirements. Pursuant to the terms of the repurchase plan, repurchases began on March 2, 2020. On April 9, 2020, the Company’s Board of Directors unanimously approved the termination of the Company’s stock repurchase program.

The following table summarizes share repurchases under the Company’s stock repurchase program for the three and nine months ended September 30, 2021 and 2020 (in thousands, except share and per share data).

Three Months Ended
September 30, 2021
Three Months Ended
September 30, 2020
Nine months ended
September 30, 2021
Nine months ended
September 30, 2020

Dollar amount repurchased

$ $ $ $ 2,208

Shares repurchased

192,415

Average price per share including commission

$ $ $ $ 11.48

Weighted average discount to net asset value

40.89 % (1)

(1)

Weighted average discount is calculated using the December 31, 2019 proforma combined NAV of $19.42 per share assuming the effect of the Alcentra Acquisition.

Note 15. Subsequent Events

The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. Other than the items below, there have been no subsequent events that occurred during such period that would require disclosure in this Form 10-Q or would be required to be recognized in the consolidated financial statements as of September 30, 2021 and for the nine months ended September 30, 2021.

70


Table of Contents

On October 27, 2021, the Company entered into a senior secured revolving credit agreement (the “SMBC Corporate Revolving Facility”) with Sumitomo Mitsui Banking Corporation, as Administrative Agent, Collateral Agent and Lender and concurrently terminated its $200,000 Corporate Revolving Facility with Ally Bank. The maximum principal amount of the SMBC Corporate Revolving Facility is $300,000, subject to availability under the borrowing base. Borrowings under the SMBC Corporate Revolving Facility bear interest at LIBOR plus 1.875% or 2.000%, subject to certain provisions in the SMBC Corporate Revolving Facility agreement, with no LIBOR floor. Any amounts borrowed under the SMBC Corporate Revolving Facility, and all accrued and unpaid interest, will be due and payable, on October 27, 2026.

On November 5, 2021, the Company’s Board of Directors declared the following cash dividends:

Cash Dividend Type

Record Date

Payment Date

Amount Per Share

Regular

December 31, 2021 January 17, 2022 $ 0.41

Special

December 3, 2021 December 15, 2021 $ 0.05

Special

March 4, 2022 March 15, 2022 $ 0.05

Special

June 3, 2022 June 15, 2022 $ 0.05

Special

September 2, 2022 September 15, 2022 $ 0.05

71


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The information contained in this section should be read in conjunction with the financial statements and notes thereto appearing elsewhere in this report. This discussion also should be read in conjunction with the “Cautionary Statement Regarding Forward Looking Statements” set forth on page 1 of this Quarterly Report on Form 10-Q. In this report, “we,” “us,” “our” and “Company” refer to Crescent Capital BDC, Inc. and its consolidated subsidiaries.

OVERVIEW

We are a specialty finance company focused on lending to middle-market companies. We were incorporated under the laws of the State of Delaware on February 5, 2015 and on January 30, 2020, we changed our state of incorporation from the State of Delaware to the State of Maryland. We have elected to be treated as a BDC under the 1940 Act. In addition, we have elected to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. As such, we are required to comply with various regulatory requirements, such as the requirement to invest at least 70% of our assets in “qualifying assets,” source of income limitations, asset diversification requirements, and the requirement to distribute annually at least 90% of our taxable income and tax-exempt interest.

On January 31, 2020, we completed a transaction to acquire Alcentra Capital Corporation in a cash and stock transaction (the “Alcentra Acquisition”). We were listed and began trading on the NASDAQ stock exchange on February 3, 2020.

We are managed by Crescent Cap Advisors, LLC (the “Adviser”), an investment adviser that is registered with the SEC under the 1940 Act. CCAP Administration, LLC (the “Administrator”), provides the administrative services necessary for us to operate. Company management consists of investment and administrative professionals from the Adviser and Administrator along with our Board. The Adviser directs and executes our investment operations and capital raising activities subject to oversight from the Board, which sets our broad policies. The Board has delegated investment management of our investment assets to the Adviser. The Board consists of five directors, four of whom are independent.

Our investment objective is to maximize the total return to our stockholders in the form of current income and capital appreciation through debt and related equity investments. We invest primarily in secured debt (including first lien, unitranche first lien and second-lien debt) and unsecured debt (including mezzanine and subordinated debt), as well as related equity securities of private U.S. middle-market companies. We may purchase interests in loans or make debt investments, either (i) directly from our target companies as primary market or private credit investments ( i.e. , private credit transactions), or (ii) primary or secondary market bank loan or high yield transactions in the broadly syndicated “over-the-counter” market ( i.e. , broadly syndicated loans and bonds). Although our focus is to invest in less liquid private credit transactions, we may from time to time invest in more liquid broadly syndicated loans to complement our private credit transactions.

“First lien” investments are senior loans on a lien basis to other liabilities in the issuer’s capital structure that have the benefit of a first-priority security interest in assets of the issuer. The security interest ranks above the security interest of any second-lien lenders in those assets.

“Unitranche first lien” investments are loans that may extend deeper in a company’s capital structure than traditional first lien debt and may provide for a waterfall of cash flow priority among different lenders in the unitranche loan. In certain instances, we may find another lender to provide the “first out” portion of such loan and retain the “last out” portion of such loan, in which case, the “first out” portion of the loan would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last out” portion that we would continue to hold. In exchange for the greater risk of loss, the “last out” portion earns a higher interest rate.

“Second lien” investments are loans with a second priority lien on all existing and future assets of the portfolio company. The security interest ranks below the security interests of any first lien and unitranche first lien lenders in those assets.

“Unsecured debt” investments are loans that generally rank senior to a borrower’s equity securities and junior in right of payment to such borrower’s other senior indebtedness.

CRITICAL ACCOUNTING POLICIES

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially. The critical accounting policies should be read in connection with our risk factors as disclosed herein.

72


Table of Contents

For a description of our critical accounting policies, see Note 2 “Significant Accounting Policies” to our consolidated financial statements included in this report. We consider the most significant accounting policies to be those related to our Valuation of Portfolio Investments, Revenue Recognition, Non-Accrual Investments, Distribution Policy, and Income Taxes.

COMPONENTS OF OPERATIONS

Investments

We expect our investment activity to vary substantially from period to period depending on many factors, the general economic environment, the amount of capital we have available to us, the level of merger and acquisition activity for middle-market companies, including the amount of debt and equity capital available to such companies and the competitive environment for the type of investments we make. In addition, as part of our risk strategy on investments, we may reduce certain levels of investments through partial sales or syndication to additional investors.

We may not invest in any assets other than “qualifying assets” specified in the 1940 Act, unless, at the time the investments are made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” Pursuant to rules adopted by the SEC, “eligible portfolio companies” include certain companies that do not have any securities listed on a national securities exchange and public companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.

The Investment Adviser

Our investment activities are managed by the Adviser, which is responsible for originating prospective investments, conducting research and due diligence investigations on potential investments, analyzing investment opportunities, negotiating and structuring our investments and monitoring our investments and portfolio companies on an ongoing basis. The Adviser has entered into a resource sharing agreement with Crescent Capital Group LP (“Crescent”), pursuant to which Crescent provides the Adviser with experienced investment professionals (including the members of the Adviser’s investment committee) and access to Crescent’s resources so as to enable the Adviser to fulfill its obligations under the Investment Advisory Agreement. Through the resource sharing agreement, the Adviser intends to capitalize on the deal origination, credit underwriting, due diligence, investment structuring, execution, portfolio management and monitoring experience of Crescent’s investment professionals. On January 5, 2021, Sun Life Financial Inc. (together with its subsidiaries and joint ventures, “Sun Life”) acquired a majority interest in Crescent (the “Sun Life Transaction”). There were no changes to our investment objective, strategies and process or to the Crescent team responsible for the investment operations as a result of the Sun Life Transaction.

Revenues

We generate revenue primarily in the form of interest income on debt investments, capital gains and distributions, if any, on equity securities that we may acquire in portfolio companies. Certain investments may have contractual PIK interest or dividends. PIK represents accrued interest or accumulated dividends that are added to the loan principal of the investment on the respective interest or dividend payment dates rather than being paid in cash and generally becomes due at maturity or upon being called by the issuer. PIK is recorded as interest or dividend income, as applicable. We also generate revenue in the form of commitment or origination fees. Loan origination fees, original issue discount and market discount or premium are capitalized, and we accrete or amortize such amounts into income over the life of the loan using the effective yield method.

Dividend income from common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies. Dividend income from preferred equity securities is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected.

We may receive other income, which may include income such as consent, waiver, amendment, underwriting, and arranger fees associated with our investment activities as well as any fees for managerial assistance services rendered to the portfolio companies. Such fees are recognized as income when earned or the services are rendered.

Expenses

Our primary operating expenses include the payment of management fees and incentive fees to the Adviser under the Investment Advisory Agreement, as amended, our allocable portion of overhead expenses under the administration agreement with our Administrator (the “Administration Agreement”), operating costs associated with our sub-administration agreement and other operating costs described below. The management and incentive fees compensate the Adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other out-of-pocket costs and expenses of our operations and transactions, including:

the cost of calculating our net asset value, including the cost of any third-party valuation services;

fidelity bond, directors’ and officers’ liability insurance and other insurance premiums;

73


Table of Contents

fees and expenses associated with independent audits and outside legal costs;

independent directors’ fees and expenses;

administration fees and expenses, if any, payable under the Administration Agreement (including payments based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, rent and the allocable portion of the cost of certain professional services provided to us, including but not limited to, our accounting professionals, our legal counsel and compliance professionals);

U.S. federal, state and local taxes;

the cost of effecting sales and repurchases of shares of our common stock and other securities;

fees payable to third parties relating to making investments, including out-of-pocket fees and expenses associated with performing due diligence and reviews of prospective investments;

out-of-pocket fees and expenses associated with marketing efforts;

federal and state registration fees and any stock exchange listing fees;

brokerage commissions;

costs associated with our reporting and compliance obligations under the 1940 Act and other applicable U.S. federal and state securities laws;

debt service and other costs of borrowings or other financing arrangements; and

all other expenses reasonably incurred by us in connection with making investments and administering our business.

We expect our general and administrative expenses to be relatively stable or decline as a percentage of total assets during periods of asset growth and to increase during periods of asset declines.

Leverage

Our financing facilities allow us to borrow money and lever our investment portfolio, subject to the limitations of the 1940 Act, with the objective of increasing our yield. This is known as “leverage” and could increase or decrease returns to our stockholders. The use of leverage involves significant risks.

Prior to the Small Business Credit Availability Act being signed into law, a BDC generally was not permitted to incur indebtedness unless immediately after such borrowing it has an asset coverage for total borrowings of at least 200%. The Small Business Credit Availability Act, signed into law on March 23, 2018, contains a provision that grants a BDC the option, subject to certain conditions and disclosure obligations, to reduce the asset coverage requirement to 150%. On March 3, 2020, our Board of Directors approved, and on May 4, 2020, at an annual meeting of our stockholders, our stockholders approved, the application to us of the reduced asset coverage requirements in Section 61(a) of the 1940 Act. The application of the reduced asset coverage requirement, which became effective on May 4, 2020, permits us, provided certain requirements are satisfied, to double the maximum amount of leverage that it is permitted to incur by reducing the asset coverage requirement applicable to us from 200% to 150% (i.e., we are permitted to borrow up to two dollars for every dollar we have in assets less all liabilities and indebtedness not represented by senior securities issued by us) in order to issue senior securities. Short-term credits necessary for the settlement of securities transactions and arrangements with respect to securities lending will not be considered borrowings for these purposes. The amount of leverage that we employ depends on our Adviser’s and our Board’s assessment of market conditions and other factors at the time of any proposed borrowing.

PORTFOLIO INVESTMENT ACTIVITY

We seek to create a broad and diversified portfolio that generally includes senior secured first lien, unitranche, senior secured second lien, unsecured loans and minority equity securities of U.S. middle market companies. The size of our individual investments varies proportionately with the size of our capital base. We generally invest in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if they were rated. These securities have speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal. In addition, many of our debt investments have floating interest rates that reset on a periodic basis and typically do not fully pay down principal prior to maturity.

74


Table of Contents

As of September 30, 2021 and December 31, 2020, our portfolio at fair value was comprised of the following:

$ in millions

September 30, 2021 December 31, 2020

Investment Type

Fair Value Percentage Fair Value Percentage

Senior Secured First Lien

$ 349.8 30.7% $ 373.6 36.1%

Unitranche First Lien

597.0 52.4 413.6 40.0

Unitranche First Lien - Last Out

13.5 1.2 14.9 1.5

Senior Secured Second Lien

56.4 5.0 104.7 10.1

Unsecured Debt

5.4 0.5 3.0 0.3

Equity & Other

57.9 5.1 69.3 6.7

LLC/LP Equity Interests

58.6 5.1 54.9 5.3

Total investments

$ 1,138.6 100.0% $ 1,034.0 100.0%

The following table shows our investment activity by investment type:

$ in millions

For the three months ended For the nine months ended
September 30, 2021 September 30, 2020 September 30, 2021 September 30, 2020 (1)

New investments at cost:

Senior Secured First Lien

$ 36.4 $ 30.4 $ 101.0 $ 79.2

Unitranche First Lien

114.1 51.6 252.2 129.1

Unitranche First Lien – Last Out

Senior Secured Second Lien

9.4

Unsecured Debt

2.3

Equity & Other

5.3 2.1 7.3 2.1

LLC/LP Equity Interests

2.7 4.9 8.5

Total

$ 158.5 $ 84.1 $ 367.7 $ 228.3

Proceeds from investments sold or repaid:

Senior Secured First Lien

$ 59.0 $ 26.3 $ 131.3 $ 127.2

Unitranche First Lien

14.5 3.9 77.4 27.3

Unitranche First Lien - Last Out

0.2

Senior Secured Second Lien

9.1 10.1 50.6 18.8

Unsecured Debt

0.3 6.6 0.3 6.6

Equity & Other

39.8 47.4 0.4

LLC/LP Equity Interests

0.1 2.6 1.8

Total

$ 122.8 $ 46.9 $ 309.6 $ 182.3

Net increase (decrease) in portfolio

$ 35.7 $ 37.2 $ 58.1 $ 46.0

(1)

Excludes $195.7 million of assets at cost acquired in connection with the Alcentra Acquisition. The assets acquired, at cost, were comprised of $82.2 million of senior secured first lien, $45.0 million of unitranche first lien, $53.0 million of senior secured second lien, $1.2 million of unsecured debt and $14.3 million of equity investments.

The following table presents certain selected information regarding our investment portfolio as of September 30, 2021 and December 31, 2020:

September 30,
2021
December 31,
2020

Weighted average yield on income producing securities (at cost) (1)

7.6% 8.0%

Percentage of debt bearing a floating rate (at fair value)

99.7% 98.4%

Percentage of debt bearing a fixed rate (at fair value)

0.3% 1.6%

Number of portfolio companies

132 132

(1)

Yield excludes investments on non-accrual status.

75


Table of Contents

The following table shows the amortized cost of our performing and non-accrual debt and income producing debt securities as of September 30, 2021 and December 31, 2020.

$ in millions

September 30, 2021 December 31, 2020
Cost % of Cost Fair Value % of Fair
Value
Cost % of Cost Fair Value % of Fair Value

Performing

$ 1,004.0 98.5% $ 1,010.5 98.9% $ 899.2 98.3% $ 899.5 98.7%

Non-Accrual

15.6 1.5% 11.7 1.1% 15.6 1.7% 12.1 1.3%

Total

$ 1,019.6 100.0% $ 1,022.2 100.0% $ 914.8 100.0% $ 911.6 100.0%

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management’s judgment, are likely to remain current. Management may determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.

As of September 30, 2021, we had investments in two portfolio companies with three investment positions on non-accrual status, which represented 1.5% and 1.1% of the total debt investments at cost and fair value, respectively. As of December 31, 2020, we had investments in two portfolio companies with three investment positions on non-accrual status, which represented 1.7% and 1.3% of the total debt investments at cost and fair value, respectively. The remaining debt investments were performing and current on their interest payments as of September 30, 2021 and December 31, 2020.

The Adviser monitors our portfolio companies on an ongoing basis. The Adviser monitors the financial trends of each portfolio company to determine if it is meeting its business plans and to assess the appropriate course of action for each company. The Adviser has a number of methods of evaluating and monitoring the performance and fair value of our investments, which may include the following:

assessment of success of the portfolio company in adhering to its business plan and compliance with covenants;

review of monthly and quarterly financial statements and financial projections for portfolio companies.

contact with portfolio company management and, if appropriate, the financial or strategic sponsor, to discuss financial position, requirements and accomplishments;

comparisons to other companies in the industry; and

attendance and participation in board meetings.

As part of the monitoring process, the Adviser regularly assesses the risk profile of each of our investments and, on a quarterly basis, grades each investment on a risk scale of 1 to 5. Risk assessment is not standardized in our industry and our risk assessment may not be comparable to ones used by our competitors. Our assessment is based on the following categories:

1

Involves the least amount of risk in our portfolio. The investment/borrower is performing above expectations since investment, and the trends and risk factors are generally favorable, which may include the financial performance of the borrower or a potential exit.

2

Involves an acceptable level of risk that is similar to the risk at the time of investment. The investment/borrower is generally performing as expected, and the risk factors are neutral to favorable.

3

Involves an investment/borrower performing below expectations and indicates that the investment’s risk has increased somewhat since investment. The borrower’s loan payments are generally not past due and more likely than not the borrower will remain in compliance with debt covenants. An investment rating of 3 requires closer monitoring.

4

Involves an investment/borrower performing materially below expectations and indicates that the loan’s risk has increased materially since investment. In addition to the borrower being generally out of compliance with debt covenants, loan payments may be past due (but generally not more than 180 days past due). Placing loans on non-accrual status should be considered for investments rated 4.

5

Involves an investment/borrower performing substantially below expectations and indicates that the loan’s risk has substantially increased since investment. Most or all of the debt covenants are out of compliance and payments are substantially delinquent. Loans rated 5 are not anticipated to be repaid in full and the fair market values of the loans are generally reduced to the anticipated recovery amounts. Loans with an investment rating of 5 are generally placed on non-accrual status.

76


Table of Contents

The following table shows the composition of our portfolio on the 1 to 5 investment performance rating scale as of September 30, 2021 and December 31, 2020. Investment performance ratings are accurate only as of those dates and may change due to subsequent developments relating to a portfolio company’s business or financial condition, market conditions or developments, and other factors.

$ in millions

September 30, 2021 December 31, 2020

Investment Performance Rating

Investments at
Fair Value
Percentage of
Total Portfolio
Investments at
Fair Value
Percentage of
Total Portfolio

1

$ 13.4 1.2 % $ 9.8 0.9 %

2

1,003.7 88.2 895.1 86.6

3

109.8 9.6 117.0 11.3

4

11.7 1.0 12.1 1.2

5

Total

$ 1,138.6 100.0 % $ 1,034.0 100.0 %

RESULTS OF OPERATIONS

Operating results for the three and nine months ended September 30, 2021 and 2020 were as follows:

$ in millions

For the three months ended
September 30,
For the nine months ended
September 30,
2021 2020 2021 2020

Total investment income

$ 25.5 $ 18.7 $ 69.8 $ 56.8

Total net expenses

12.8 6.5 34.7 20.1

Net investment income

$ 12.7 $ 12.2 $ 35.1 $ 36.7

Net realized gain (loss) on investments

27.9 (0.5 ) 32.2 (1.7 )

Net unrealized appreciation (depreciation) on investments and forward contracts

(23.5 ) 26.8 4.2 (11.1 )

Net realized and unrealized gains (losses)

$ 4.4 $ 26.3 $ 36.4 $ (12.8 )

Realized loss on asset acquisition

(3.8 )

Benefit/(Provision) for taxes on realized and unrealized appreciation (depreciation) on investments

(0.4 ) (0.2 ) (0.7 ) 0.1

Net increase (decrease) in net assets resulting from operations

$ 16.7 $ 38.3 $ 70.8 $ 20.2

Investment Income

$ in millions

For the three months ended
September 30,
For the nine months ended
September 30,
2021 2020 2021 2020

Interest from investments

$ 22.8 $ 17.5 $ 63.5 $ 52.1

Dividend Income

2.4 1.2 5.7 3.6

Other Income

0.3 0.6 1.1

Total investment income

$ 25.5 $ 18.7 $ 69.8 $ 56.8

77


Table of Contents

Interest income, which includes amortization of upfront fees, increased from $17.5 million for the three months ended September 30, 2020 to $22.8 million for the three months ended September 30, 2021, due to higher accelerated accretion of OID and organic net deployment. Included in interest from investments for the three months ended September 30, 2021 and 2020 are $3.9 million and $0.3 million of accelerated accretion of OID related to paydown activity, respectively.

Dividend income increased from $1.2 million for the three months ended September 30, 2020 to $2.4 million for the three months ended September 30, 2021 due to a one-time dividend distribution from a portfolio company. Other income which includes consent, waiver, amendment, agency, underwriting and arranger fees associated with our investment activities increased from $0 for the three months ended September 30, 2020 to $0.3 million for the three months ended September 30, 2021.

Interest income, which includes amortization of upfront fees, increased from $52.1 million for the nine months ended September 30, 2020 to $63.5 million for the nine months ended September 30, 2021, due to organic net deployment and higher accelerated accretion of OID related to paydown activity. Included in interest from investments for the nine months ended September 30, 2021 and 2020 are $7.0 million and $1.6 million of accelerated accretion of OID, respectively.

Dividend income increased from $3.6 million for the nine months ended September 30, 2020 to $5.7 million for the nine months ended September 30, 2021 due to a one-time dividend distribution from a portfolio company. Other income which includes consent, waiver, amendment, agency, underwriting and arranger fees associated with our investment activities decreased from $1.1 million for the nine months ended September 30, 2020 to $0.6 million for the nine months ended September 30, 2021.

Expenses

$ in millions

For the three months ended
September 30,
For the nine months ended
September 30,
2021 2020 2021 2020

Interest and other debt financing costs

$ 5.7 $ 3.5 $ 14.5 $ 11.5

Management fees

3.5 2.9 10.1 8.3

Income based incentive fees

2.7 2.1 7.5 6.3

Capital gains based incentive fees

0.8 6.2

Professional fees

0.5 0.4 1.5 1.1

Directors’ fees

0.1 0.1 0.4 0.3

Other general and administrative expenses

0.7 0.7 2.0 1.8

Total expenses

$ 14.0 $ 9.7 $ 42.2 $ 29.3

Management fee waiver

(0.5 ) (1.2 ) (3.1 ) (3.4 )

Income based incentive fees waiver

(0.9 ) (2.1 ) (5.8 ) (6.3 )

Net expenses

$ 12.6 $ 6.4 $ 33.3 $ 19.6

Income and excise taxes

0.2 0.1 1.4 0.5

Total

$ 12.8 $ 6.5 $ 34.7 $ 20.1

Interest and other debt financing costs

Interest and other debt financing costs include interest, amortization of deferred financing costs including upfront commitment fees and unused fees on our credit facilities. For the three months ended September 30, 2021 and 2020 interest and other debt financing costs were $5.7 million and $3.5 million, respectively. For the nine months ended September 30, 2021 and 2020 interest and other debt financing costs were $14.5 million and $11.5 million, respectively. The increase for both periods was due to a higher weighted average debt outstanding, higher weighted average cost of debt and acceleration of certain deferred financing costs.

Base Management Fees

For the three months ended September 30, 2021 and 2020, we incurred management fees of $3.0 million and $1.7 million, respectively, which are net of waived amounts of $0.5 million and $1.2 million, respectively. For the nine months ended September 30, 2021 and 2020, we incurred management fees of $7.0 million and $4.9 million, respectively, which are net of waived amounts of $3.1million and $3.4 million, respectively. The increase in net management fees for both three and nine month periods was driven by growing assets under management and expiration of the management fee waiver on July 31, 2021.

78


Table of Contents

The Adviser has voluntarily waived its right to receive management fees on our investments in GACP II LP and WhiteHawk III Onshore Fund LP for any period in which these investments remain in the investment portfolio.

Incentive Fees

For the three months ended September 30, 2021 and 2020 we incurred income based incentive fees of $2.7 million and $2.1 million, of which $0.9 million and $2.1 million, respectively, were waived. For the nine months ended September 30, 2021 and 2020 we incurred income based incentive fees of $7.5 million and $6.3 million, of which $5.8 million and $6.3 million, respectively, were waived. The increase in net incentive fees for both three and nine month periods was driven by expiration of the income based incentive fee waiver on July 31, 2021.

For the three months ended September 30, 2021 and 2020 we accrued $0.8 million and $0, respectively, of capital gains based incentive fees. For the nine months ended September 30, 2021 and 2020 we accrued $6.2 million and $0, respectively, of capital gains based incentive fees. As of September 30, 2021 and December 31, 2020, $6.2 million and $0, respectively, was accrued and unpaid. The increase in incentive fees on cumulative unrealized capital appreciation was attributable to the inception to date performance of the investment portfolio.

Professional Fees and Other General and Administrative Expenses

Professional fees generally include expenses from independent auditors, tax advisors, legal counsel and third party valuation agents. Other general and administrative expenses generally include overhead and staffing costs allocated from the Administrator, insurance premiums, sub-administration expenses and miscellaneous administrative costs associated with our operations and investment activity.

For the three months ended September 30, 2021 and 2020, professional fees were $0.5 million and $0.4 million, respectively. For the nine months ended September 30, 2021 and 2020, professional fees were $1.5 million and $1.1 million, respectively.

For the three months ended September 30, 2021 and 2020, other general and administrative expenses were $0.7 million and $0.7 million, respectively. For the nine months ended September 30, 2021 and 2020, other general and administrative expenses were $2.0 million and $1.8 million, respectively.

The increase in professional fees and other general and administrative expenses was attributable to servicing a growing investment portfolio.

Income and Excise Taxes

For the three months ended September 30, 2021 and 2020, we expensed income and excise taxes of $0.2 million and $0.1 million. For the nine months ended September 30, 2021 and 2020, we expensed income and excise taxes of $1.4 million and $0.5 million. The increase in income and excise tax was attributable to taxes due on allocated taxable income from an equity investment held in a blocker. We accrued an offsetting tax distribution, which was declared by the portfolio company, under dividend income.

Net Investment Income

For the three months ended September 30, 2021 and 2020, GAAP net investment income was $12.7 million or $0.45 per share and $12.2 million or $0.43 per share, respectively. The increase was due to higher accelerated amortization income. For the nine months ended September 30, 2021 and 2020, GAAP net investment income was $35.1 million or $1.25 per share and $36.7 million or $1.33 per share, respectively. The decrease was due to accrued capital gains based incentive fees recorded during current year.

For the three months ended September 30, 2021 and 2020, net investment income excluding capital gains incentive fees (“Adjusted Net Investment Income”), was $13.5 million or $0.48 per share and $12.2 million or $0.43 per share, respectively. For the nine months ended September 30, 2021 and 2020, Adjusted Net Investment Income was $41.3 million or $1.47 per share and $36.7 million or $1.33 per share, respectively. The increase was due to a higher investment income from a growing investment portfolio and higher accelerated amortization income.

79


Table of Contents

The following table provides a reconciliation of net investment income (the most comparable U.S. GAAP measure) to Adjusted Net Investment Income for the periods presented:

For the three months ended September 30, For the nine months ended September 30,
2021 2020 2021 2020
Amount Per Share Amount Per Share Amount Per Share Amount Per Share

GAAP net investment income

$ 12.7 $ 0.45 $ 12.2 $ 0.43 $ 35.1 $ 1.25 $ 36.7 $ 1.33

Capital gains based incentive fee

0.8 0.03 6.2 0.22

Adjusted Net Investment Income

$ 13.5 $ 0.48 $ 12.2 $ 0.43 $ 41.3 $ 1.47 $ 36.7 $ 1.33

On a supplemental basis, we are disclosing Adjusted Net Investment Income and per share Adjusted Net Investment Income, each of which is a financial measure that is calculated and presented on a basis of methodology other than in accordance with U.S. GAAP (“non-GAAP”). Adjusted Net Investment Income represents net investment income, excluding capital gains incentive fees. We use this non-GAAP financial measure internally to analyze and evaluate financial results and performance and believe that this non-GAAP financial measure is useful to investors as an additional tool to evaluate ongoing results and trends without giving effect to capital gains incentive fees. The Company’s investment advisory agreement provides that a capital gains-based incentive fee is determined and paid annually with respect to realized capital gains (but not unrealized capital appreciation) to the extent such realized capital gains exceed realized capital losses and unrealized capital depreciation on a cumulative basis. We believe that Adjusted Net Investment Income is a useful performance measure because it reflects the net investment income produced on the Company’s investments during a period without giving effect to any changes in the value of such investments and any related capital gains incentive fees between periods. The presentation of Adjusted Net Investment Income is not intended to be a substitute for financial results prepared in accordance with GAAP and should not be considered in isolation.

80


Table of Contents

Net Realized and Unrealized Gains and Losses

We value our portfolio investments quarterly and any changes in fair value are recorded as unrealized appreciation (depreciation) on investments. For the three and nine months ended September 30, 2021 and 2020, net realized gains (losses) and net unrealized appreciation (depreciation) on our investment portfolio were comprised of the following:

$ in millions

For the three months ended
September 30,
For the nine months ended
September 30,
2021 2020 2021 2020

Realized losses on non-controlled and non-affiliated investments

$ (0.1 ) $ $ (0.2 ) $ (1.5 )

Realized gains on non-controlled and non-affiliated investments

0.5 5.1 0.4

Realized losses on non-controlled and affiliated investments

(1.8 ) (1.8 )

Realized gains on non-controlled and affiliated investments

27.5 1.3 27.5 1.3

Realized losses on foreign currency forwards

(0.1 ) (0.1 ) (0.3 )

Realized gains on foreign currency forwards

0.2

Realized losses on foreign currency transactions

(0.2 ) (0.3 )

Realized gains on foreign currency transactions

0.1 0.1 0.2

Net realized gains (losses) on investments

$ 27.9 $ (0.5 ) $ 32.2 $ (1.8 )

Change in unrealized depreciation on non-controlled and non-affiliated investments

(9.3 ) (15.0 ) (21.0 )

Change in unrealized appreciation on non-controlled and non-affiliated investments

12.2 18.7 28.2 0.8

Change in unrealized depreciation on foreign currency translation

(0.3 ) (0.5 )

Change in unrealized appreciation on foreign currency translation

0.6 0.5

Change in unrealized depreciation on non-controlled and affiliated investments

(28.8 ) (0.5 ) (14.2 ) (1.0 )

Change in unrealized appreciation on non-controlled and affiliated investments

0.6 6.2 1.7 15.0

Change in unrealized depreciation on controlled and affiliated investments

(5.5 )

Change in unrealized appreciation on controlled and affiliated investments

0.3 3.4 1.5

Change in unrealized depreciation on foreign currency forwards

(1.3 ) (0.1 )

Change in unrealized appreciation on foreign currency forwards

1.5 2.0 0.7

Net unrealized appreciation (depreciation) on investments

(23.5 ) 26.8 4.2 (11.1 )

Realized loss on asset acquisition

(3.8 )

Net realized and unrealized gains (losses) on investments and asset acquisition

$ 4.4 $ 26.3 $ 36.4 $ (16.7 )

Hedging

We may, but are not required to, enter into interest rate, foreign exchange or other derivative agreements to hedge interest rate, currency, credit or other risks. Generally, we do not intend to enter into any such derivative agreements for speculative purposes. Any derivative agreements entered into for speculative purposes are not expected to be material to our business or results of operations. These hedging activities, which are in compliance with applicable legal and regulatory requirements, may include the use of various instruments, including futures, options and forward contracts. We bear the costs incurred in connection with entering into, administering and settling any such derivative contracts. There can be no assurance any hedging strategy we employ will be successful.

During the nine months ended September 30, 2021 and 2020, our average U.S. Dollar notional exposure to foreign currency forward contracts were $70.1 million and $34.1 million, respectively.

81


Table of Contents

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

The primary uses of our cash and cash equivalents are for (1) investments in portfolio companies and other investments; (2) the cost of operations (including paying the Adviser); (3) debt service, repayment, and other financing costs; and (4) cash distributions to the holders of our common stock. We expect to generate additional liquidity from (1) future offerings of securities, (2) future borrowings and (3) cash flows from operations.

As of September 30, 2021, we had $19.5 million in cash and cash equivalents and restricted cash and cash equivalents and $173.1 million of undrawn capacity on our senior revolving credit and special purpose vehicle asset facilities, subject to borrowing base and other limitations. As of September 30, 2021, the undrawn capacity under our facilities is in excess of our unfunded commitments.

As of September 30, 2021, we were in compliance with our asset coverage requirements under the 1940 Act. In addition, we were in compliance with all the financial covenant requirements of our credit facilities as of September 30, 2021. However, any increase in realized losses or unrealized depreciation of our investment portfolio or significant reductions in our net asset value as a result of the effects of the COVID-19 pandemic, increase the risk of breaching the relevant covenants requirements. Any breach of these requirements may adversely affect the access to sufficient debt and equity capital.

Capital Share Activity

Between June 26, 2015, commencement of operations, and January 31, 2020, the date of Alcentra Acquisition, we entered into subscription agreements (collectively, the “Subscription Agreements”) with several investors, including Crescent, providing for the private placement of our common shares. Pursuant to the Subscription Agreements, between June 26, 2015 and January 31, 2020, we issued 23,127,335 common shares for aggregate proceeds of $456.3 million, of which $10.0 million was from Crescent. Proceeds from the issuances were used to fund our investing activities and for other general corporate purposes. Subsequently, on January 31, 2020, we issued 5,203,016 shares in connection with the Alcentra Acquisition. Upon closing of the Alcentra Acquisition, all unfunded commitments of stockholders subscribing in the private offering were terminated.

During the nine months ended September 30, 2021 we issued no common stock. During the nine months ended September 30, 2020, we issued 30,128 shares of our common stock to investors who have opted into our dividend reinvestment plan for proceeds of $0.6 million.

Debt

Debt consisted of the following as of September 30, 2021 and December 31, 2020:

$ in millions

September 30, 2021
Aggregate Principal
Amount Committed
Drawn
Amount
Amount
Available (1)
Carrying
Value (2)
Weighted
Average

Debt
Outstanding
Weighted
Average
Interest

Rate

SPV Asset Facility

$ 350.0 $ 276.7 $ 73.3 $ 276.7 $ 263.6 2.42 %

Corporate Revolving Facility

200.0 100.2 99.8 100.2 101.6 3.00 %

2023 Unsecured Notes

50.0 50.0 50.0 50.0 6.50 %

2026 Unsecured Notes

135.0 135.0 135.0 87.8 4.21 %

InterNotes ®

4.0 %

Total Debt

$ 735.0 $ 561.9 $ 173.1 $ 561.9 $ 507.0 3.32 %

December 31, 2020
Aggregate Principal
Amount Committed
Drawn
Amount
Amount
Available (1)
Carrying
Value (2)
Weighted
Average
Debt
Outstanding
Weighted
Average
Interest
Rate

SPV Asset Facility

$ 350.0 $ 260.2 $ 89.8 $ 260.2 $ 235.3 2.63 %

Corporate Revolving Facility

200.0 149.9 50.1 149.9 150.4 2.93 %

2023 Unsecured Notes

50.0 50.0 50.0 15.0 6.49 %

InterNotes ®

16.4 16.4 16.4 20.4 6.40 %

Total Debt

$ 616.4 $ 476.5 $ 139.9 $ 476.5 $ 421.1 3.26 %

(1)

The amount available is subject to any limitations related to the respective debt facilities’ borrowing bases and foreign currency translation adjustments.

(2)

Amount presented excludes netting of deferred financing costs.

82


Table of Contents

SPV Asset Facility

On March 28, 2016, Crescent Capital BDC Funding, LLC (“CCAP SPV”), a wholly owned subsidiary of CCAP, entered into a loan and security agreement, as amended from time to time (the “SPV Asset Facility”) with us as the collateral manager, seller and equity holder, CCAP SPV as the borrower, the banks and other financial institutions from time to time party thereto as lenders, and Wells Fargo Bank, National Association (“Wells Fargo”), as administrative agent, collateral agent, and lender. We consolidate CCAP SPV in our consolidated financial statements and no gain or loss is recognized from the transfer of assets to and from CCAP SPV.

The maximum commitment amount under the SPV Asset Facility is $350 million, and may be increased with the consent of Wells Fargo or reduced upon our request. Proceeds of the advances under the SPV Asset Facility may be used to acquire portfolio investments, to make distributions to us in accordance with the SPV Asset Facility, and to pay related expenses. The maturity date is the earlier of (a) the date the borrower voluntarily reduces the commitments to zero, (b) June 22, 2026 and (c) the date upon which Wells Fargo declares the obligations due and payable after the occurrence of an Event of Default. Borrowings under the SPV Asset Facility bear interest at LIBOR plus a margin with no LIBOR floor. The margin is between 1.65% and 2.10% as determined by the proportion of liquid and illiquid loans pledged to the SPV Asset Facility. We pay unused facility fees of 0.50% per annum on committed but undrawn amounts under the SPV Asset Facility. The unused facility fee rate may vary based on the utilization. The SPV Asset Facility includes customary covenants, including certain limitations on the incurrence of additional indebtedness and liens, as well as usual and customary events of default for revolving credit facilities of this nature.

The facility size is subject to availability under the borrowing base, which is based on the amount of CCAP SPV’s assets from time to time, and satisfaction of certain conditions, including an asset coverage test and certain concentration limits.

Corporate Revolving Facility

On August 20, 2019, we entered into the “Corporate Revolving Facility” with Ally Bank, as Administrative Agent and Arranger. Proceeds of the advances under the Revolving Credit Agreement may be used to acquire portfolio investments, to make distributions to us in accordance with the Revolving Credit Agreement and to pay related expenses. The maximum principal amount of the Corporate Revolving Facility is $200 million, subject to availability under the borrowing base.

Borrowings under the Corporate Revolving Facility bear interest at LIBOR plus a 2.35% margin with no LIBOR floor. We pay unused facility fees of 0.50% per annum on committed but undrawn amounts under the Corporate Revolving Facility. The unused facility fee rate may vary based on the utilization. Interest is payable quarterly in arrears. Any amounts borrowed under the Corporate Revolving Facility, and all accrued and unpaid interest, will be due and payable, on August 20, 2024.

2023 Unsecured Notes

On July 30, 2020, we completed a private offering of $50.0 million aggregate principal amount of 5.95% senior unsecured notes due July 30, 2023 (the “2023 Unsecured Notes”). The 2023 Unsecured Notes were issued in two $25.0 million issuances on July 30, 2020 and October 28, 2020.

The 2023 Unsecured Notes will mature on July 30, 2023 and may be redeemed in whole or in part, at our option, at any time or from time to time at par plus a “make-whole” premium, if applicable. Interest on the 2023 Unsecured Notes is due and payable semiannually in arrears on January 30 th and July 30 th of each year. As of September 30, 2021, we were in compliance with the terms of the note purchase agreement governing the 2023 Unsecured Notes.

83


Table of Contents

2026 Unsecured Notes

On February 17, 2021, we completed a private offering of $135,000 aggregate principal amount of 4.00% senior unsecured notes due February 17, 2026 (the “2026 Unsecured Notes”). The initial issuance of $50,000 of 2026 Unsecured Notes closed February 17, 2021. The issuance of the remaining $85,000 of 2026 Unsecured Notes closed on May 5, 2021.

The 2026 Unsecured Notes will mature on February 17, 2026 and may be redeemed in whole or in part, at our option, at any time or from time to time at par plus a “make-whole” premium, if applicable. Interest on the 2026 Unsecured Notes is due and payable semiannually in arrears on February 17 th and August 17 th of each year. As of September 30, 2021, we were in compliance with the terms of the note purchase agreement governing the 2026 Unsecured Notes.

InterNotes ®

On January 31, 2020, in connection with the Alcentra Acquisition, we assumed direct unsecured fixed interest rate obligations or “InterNotes ® ”. The InterNotes ® bore interest at fixed interest rates ranging between 6.25% and 6.75% and offered a variety of maturities ranging between February 15, 2021 and April 15, 2022. We redeemed or paid down the remaining $16.4 million of InterNotes ® during the first quarter of 2021.

The summary of costs incurred in connection with the SPV Asset Facility, Corporate Revolving Facility, 2023 Unsecured Notes, 2026 Unsecured Notes and InterNotes ® for the three and nine months ended September 30, 2021 and 2020, is presented below:

$ in millions

For the three months ended
September 30,
For the nine months ended
September 30,
2021 2020 2021 2020

Borrowing interest expense

$ 4.2 $ 2.9 $ 11.7 $ 9.9

Unused facility fees

0.3 0.2 0.8 0.6

Amortization of financing costs

1.2 0.4 2.0 1.0

Total interest and other debt financing costs

$ 5.7 $ 3.5 $ 14.5 $ 11.5

Weighted average outstanding balance

$ 507.1 $ 410.9 $ 529.8 $ 405.9

To the extent we determine that additional capital would allow us to take advantage of additional investment opportunities, if the market for debt financing presents attractively priced opportunities, or if our Board otherwise determines that leveraging our portfolio would be in our best interest and the best interests of our stockholders, we may enter into new debt financing opportunities in addition to our existing debt. The pricing and other terms of any such opportunities would depend upon market conditions and the performance of our business, among other factors.

In accordance with applicable SEC staff guidance and interpretations, effective May 5, 2020 with shareholder approval, we, as a BDC, are permitted to borrow amounts such that our asset coverage ratio is at least 150% after such borrowing (if certain requirements are met), rather than 200%, as previously required. Short-term credits necessary for the settlement of securities transactions and arrangements with respect to securities lending will not be considered borrowings for these purposes. The amount of leverage that we employ depends on our Adviser’s and our Board’s assessment of market conditions and other factors at the time of any proposed borrowing.

As of September 30, 2021 and December 31, 2020, our asset coverage ratio was 205% and 217%, respectively. We may also refinance or repay any of our indebtedness at any time based on our financial condition and market conditions. See Note 6. Debt to our consolidated financial statements for more detail on the debt facilities.

STOCK REPURCHASE PROGRAM

On January 31, 2020, we entered into a $20.0 million repurchase plan which allowed us to purchase shares in the open market any time our common stock traded below 90% of the most recently disclosed net asset value per share. The plan was subject to compliance with our liquidity, covenant, leverage and regulatory requirements. Pursuant to the terms of the repurchase plan, repurchases began on March 2, 2020. On April 9, 2020, our Board of Directors unanimously approved the termination of the stock repurchase program.

84


Table of Contents

There was no stock repurchased for the nine months ended September 30, 2021. For the nine months ended September 30, 2020, we repurchased 192,415 shares at an average price per share, including commissions, of $11.48.

OFF BALANCE SHEET ARRANGEMENTS

Our investment portfolio may contain investments that are in the form of lines of credit or unfunded commitments which require us to provide funding when requested by portfolio companies in accordance with the terms of the underlying agreements. Unfunded commitments to provide funds to portfolio companies are not reflected on our Consolidated Statements of Assets and Liabilities. These commitments are subject to the same underwriting and ongoing portfolio maintenance as are the on-balance sheet financial instruments that we hold. Since these commitments may expire without being drawn, the total commitment amount does not necessarily represent future cash requirements. As of September 30, 2021 and December 31, 2020, we had aggregate unfunded commitments totaling $166.3 million and $80.8 million, respectively.

RECENT DEVELOPMENTS

On October 27, 2021, we entered into a senior secured revolving credit agreement (the “SMBC Corporate Revolving Facility”) with Sumitomo Mitsui Banking Corporation, as Administrative Agent, Collateral Agent and Lender and concurrently terminated our $200.0 million Corporate Revolving Facility with Ally Bank. The maximum principal amount of the SMBC Corporate Revolving Facility is $300.0 million, subject to availability under the borrowing base. Borrowings under the SMBC Corporate Revolving Facility bear interest at LIBOR plus 1.875% or 2.000%, subject to certain provisions in the SMBC Corporate Revolving Facility agreement, with no LIBOR floor. Any amounts borrowed under the SMBC Corporate Revolving Facility, and all accrued and unpaid interest, will be due and payable, on October 27, 2026.

On November 5, 2021, our Board of Directors declared the following cash dividends:

Cash Dividend Type

Record Date

Payment Date

Amount Per Share

Regular

December 31, 2021 January 17, 2022 $ 0.41

Special

December 3, 2021 December 15, 2021 $ 0.05

Special

March 4, 2022 March 15, 2022 $ 0.05

Special

June 3, 2022 June 15, 2022 $ 0.05

Special

September 2, 2022 September 15, 2022 $ 0.05

85


Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are subject to financial market risks, including valuation risk, interest rate risk and currency risk.

Valuation Risk

We have invested, and plan to continue to invest, in illiquid debt and equity securities of private companies. These investments will generally not have a readily available market price, and we will value these investments at fair value as determined in good faith by our Board in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we may realize amounts that are different from the amounts presented and such differences could be material. See Note 2. Summary of Significant Account Policies to our consolidated financial statements for more details on estimates and judgments made by us in connection with the valuation of our investments.

Interest Rate Risk

Interest rate sensitivity refers to the change in earnings that may result from changes in the level of interest rates. We also fund a portion of our investments with borrowings and our net investment income will be affected by the difference between the rate at which we invest and the rate at which we borrow. Accordingly, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

We regularly measure our exposure to interest rate risk. We assess interest rate risk and manage our interest rate exposure on an ongoing basis by comparing our interest rate-sensitive assets to our interest rate-sensitive liabilities. Based on that review, we determine whether or not any hedging transactions are necessary to mitigate exposure to changes in interest rates.

As of September 30, 2021, 99.7% of the investments at fair value in our portfolio were at variable rates, subject to interest rate floors. The SPV Asset Facility and Corporate Revolving Facility also bear interest at variable rates.

Assuming that our Consolidated Statements of Assets and Liabilities as of September 30, 2021 were to remain constant and that we took no actions to alter our existing interest rate sensitivity, the following table shows the annualized impact of hypothetical base rate changes in interest rates (considering interest rate floors for floating rate instruments):

$ in millions

Basis Point Change

Interest Income Interest Expense Increase (decrease)
in net assets
resulting from
operations

Up 300 basis points

$ 23.1 $ 11.3 $ 11.8

Up 200 basis points

12.7 7.5 5.2

Up 100 basis points

2.6 3.8 (1.2 )

Up 75 basis points

0.9 2.8 (1.9 )

Up 50 basis points

0.4 1.9 (1.5 )

Up 25 basis points

0.3 0.9 (0.6 )

Down 25 basis points

(0.1 ) (0.5 ) 0.4

Down 50 basis points

(0.1 ) (0.5 ) 0.4

Down 75 basis points

(0.1 ) (0.5 ) 0.4

Down 100 basis points

(0.1 ) (0.5 ) 0.4

Although we believe that this analysis is indicative of our existing sensitivity to interest rate changes, it does not adjust for changes in the credit market, credit quality, the size and composition of the assets in our portfolio and other business developments that could affect our net income. Accordingly, we cannot assure you that actual results would not differ materially from the analysis above.

86


Table of Contents

We may in the future hedge against interest rate fluctuations by using hedging instruments such as interest rate swaps, futures, options and forward contracts. While hedging activities may mitigate our exposure to adverse fluctuations in interest rates, certain hedging transactions that we may enter into in the future, such as interest rate swap agreements, may also limit our ability to participate in the benefits of lower interest rates with respect to our portfolio investments.

Currency Risk

From time to time, we may make investments that are denominated in a foreign currency. These investments are converted into U.S. dollars at the balance sheet date, exposing us to movements in foreign exchange rates. We may employ hedging techniques to minimize these risks, but we cannot assure you that such strategies will be effective or without risk to us. We may seek to utilize instruments such as, but not limited to, forward contracts to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates. To the extent the loan or investment is based on a floating rate, we may seek to utilize interest rate derivatives to hedge our exposure to changes in the associated rate. As of September 30, 2021, we had £21.2 million, €17.1 million and CAD $25.5 million notional exposure to foreign currency forward contracts related to investments totaling £20.8 million, €17.5 million and CAD $25.5 million at par.

ITEM 4.

CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2021. Based upon that evaluation and subject to the foregoing, our principal executive officer and principal financial officer concluded that, as of September 30, 2021, the design and operation of our disclosure controls and procedures were effective to accomplish their objectives at the reasonable assurance level.

(b) Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes maintaining records that in reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of our consolidated financial statements; providing reasonable assurance that receipts and expenditures of company assets are made in accordance with management authorization; and providing reasonable assurance that unauthorized acquisition, use or disposition of company assets that could have a material effect on our consolidated financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a material misstatement of our consolidated financial statements would be prevented or detected.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective as of September 30, 2021.

(c) Changes in Internal Control over Financial Reporting. There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2021, that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

87


Table of Contents

PART II. OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

We are party to certain lawsuits in the normal course of business, including proceedings relating to the enforcement of our rights under loans to or other contracts with our portfolio companies. Furthermore, third parties may try to seek to impose liability on us in connection with our activities or the activities of our portfolio companies. While the outcome of any such legal proceedings cannot at this time be predicted with certainty, we do not expect that these legal proceedings will materially affect our business, financial condition or results of operations.

ITEM 1A.

RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which could materially affect our business, financial condition and/or operating results. These risks are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Stock Repurchase Program

On January 31, 2020, we entered into a $20.0 million repurchase plan, which allowed us to purchase shares in the open market any time our common stock traded below 90% of the most recently disclosed net asset value per share. The plan was subject to compliance with our liquidity, covenant, leverage and regulatory requirements. Pursuant to the terms of the repurchase plan, repurchases began on March 2, 2020. We have provided our stockholders with notice of our ability to repurchase shares of our common stock in accordance with 1940 Act requirements. We have retired all such shares of common stock that we purchased in connection with the stock repurchase program. On April 9, 2020, our Board of Directors unanimously approved the termination of our stock repurchase program.

The following table presents information with respect to our stock repurchase program during the three and nine months ended September 30, 2021 and 2020.

($ in millions except per share price)

Three Months Ended
September 30, 2021
Three Months Ended
September 30, 2020
Nine months ended
September 30, 2021
Nine months ended
September 30, 2020

Dollar amount repurchased

$ $ $ $ 2.2

Shares repurchased

192,415

Average price per share including commission

$ $ $ $ 11.48

Weighted average discount to net asset value

40.89 % (1)

(1)

Weighted average discount is calculated using the December 31, 2019 proforma combined NAV of $19.42 per share assuming the effect of the Alcentra Acquisition.

88


Table of Contents

Sun Life Purchase Program

On May 17, 2021, Sun Life Financial Inc., the majority owner of Crescent Capital Group LP, our investment advisor, caused Sun Life Assurance Company of Canada, a wholly owned subsidiary of Sun Life, to enter into a $10.0 million stock purchase program (the “Sun Life purchase program”) that makes open-market purchases of shares of our common stock. The Sun Life purchase program, which commenced on June 29, 2021, purchased 405,500 shares of our common stock at an average price per share (inclusive of commissions paid) of $18.90 (totaling $7.7 million) through September 30, 2021. Purchases of our common stock pursuant to the Sun Life purchase program are subject to certain conditions as set forth in the program and are conducted in accordance with Rules 10b5-1 and 10b-18 under the Securities and Exchange Act of 1934, as amended and other applicable securities laws and regulations that set certain restrictions on the method, timing, price, and volume of stock purchases.

Affiliate Purchase Program

An entity owned by certain officers of Crescent Capital BDC, Inc. and employees and affiliates of Crescent has implemented a stock purchase program (the “affiliate purchase program”). The affiliate purchase program, which totals $1.2 million in commitments, commenced on April 12, 2021, and is expected to be in effect through March 31, 2022, unless extended, or until the aggregate approved purchase amount has been expended. The affiliate purchase program is expected to make open-market purchases of shares of our common stock at then-current market prices at any time shares trade at or below 95% of the most recently disclosed net asset value per share, as set forth in the affiliate purchase program. From April 12, 2021 through September 30, 2021, the affiliate purchase program purchased 46,484 shares of our common stock at an average price per share (inclusive of commissions paid) of $18.72 (totaling $0.9 million). The affiliate purchase program is the third such plan implemented on behalf of certain officers of Crescent Capital BDC, Inc. and affiliates and employees of Crescent since the public listing, following the cumulative purchase of approximately $4.9 million of our common stock pursuant to the first two plans. Purchases of our common stock pursuant to the affiliate purchase program will be subject to certain conditions as set forth in such program and will be conducted in accordance with Rules 10b5-1 and 10b-18 under the Securities and Exchange Act of 1934, as amended and other applicable securities laws and regulations that set certain restrictions on the method, timing, price, and volume of stock purchases.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.

OTHER INFORMATION

None.

89


Table of Contents
ITEM 6.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

The following documents are filed as part of this Quarterly Report:

1. Financial Statements—Financial statements are included in Item 1. See the Index to the Consolidated Financial Statements on page F-1 of this quarterly report on Form 10-Q.
2 Financial Statement Schedules—None. We have omitted financial statements schedules because they are not required or are not applicable, or the required information is shown in the consolidated financial statements or notes to the consolidated financial statements included in this quarterly report on Form 10-Q.
3. Exhibits—The following is a list of all exhibits filed as a part of this quarterly report on Form 10-Q, including those incorporated by reference.
2.1 Agreement and Plan of Merger, dated August 12, 2019, by and among the Company, Atlantis Acquisition Sub, Inc., Alcentra Capital Corporation and Crescent Cap Advisors, LLC (formerly CBDC Advisors, LLC) (incorporated by reference to Exhibit 2.1 to the Company’s current report on Form 8-K filed on August 13, 2019).
2.2 Amendment No. 1, dated September 27, 2019, to Agreement and Plan of Merger by and among the Company, Atlantis Acquisition Sub, Inc., Alcentra Capital Corporation and Crescent Cap Advisors, LLC (incorporated by reference to Annex B to the Company’s Preliminary Proxy Statement filed on October 3, 2019.
2.3 Agreement and Plan of Merger, dated September 27, 2019, by and between the Company and Crescent Reincorporation Sub, Inc. (incorporated by reference to Exhibit 2.3 to the Company’s quarterly report on Form 10-Q filed on November 7, 2019).
3.1 Articles of Amendment and Restatement (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on January 30, 2020).
3.2 Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company’s Form 8-K filed on January 30, 2020).
4.1 Amended and Restated Dividend Reinvestment Plan (incorporated by reference to Exhibit 4.1 to the Company’s Form 10-K filed on March 4, 2020).
4.2 Description of Securities (incorporated by reference to Exhibit 4.27 to the Company’s current report on Form 10-K filed on February 24, 2021).
10.1 Amended and Restated Investment Advisory Agreement by and between the Company and Crescent Cap Advisors, LLC (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on February 3, 2020).
10.2 Loan and Security Agreement, dated August 20, 2019, by and among the Company, as the Borrower, and certain banks and other financial intuitions party thereto from time to time as lenders and Ally Bank, as administrative agent, arranger and lender (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on August 20, 2019).
10.3 Amended and Restated Administration Agreement by and between the Company and CCAP Administration LLC (incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed on February 3, 2020).
10.4 Trademark License Agreement, dated April 30, 2015, by and between the Company and Crescent (incorporated by reference to Exhibit 10.3 to the Company’s Registration Statement on Form 10 (File No. 000-55380) filed on June 5, 2015).
10.5 Form of Indemnification Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Form 8-K filed on January 31, 2020).
10.6 Form of Advisory Fee Waiver Agreement by and between the Company and the Adviser (incorporated by reference to Exhibit 10.4 to the Company’s Registration Statement on Form 10 (File No. 000-55380) filed on June 5, 2015).
10.7 Amended and Restated Advisory Fee Waiver Agreement, dated August 7, 2018, by and between the Company and the Adviser (incorporated by reference to Exhibit 10.11 to the Company’s current report on Form 10-Q filed on August 10, 2018).
10.8 Form of Subscription Agreement (incorporated by reference to Exhibit 10.5 to the Company’s Registration Statement on Form 10 (File No. 000-55380) filed on June 5, 2015).

90


Table of Contents
10.9 Custodial Agreement, dated as of May 21, 2021, by and between the Company and U.S. Bank National Association (incorporated by reference to Exhibit 10.9 to the Company’s current report on Form 10-Q filed on August 11, 2021).
10.10 Transaction Support Agreement, dated August 12, 2019, between Crescent Capital BDC, Inc. and Crescent Cap Advisors, LLC (f/k/a CBDC Advisors, LLC) (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 814-01132), filed on August 13, 2019).
10.11 Conformed Loan and Security Agreement (conformed through Amendment No. 4) (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on March 17, 2020).
10.12 Fifth Amendment to Loan and Security Agreement, dated June 21, 2021, among Crescent Capital BDC, Inc., as the collateral manager, seller and equityholder, Crescent Capital BDC Funding, LLC, as the borrower, the banks and other financial institutions from time to time party thereto as lenders, and Wells Fargo Bank, National Association, as administrative agent, collateral agent, and lender (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on June 25, 2021).
10.13 Second Amendment to the Loan and Security Agreement, dated July 14, 2020, by and among the Company, as the Borrower, and certain banks and other financial institutions party thereto from time to time as lenders and Ally Bank, as administrative agent, arranger and lender (incorporated by reference to Exhibit 10.19 to the Company’s Current Report on Form 10-Q, filed on August 10, 2020).
10.14 Master Note Purchase Agreement, dated July 30, 2020, by and among Crescent Capital BDC, Inc. and the Purchasers signatory thereto (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on July 30, 2020).
10.15 Form of 5.95% Series 2020A Senior Notes due July 30, 2023 (included in Exhibit 10.20).
10.16 First Supplement and Amendment to Note Purchase Agreement, dated February 17, 2021, by and among Crescent Capital BDC, Inc. and the Purchasers signatory thereto (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on February 17, 2021).
10.17 Form of 4.00% SERIES 2021A Senior Note Due February 17, 2026 (included in Exhibit 10.22).
10.18 Senior Secured Revolving Credit Agreement dated October  27, 2021, by and among Crescent Capital BDC, Inc. as the Borrower, certain lenders party thereto and Sumitomo Mitsui Banking Corporation, as administrative agent, arranger, and lender (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on October 29, 2021).
14.1 Code of Ethics (incorporated by reference to Exhibit 14.1 to the Company’s Form 10-K filed on March 4, 2020).
21.1 Subsidiaries of Crescent Capital BDC Inc. (incorporated by reference to Exhibit 21.1 to the Company’s current report on Form 10-K filed on February 24, 2021).
31.1 Certification of Chief Executive Officer, Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
31.2 Certification of Chief Financial Officer, Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
32 Certification of Chief Executive Officer and Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).

91


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Crescent Capital BDC, Inc.
Date: November 10, 2021 By:

/s/ Jason A. Breaux

Jason A. Breaux
Chief Executive Officer
Date: November 10, 2021 By:

/s/ Gerhard Lombard

Gerhard Lombard
Chief Financial Officer

92

TABLE OF CONTENTS
Note 1. Organization and Basis Of PresentationNote 2. Summary Of Significant Accounting PoliciesNote 3. Agreements and Related Party TransactionsNote 4. InvestmentsNote 5. Fair Value Of Financial InstrumentsNote 6. DebtNote 7. DerivativesNote 8. Commitments, Contingencies and IndemnificationsNote 9. Stockholders EquityNote 10. Earnings Per ShareNote 11. Income TaxesNote 12. Financial HighlightsNote 13. Alcentra AcquisitionNote 14. Stock Repurchase ProgramNote 15. Subsequent EventsItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II. Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits and Financial Statement Schedules

Exhibits

2.1 Agreement and Plan of Merger, dated August12, 2019, by and among the Company, Atlantis Acquisition Sub, Inc., Alcentra Capital Corporation and Crescent Cap Advisors, LLC (formerly CBDC Advisors, LLC) (incorporated by reference to Exhibit 2.1 to the Companys current report on Form8-Kfiled on August13, 2019). 2.3 Agreement and Plan of Merger, dated September27, 2019, by and between the Company and Crescent Reincorporation Sub, Inc. (incorporated by reference to Exhibit 2.3 to the Companys quarterly report on Form10-Qfiled on November7, 2019). 3.1 Articles of Amendment and Restatement (incorporated by reference to Exhibit 3.1 to the Companys Form8-Kfiled on January30, 2020). 3.2 Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Companys Form8-Kfiled on January30, 2020). 4.1 Amended and Restated Dividend Reinvestment Plan (incorporated by reference to Exhibit 4.1 to the Companys Form10-Kfiled on March4, 2020). 4.2 Description of Securities (incorporated by reference to Exhibit 4.27 to the Companys current report on Form10-Kfiled on February24, 2021). 10.1 Amended and Restated Investment Advisory Agreement by and between the Company and Crescent Cap Advisors, LLC (incorporated by reference to Exhibit 10.1 to the Companys Form8-Kfiled on February3, 2020). 10.2 Loan and Security Agreement, dated August20, 2019, by and among the Company, as the Borrower, and certain banks and other financial intuitions party thereto from time to time as lenders and Ally Bank, as administrative agent, arranger and lender (incorporated by reference to Exhibit 10.1 to the Companys Form8-Kfiled on August20, 2019). 10.3 Amended and Restated Administration Agreement by and between the Company and CCAP Administration LLC (incorporated by reference to Exhibit 10.2 to the Companys Form8-Kfiled on February3, 2020). 10.4 Trademark License Agreement, dated April30, 2015, by and between the Company and Crescent (incorporated by reference to Exhibit 10.3 to the Companys Registration Statement on Form 10 (File No.000-55380)filed on June5, 2015). 10.5 Form of Indemnification Agreement (incorporated by reference to Exhibit 10.3 to the Companys Form8-Kfiled on January31, 2020). 10.6 Form of Advisory Fee Waiver Agreement by and between the Company and the Adviser (incorporated by reference to Exhibit 10.4 to the Companys Registration Statement on Form 10 (File No.000-55380)filed on June5, 2015). 10.7 Amended and Restated Advisory Fee Waiver Agreement, dated August7, 2018, by and between the Company and the Adviser (incorporated by reference to Exhibit 10.11 to the Companys current report on Form10-Qfiled on August10, 2018). 10.8 Form of Subscription Agreement (incorporated by reference to Exhibit 10.5 to the Companys Registration Statement on Form 10 (File No.000-55380)filed on June5, 2015). 10.9 Custodial Agreement, dated as of May21, 2021, by and between the Company and U.S. Bank National Association (incorporated by reference to Exhibit 10.9 to the Companys current report on Form10-Qfiled on August11, 2021). 10.10 Transaction Support Agreement, dated August12, 2019, between Crescent Capital BDC, Inc. and Crescent Cap Advisors, LLC (f/k/a CBDC Advisors, LLC) (incorporated by reference to Exhibit 10.1 to the Companys Current Report on Form8-K(File No.814-01132),filed on August13, 2019). 10.11 Conformed Loan and Security Agreement (conformed through Amendment No.4) (incorporated by reference to Exhibit 10.1 to the Companys Form8-Kfiled on March17, 2020). 10.12 Fifth Amendment to Loan and Security Agreement, dated June21, 2021, among Crescent Capital BDC, Inc., as the collateral manager, seller and equityholder, Crescent Capital BDC Funding, LLC, as the borrower, the banks and other financial institutions from time to time party thereto as lenders, and Wells Fargo Bank, National Association, as administrative agent, collateral agent, and lender (incorporated by reference to Exhibit 10.1 to the Companys Form8-Kfiled on June25, 2021). 10.13 Second Amendment to the Loan and Security Agreement, dated July14, 2020, by and among the Company, as the Borrower, and certain banks and other financial institutions party thereto from time to time as lenders and Ally Bank, as administrative agent, arranger and lender (incorporated by reference to Exhibit 10.19 to the Companys Current Report on Form10-Q,filed on August10, 2020). 10.14 Master Note Purchase Agreement, dated July30, 2020, by and among Crescent Capital BDC, Inc. and the Purchasers signatory thereto (incorporated by reference to Exhibit 10.1 to the Companys Form8-Kfiled on July30, 2020). 10.15 Form of 5.95% Series 2020A Senior Notes due July30, 2023 (included in Exhibit 10.20). 10.16 First Supplement and Amendment to Note Purchase Agreement, dated February17, 2021, by and among Crescent Capital BDC, Inc. and the Purchasers signatory thereto (incorporated by reference to Exhibit 10.1 to the Companys Form8-Kfiled on February17, 2021). 10.17 Form of 4.00% SERIES 2021A Senior Note Due February17, 2026 (included in Exhibit 10.22). 10.18 Senior Secured Revolving Credit Agreement dated October 27, 2021, by and among Crescent Capital BDC, Inc. as the Borrower, certain lenders party thereto and Sumitomo Mitsui Banking Corporation, as administrative agent, arranger, and lender (incorporated by reference to Exhibit 10.1 to the Companys Form8-Kfiled on October29, 2021). 14.1 Code of Ethics (incorporated by reference to Exhibit 14.1 to the Companys Form10-Kfiled on March4, 2020). 21.1 Subsidiaries of Crescent Capital BDC Inc. (incorporated by reference to Exhibit 21.1 to the Companys current report on Form10-Kfiled on February24, 2021). 31.1 Certification of Chief Executive Officer, Pursuant to Rule13a-14(a),as Adopted Pursuant to Section302 of the Sarbanes-Oxley Act of 2002 (filed herewith). 31.2 Certification of Chief Financial Officer, Pursuant to Rule13a-14(a),as Adopted Pursuant to Section302 of the Sarbanes-Oxley Act of 2002 (filed herewith). 32 Certification of Chief Executive Officer and Chief Financial Officer, Pursuant to 18 U.S.C. Section1350, as Adopted Pursuant to Section906 of the Sarbanes-Oxley Act of 2002 (filed herewith).